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Chapter 1 
 
Introduction 
 
 
 
 
 
In this chapter
* the discovery of chirality, more than 200 years ago, is described 
and examples are given of optically pure compounds that are a part of our daily 
life. Furthermore, this chapter describes the most common methods for the 
production of optically pure compounds synthesized from other optically pure 
compounds, from pro-chiral compounds or from racemates. At the end of this 
chapter the aim and outline of this thesis are presented. 
 
* Parts of this chapter have been used for the preparation of Comprehensive Biotechnology 
2nd Ed., Chiral Separations, Chapter 128, to be published in 2011.  
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1.1   History 
More than two hundred years ago, in 1801, the French mineralogist René-Just  Haüy 
observed that quartz crystals showed hemihedral behavior, in other words, certain facets of 
the crystals are mirror images of each other.
1 In 1815, Jean-Baptiste  Biot showed that 
polarized light, when passed through an (enantiomerically enriched, to use modern 
terminology) organic liquid or solution, could be rotated clockwise or counterclockwise.
2 
In 1844, Eilhard Mitscherlich, a German scientist, examined the sodium ammonium salts of 
both enantiomerically pure and racemic tartaric acid. At that time, the main source of 
optically pure tartaric acid was potassium bitartrate, which is abundant in the sediments 
from fermenting wine. Often, another form of tartaric acid, “racemic acid” (Latin racemus 
meaning “bunch of grapes”), was found in wine barrels. Mitscherlich found that the crystals 
from enantiomerically pure and racemic sodium ammonium tartrate were identical in 
crystalline form, except that upon dissolution the former rotated polarized light whereas the 
latter did not.
3 
 
Figure 1.1 Louis Pasteur working in his laboratory as painted by Robert 
Thom. 
In 1848, Louis Pasteur (depicted in Figure 1.1) at age 26, was working on his doctorate on 
crystallization of salts of tartaric acid as a student of Biot. Pasteur could not believe that 
“tartaric acid” and “racemic acid” were the same and suspected that Mitscherlich had 
overlooked something.   
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Indeed, Pasteur observed that the crystals of natural sodium ammonium tartrate were all 
identical but that the crystals from sodium ammonium tartrate from racemic acid were a 
mixture of two mirror image crystals, which can be distinguished by the hemihedral facets 
of the crystals as depicted in Figure 1.2. He separated the right and left handed crystals into 
two piles. Despite the near universality of the story, since the crystals crumble very easily it 
is unlikely that Pasteur used a pair of tweezers to pick out the crystals.
4 Upon dissolution of 
equal amounts of each of these piles, he noticed that the solution from one pile rotated 
polarized light clockwise (levorotary) and the solution of the other pile provided the same 
magnitude of rotation but counterclockwise (dextrorotary).
5 The former pile consisted thus 
of levo or L-sodium ammonium tartrate and the latter of dextro or D-sodium ammonium 
tartrate. With this experiment Pasteur performed the first resolution (separation of mirror 
image compounds: enantiomers) and proved that racemic acid is a 1:1 mixture of left and 
right handed sodium ammonium tartrate.
6 Today, 1:1 mixtures of opposite enantiomers are 
called ‘racemates’.  
 
(R) NaO2C
OH
CO2NH4
OH
(S)
(R) CO2Na
OH
H4NO2C
OH
(R)
Mirror
 
Figure 1.2 The mirror imaged crystals and enantiomers of sodium 
ammonium tartrate. 
The story has a fascinating footnote that we can understand today. Pasteur obtained the 
crystals of racemic sodium ammonium tartrate from a man called Kestner, a French 
manufacturer. We now know that racemic sodium ammonium tartrate can occur in two 
crystalline forms: ‘conglomerate’ and ‘racemic compound’. The material Pasteur used was 
the conglomerate in which the enantiomers crystallize as separate crystals as Pasteur 
observed. This is relatively rare: only roughly 10% of chiral organic compounds crystallize 
as conglomerates. The other 90% crystallize as racemic compounds in which the 
enantiomers pair with each other and cannot be physically separated. With sodium 
ammonium tartrate the balance between the conglomerate and the racemic compound is 
extremely delicate: the conglomerate crystallizes as a tetrahydrate below 27°C. However, 
the racemic compound was only slightly less stable than the conglomerate and thus can 
form spontaneously by crystallization.
7 Pasteur had the good fortune to get the 
conglomerate form from Kestner. Other suppliers apparently used a somewhat other  
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different isolation process and provided the racemic compound used by others who tried, 
with striking lack of success, to repeat the Pasteur experiments.
8 
A few years later, in 1853, Pasteur synthesized quinotoxine,
9 which is a rearrangement 
product of quinine or quinidine on heating in dilute sulfuric acid. Two of the four chiral 
centers are removed in this reaction which is depicted in Scheme 1.1. In a similar fashion, 
cinchotoxine was prepared from cinchonine or cinchonidine.
10 The salt of quinotoxine with 
racemic tartaric acid was crystallized and showed enrichment in L-tartaric acid. 
Furthermore, crystallization of the salts of cinchotoxine with racemic tartaric acid gave salts 
that were enriched in D-tartaric acid.
11 Nearly one hundred years later, Woodward and 
Doering repeated this experiment as part of their total synthesis of quinine and showed that 
Pasteur most likely isolated the hexahydrate of the quinotoxine-L-tartrate.
12 With these 
experiments, Pasteur gave life to resolution by diastereomeric salt formation, a process left 
largely unaltered to this day. 
N
O
NH
R
HO
R
N
H
H
H
HO
R
N
H
H
H
H2SO4
H2O, ∆
OR
R= H: cinchonine
     OMe: quinidine
R= H: cinchonidine
     OMe: quinine
R= H: cinchotoxine
     OMe: quinotoxine
 
Scheme 1.1 Synthesis of quinotoxine and cinchotoxine. 
Later, in 1858, Pasteur reported that natural L-ammonium tartrate was digested by the 
mould  Penicillium Glaucum and the D-enantiomer was left untouched. Pasteur hereby 
performed the first kinetic resolution.
13,14 Penicillium Glaucum is used in blue cheeses like 
gorgonzola
15 and, as the name suggests, possesses anti-bacterial activity.
16 
Also in 1858, Friedrich August Kekulé von Stradonitz suggested the tetravalency of carbon, 
which implies that a carbon atom can form bonds to four other atoms.
17 Several years later,  
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in 1874, Jacobus Henricus van 't Hoff
18 (the first winner of the Nobel prize for chemistry, 
however, not for the tetraedric carbon
19) and  Joseph Achille Le Bel,
20 nearly simultaneous 
proposed the theory of the position of atoms in space and the tetrahedral carbon. A carbon 
atom, surrounded by four different moieties, can exist as two mirror image molecules: 
enantiomers (Greek enantios = opposite, meros = part
21) as depicted in Scheme 1.2. These 
enantiomers have the same physical properties except for the rotation of polarized light, as 
Pasteur observed also. In 1883, Lord Kelvin
22 proposed the term ‘chirality’, derived from 
the Greek word kheir for handedness. 
CO2H H2N
CH3
H
CO2H H2N
CH3
H
L-alanine D-alanine  
Scheme 1.2 The enantiomers of alanine. 
In most organisms, amino acids like alanine (Scheme 1.2), only exist in the L-form. 
Furthermore, sugars exist only in the D-form. This phenomenon whereby compounds 
closely related in structure (families) have identical absolute configurations is known as 
homochirality.
23  
Today, the D and L designations are mainly used in biology for amino acids and 
carbohydrates. However, chemists prefer the designations R (for rectus) and S (for sinister) 
for chiral molecules. The designation depends on the difference in atom weight of the four 
substituents of the chiral atom (chiral centre). With these designations, each chiral centre 
can have either an R or S label and thus multiple chiral centers in a single molecule can be 
assigned, impossible with the D/L system. 
CO2H HO
CO2H
(R)
(R) HO
L-tartaric acid D-tartaric acid mesotartaric acid
enantiomers
diastereomers
CO2H HO
CO2H
(S)
(S) HO
CO2H HO
CO2H
(S)
(R) HO
plane of symmetry
 
Scheme 1.3 D- and L-tartaric acid, enantiomers. Mesotartaric acid is a 
diastereomer of these compounds.  
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By definition, stereo isomers that are not each others mirror image are diastereomers. An 
example is tartaric acid that is shown in Scheme 1.3. D- and L-tartaric acid are mirror 
images of each other and thus enantiomers. Mesotartaric acid however, has one different 
chiral center compared to either D- or L-tartaric acid and the latter are thus a diastereomers 
of mesotartaric acid. Due to the internal plane of symmetry in mesotartaric acid, the two 
chiral centers cancel each other out and the compound does not rotate light. 
1.2   Optically Pure Compounds in Our Daily Life 
More than half of the drugs marketed today are chiral and nonracemic.
24 Of course, the 
human body is also made of chiral molecules like enzymes, DNA and proteins. With this in 
mind, it is not hard to imagine that the enantiomers of chiral drugs can have different 
biological activities and toxicities.
25 Therefore, for drugs that enter the market today, the 
enantiomers have to be tested independently even when the drug is administered as a 
racemate. For example, penicillins (as depicted in Scheme 1.4) are only active on peptide 
links of D-alanine that occur in the cell walls of bacteria. The antibiotic can only kill 
bacteria and not human cells because the latter do not contain D-amino acids.
26 
N
S
H
N
O
O
R
OH
O  
Scheme 1.4 Penicillin core structure. 
The smell receptors in the nose are a striking example of the working of chirality. A famous 
example is limonene (depicted in Scheme 1.5). The (R)-enantiomer smells like orange 
whereas the (S)-enantiomer smells like lemon.
27 Limonene is also widely used as a 
biodegradable degreasing agent.
28 
(R)
(R)-(–)-limonene
(S)
(S)-(+)-limonene  
Scheme 1.5 The enantiomers of limonene.  
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The taste receptors on the tongue also can distinguish between enantiomers as demonstrated 
by carvone as shown in Scheme 1.6. The (S)-enantiomer tastes and smells like caraway 
(anise-like) whereas the (R)-enantiomer tastes and smells like spearmint.
27  
(S)
(S)-(+)-carvone
(R)
(R)-(–)-carvone
O O
 
Scheme 1.6 The enantiomers of carvone. 
Most of the naturally occurring (S)-amino acids taste sweet, whereas the unnatural 
(R)-enantiomers taste bitter.
29 The artificial sweetener, aspartame (as shown in Scheme 
1.7), is chiral and only the depicted enantiomer tastes sweet whereas the other taste bitter. 
Aspartame, which is not a sugar but a peptide, is 180–200 times sweeter than ordinary 
sugar.
30 
O O
(S)
N
H
(S) NH2
OH
O
O
 
Scheme 1.7 Aspartame, an artificial sweetener. 
Menthol is also a chiral compound, the (+)- and (–)-enantiomers are depicted in Scheme 
1.8. The naturally occurring (–)-menthol can be described as fresh, sweet, minty, cooling 
and refreshing. The (+)-isomer is similar, but less minty, herbier, with musty, bitter, 
phenolic and herbaceous notes, and this enantiomer is less refreshing. (–)-Menthol has also 
about four times more cooling power than the (+)-isomer because the heat receptors in the 
skin are also chiral.
31 
(S)
(R) (S)
OH
(+)-menthol
(R)
(S) (R)
OH
(–)-menthol  
Scheme 1.8 Both enantiomers of menthol.  
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O
C10H21
N
H
O
O
*
 
Scheme 1.9 Liquid crystal forming chiral compound. 
The role of chirality goes further than living organisms. The working of liquid crystal 
displays (LCD) is based on optically pure molecules, like the compound in Scheme 1.9. 
Such compounds are liquid crystals which mean that the liquid compound self orients into 
e.g. helical structures: so called twisted nematic (TN) liquid crystals. Displays containing 
these TN liquid crystals represent the majority of the consumer LCD’s.
32 
 
 
Figure 1.3 Schematic projection of an LCD pixel.
33 
The working of an LCD pixel is illustrated in Figure 1.3a. When ordinary light (L) is 
polarized (P2) and passed through a cell containing a twisted nematic liquid crystal (LC), 
which is placed in between two glass plates (G),  this polarized light is rotated exactly 
90°C. This light then passes through another polarizer (P1) which is placed perpendicular to 
P2. In this manner, the cell (or pixel) looks white. However, if a current is placed (S) over 
the electrodes (E1 and E2), the molecules in the liquid crystal orient themselves towards the  
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current of the electrons. The polarized light is not rotated in this medium and is then 
blocked by the perpendicular polarizer P1. The pixel in this case appears black as shown in 
Figure 1.3b.
34 
1.3   Calculations 
The enantio purity of enantiomers is usually expressed as enantiomeric excess (ee) and the 
diastereomeric purity of diastereomers as diastereomeric excess (de). These parameters can 
be calculated from the relative amounts of each enantiomer (p and q) or diastereomer (ap 
and aq) with Equation 1.1. 
For example, the de of diastereomeric salts can be measured by chiral HPLC. Samples are 
liberated before injection or on column by the eluent thus the ee is measured by chiral 
HPLC. The areas under the peaks of both enantiomers are taken for ap and aq. Presuming 
the resolving agent is optically pure, the de equals the ee. In racemates, the area under both 
peaks is equal thus the ee is 0%. 
100 (%) ×
+
−
=
q p
q p
ee         100 (%) ×
+
−
=
aq ap
aq ap
de  
Equation 1.1 Calculation of the ee and de from the amounts of 
enantiomers or diastereomers. 
To compare resolutions, Fogassy
35 introduced the resolution efficiency or resolvability (S). 
This S-factor ranges from 0 (no resolution) to 1 (perfect resolution) and is calculated with 
Equation 1.2. 
2 × × = Y de S  
Equation 1.2 The S-factor. 
Wherein de is the diastereomeric excess of the first salt and Y is the yield, both ranging 
from 0 to 1. In a resolution without racemization, the maximum yield for a single 
diastereomer is thus 0.5. The factor 2 adjusts the S-factor to a value between 0 and 1. 
Often, the purity of the crystals from diastereomeric salts suffer from some incorporation of 
the one other diastereomer in the other diastereomer producing impure crystals.
71 This 
phenomenon is known as an end-solid solution.
36 The S-factor is only useful to compare 
resolutions that have the same amount of end-solid solution. Since the amount of end-solid 
solution is in general not known and end-solid solutions are very common in diastereomeric  
 
 
 
 
 
 
CHAPTER 1 
10
salt formations, it is only suitable for comparing the effectiveness of additives for 
nucleation inhibition effects as in Chapter 3. 
1.4   Methods for the Preparation of Optically Pure 
Compounds 
The sourcing of enantiopure materials has become a very important issue over the years.
37 
There are several methods to arrive at a desired optically pure compound. A summary of 
the most frequently used methodologies is given in Scheme 1.10. A brief explanation and 
example of each of the techniques is given in the following paragraphs. 
chiral pool
prochiral 
substrates
racemates
chromatographic
resolution kinetic resolution direct
crystallization
resolution by 
diasteromer
formation
synthesis
chiral
auxiliary biocatalysis chemocatalysis
Enantiopure compounds
 
Scheme 1.10 Routes to enantiopure compounds. 
1.4.1  Chiral Pool 
Usually nature prepares chiral compounds an enantioselective fashion. These optical pure 
or enriched compounds (e.g. amino acids, alkaloids and carbohydrates) can then be 
harvested by extraction from e.g. leaves, bark or fermentation processes, can be further 
functionalized in subsequent synthesis. Although these chiral compounds are often 
relatively cheap, the subsequent synthesis can become more challenging if transformation 
to the desired product requires multiple steps.
38 Furthermore, usually only one  
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enantiomer/diastereomer is available, which might not be the enantiomer/diastereomer of 
interest. Natural amino acids are the most frequently used compounds from the chiral 
pool.
39 Other optically pure compounds are also available which are produced on a large 
scale and thus available at a relatively low price. These compounds form, what is known as, 
the extended chiral pool. 
An example of a chiral drug which is synthesized from a compound from the chiral pool is 
Lipitor made by Pfizer.
40 Lipitor is a cholesterol lowering agent which is sold as the 
calcium salt and is the largest selling brand-name drug in the world for the last couple of 
years with sales of US$6.17 billion in 2007.
41 An overview of the synthesis of Lipitor is 
given in Scheme 1.11. 
N
OH OH
CO2
HN
O
F
Lipitor
HO2C
OH
CO2H
L-malic acid
OH
CO2Et
NC
1.1
OH
NC
1.2
OH
CO2t-Bu
O
1.3
O
CO2t-Bu
H2N
O
HN
O
O
HN
O
O
F
1.4
1.5
1.3
N
O O
CO2t-Bu
HN
O
F
1.6
2
Ca2
+
 
Scheme 1.11 Synthesis of Lipitor starting from L-malic acid. 
Starting from L-malic acid (available from the chiral pool) a nitrile group is introduced to 
give  1.1. This nitrile group is later used in the coupling with building block 1.5. 
Subsequently, a second chiral centre is introduced whose chirality is controlled by the 
hydroxyl group in compound 1.1. Compound 1.2 is then reduced and protected to give 
building block 1.3. Compound 1.6 is synthesized by a Paal-Knorr condensation of building  
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block  1.3 and compound 1.5. The latter was synthesized by a Stetter reaction from 
compound  1.4. Deprotection and subsequently isolation as the calcium salt furnishes 
Lipitor.
 42 
1.4.2  Prochiral Substrates 
Achiral compounds that can be made into a chiral compound by a chemical reaction are 
called prochiral substrates. For example, if an addition to a double bond eliminates the 
planes of symmetry, chiral centers are created. If the stereoselectivity of a reaction is not 
high enough, one might consider to use a technique from §1.4.3 to raise the optical purity 
of this partially enriched material to a satisfactory high level.
43 
1.4.2.1  Chiral Auxiliary
44 
Another approach is to use the chirality of an inexpensive compound,  a chiral auxiliary, to 
induce new chiral molecules preferably with high stereoselectivity. After the chirality 
transfer, the chiral auxiliary can be removed completely or a part of the chiral auxiliary 
might be retained. The latter is exemplified by the synthesis of (R)-1-phenylbut-3-en-1-
amine (1.14) as given in Scheme 1.12. 
Imine 1.9 is synthesized starting from (R)-phenylglycinamide (1.7) and benzaldehyde (1.8). 
Subsequent reaction with allylzinc (1.10) gives compound 1.11 in a highly stereoselective 
manner with a diastereomeric ratio (dr) of 99:1. The authors propose a mechanism which is 
controlled by chelation of zinc to both the amide oxygen and the imine nitrogen. The non-
reductive removal of the chiral auxiliary from 1.11 is performed in three steps to give 
alkene  1.14 which can then be further functionalized. Although the synthesis is quite 
lengthy, the overall yield is 65%, which is better than a resolution without racemization 
(§1.4.3). 
1.4.2.2  Biocatalysis 
The synthesis of optically pure compounds can also be achieved by biocatalysis, using 
enzymes.
38 In the example below, optically pure amino alcohols are prepared by an enzyme 
catalyzed reaction in which an optically pure cyanohydrin (1.16) is synthesized from a 
prochiral aldehyde (1.15) which is then reduced to amino alcohol 1.17 as shown in Scheme 
1.13.
45 Although the process delivers amino alcohol 1.17 in high enantiomeric excesses 
(ee), the process requires liquid hydrogen cyanide, which is extremely toxic.  
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Scheme 1.12 Synthesis of a optically pure amine which can be further 
functionalized.  
Enzymes may be altered by genetic modifications and thereby improving the activities, 
stabilities and/or enantioselectivities of the enzyme.
46 Although enzymes can deliver high 
ee’s with high yields, they are notoriously difficult to remove from the reaction mixture.
47 
However, by immobilization on a carrier
48 or genetic modification
49 the removal of 
enzymes can be made easier. 
NH2
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O
CN
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O
O
O
H
HCN, HbHNL
TBME / buffer
pH 4.9, 0oC
NaBH4
CF3COOH
THF
1.15 1.16
 >99.5%ee
1.17
>99.5%ee  
Scheme 1.13 Synthesis of optically pure (R)-2-amino-1-(2-furyl)ethanol. 
1.4.2.3  Chemocatalysis 
Using optically pure catalysts, prochiral substrates can often be converted to chiral 
compounds with high selectivity. These catalysts can be completely organic in nature (for 
example proline
50) or contain a transition metal which coordinates to an organic chiral 
ligand. An example of the latter is given in Scheme 1.14.  
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Scheme 1.14 Asymmetric catalytic homogeneous hydrogenation. 
The Z-double bond in compound 1.18 is reduced with hydrogen and a rhodium/Monophos 
based catalyst to give compound 1.19 in high ee.
51 Monophos based catalysts have been 
used by DSM for large scale synthesis of pharmaceutical intermediates.
52 The downside of 
metal-based catalysts is that the transition metals used are often very expensive, toxic and 
often difficult to remove.
53  
1.4.3  Resolution of Racemates
54 
Often, only racemic or partly enriched materials
55 are available and both enantiomers need 
to be separated. Several techniques are available to chemists and these are described below. 
1.4.3.1  Chromatographic Resolution 
Chromatographic separation of compounds is a method based on the different affinities of a 
compound to the stationary phase (column material) and the mobile phase (eluent).
56 This 
means that a racemate can only be separated on a chiral column or on an achiral column 
with a chiral eluent.
57 The latter however, utilizes relatively expensive optically pure 
solvents or additives and hence, not used much.  
The bulk of chiral separations with column chromatography is performed on chiral columns 
with achiral eluents. These columns are available with a wide diversity of functionalized 
chiral groups e.g. cyclodextrins,
58 alkaloids
59 and antibiotics.
60  
For preparative separation of racemates, simulated moving bed chromatography (SMBC) is 
an attractive method. SMBC utilizes a number of identical columns and valves which 
simulates an indefinitely long column. By switching the columns one achieves an effect 
that the enantiomer that has the least affinity with the stationary phase moves in the 
opposite direction of the stationary phase, hence the name: simulated moving bed.
61 This is 
exemplified by the cartoon in Figure 1.4. 
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Figure 1.4 Visualization of the SMBC principle.
 62 
Separated enantiomers are removed via the valves and racemate is also introduced via these 
valves.
46 This continuous process is successfully used to separate a racemate on ton-scale 
and otherwise difficult to separate racemates.
63 The investment costs for SMBC approach 
are high and it’s used almost exclusively in industrial settings if other low-cost solutions 
fail. 
1.4.3.2  Kinetic Resolution 
If an enzyme
64 or other chiral catalyst
65 reacts selectively with only one enantiomer, for 
instance, acylating only the (R)-enantiomer, the product and the unreacted (S)-enantiomer 
can be conveniently separated by standard laboratory procedures like chromatography, 
crystallization, distillation or extraction. In 1858, Pasteur observed that a mold consumed 
only one enantiomer of ammonium tartrate, as described in §1.1.  
Kinetic resolution can also be performed with optically pure chemicals in which one 
enantiomer of the racemate reacts faster with the optically pure chemical as depicted in 
Scheme 1.15 for the reaction of racemic mandelic acid with optically pure menthol which 
was discovered in 1899.
66 Since (R)-mandelic acid reacts faster with (–)-menthol than 
(S)-mandelic acid, ester 1.21 is formed faster than ester 1.20 and the former can be isolated 
by extraction. When this particular reaction is allowed to react to completion, racemic 
mandelic acid will again be isolated after saponification. It is therefore necessary to isolate  
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the compounds when the optimal ratio of product and unreacted material is reached. This 
can also be true for enzyme catalyzed kinetic resolutions, which are not always specific for 
one enantiomer. Kinetic resolutions will give a maximum yield of 50% and 100% ee. 
OH
HO
(–)-menthol
(±)-mandelic acid
OH
O
(S)
OH
O
O
(S),(–)
(R)
OH
O
O
(R),(–)
+
H+
fast
slow
(S)
OH
OH
O
(R)
OH
OH
O
(S)-mandelic acid
(R)-mandelic acid
OH-
OH-
1.20
1.21  
Scheme 1.15 Kinetic resolution of racemic mandelic acid with menthol. 
When one enantiomer of the racemate is consumed by an enzyme or other chiral catalyst 
while the remaining unreacted material is racemized, one speaks of Dynamic Kinetic 
Resolution (DKR).
42,67 This process can in principle give 100% yield and 100% ee. An 
example of DKR is given in Scheme 1.16.
68 
When racemic phenylglycine amide (1.22) is mixed with one equivalent of (S)-mandelic 
acid (MA), a diastereomeric salt is formed and the less soluble diastereomer 1.25 
crystallizes.
69 The remaining solution is racemized with a small amount of benzaldehyde to 
produce an easily racemized Schiff base 1.23 which is in equilibrium with 1.22 which 
makes the solution again racemic in 1.22. By allowing the material to crystallize under 
racemizing conditions, a 97% yield is obtained with a de of >99%. After liberation of the 
salt, D-(+)-phenylglycine amide can be isolated with >99% ee. D-(+)-phenylglycine amide 
is used in the synthesis of a semi-synthetic antibiotic, Cephalexin.
70  
1.4.3.3  Direct Crystallization
38,71 
A compound is a conglomerate if both enantiomers of a racemate crystallize in two separate 
mirror imaged crystals.
72 Because of this behavior, conglomerates can in principle be 
separated manually.
73 This behavior is essential for resolution by direct crystallization. 
However, only roughly 10% of all racemates crystallize as conglomerates.
71  
Two different techniques can be applied in preferential crystallization: simultaneous 
crystallization and resolution by entrainment. In the former technique, a supersaturated  
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solution of a racemic conglomerate is allowed to crystallize in two separate crystallizers 
simultaneously. Each crystallizer contains seeds of the respective enantiomer. Before the 
other enantiomer starts to crystallize, the mixture is filtered and returned to a make-up 
vessel to restore the concentration to the former concentration. This procedure is then 
repeated. 
H2N
NH2
O
N
NH2
O
PhCHO
(racemization)
H3N
NH2
O
HO
O
O
H3N
NH2
O
HO
O
O
more soluble salt less soluble salt
97% yield
>99% selectivity
HCl, H2O
H2N
NH2
O
D-(+)-Phenylglycine amide
>99% ee
1.22
1.23
1.24 1.25
(S)-MA (S)-MA
 
Scheme 1.16 DKR of phenylglycine amide. 
A graphic representation of resolution by entrainment (or preferential crystallization) is 
shown in Figure 1.5 and explained below.  
1.  The resolution starts with a racemic mixture in a solvent which is artificially 
biased in the (S)-enantiomer and heated to dissolution. 
2.  The mixture is cooled to supersaturation of both enantiomers. The enantiomer with 
the highest concentration, (S), will start to crystallize first and its concentration 
will return to the saturation point. The (S)-enantiomer is collected by filtration 
before the supersaturated (R)-enantiomer starts to crystallize. 
3.  Racemate, with the same weight as the (S)-enantiomer which was collected in step 
2, is added and the mixture is heated to dissolution. Note that the resulting 
situation is the same but mirror imaged to the one resulting from step 1.  
 
 
 
 
 
 
CHAPTER 1 
18
4.  Again, the mixture is cooled to supersaturation of both enantiomers and now the 
(R)-enantiomer crystallizes. The amount of crystals collected after filtration is the 
same as the amount of racemate added in the previous step. 
5.  Subsequently, racemate is added and the mixture is heated to dissolution, resulting 
in the same situation as was obtained after step 1. 
 
Figure 1.5 Representation of resolution by entrainment. 
The pure enantiomers do not always form spontaneously or fast enough. In such a case, 
enantiopure crystals may be added as a template for the enantiomers of the same 
handedness to crystallize on. This methodology is known as ‘seeding’. 
Since the mother liquor is reused, impurities can accumulate in the mother liquor and 
disturb the crystallization process. This limits the number of cycles that can be performed 
before the mother liquor needs to be replaced. 
1.4.3.4  Resolution by Diastereomeric Salt Formation
71,74 
If a racemate has an acid or base moiety, a salt can be formed with a basic or acidic enantio 
pure compound (resolving agent), respectively. The diastereomeric salts formed have 
different physical properties and can thus be separated. The easiest way to do this is by 
crystallization providing that the least soluble diastereomer crystallizes out of the solution 
selectively. By crystallizing the salts from a proper solvent, high de’s can often be found in 
the precipitated salts. If necessary, the isolated salt can then be recrystallized (if needed, 
several times) to high de if the de of the first salt is too low. The pure enantiomer can be 
liberated by addition of acid or base. This procedure is known as resolution by 
diastereomeric salt formation (or classical resolution) and is the most used procedure for 
isolation of enantiopure compounds.
38 Compounds that do not have an acid or base moiety  
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like alcohols can be separated by inclusion resolution with an appropriate complexing 
agent, which will form a diastereomeric complex or be reacted with an enantio pure 
compound producing covalently bound diastereomers which can be separated by the 
difference of their physical properties.
75 
Some resolving agents exhibit a larger solubility difference than others or might resist salt 
or crystal formation with a certain racemate. Thus it is necessary to screen several resolving 
agents to find a good combination of racemate and resolving agent. Several commonly used 
basic resolving agents are shown in Scheme 1.17.  
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Scheme 1.17 Most frequently used basic resolving agents.
74  
Although brucine and strychnine have been much used resolving agents on lab scale in the 
past, today these are not used often due to their toxicity. Common acidic resolving agents 
are given in Scheme 1.18. Although amino acids are cheap chiral compounds with a large 
diversity, they are not commonly used as resolving agents. The zwitterionic behavior 
inhibits salt formation with relatively weak acids or bases. 
These basic and acidic resolving agents shown in Scheme 1.17 and Scheme 1.18 are in 
general not expensive and can be isolated from natural sources or produced synthetically. 
Solvents also have an impact on the outcome of the resolution and efficiency. Solvate 
formation, hydrate formation, growth inhibition and polymorphism are effects influenced 
by solvents.
76,77 As a rule of thumb, the solubility of small organic compounds in organic 
solvents will be roughly doubled for every 20°C increase in temperature.
78 Not every  
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compound/solvent combination will show this ‘ideal’ behavior, of course. To obtain a high 
yield at room temperature, high boiling solvents can be used e.g. water, 2-propanol, 
2-butanone and toluene. 
The temperature of the resolution process can have an influence on the outcome of the 
resolution also. (De)hydration, (de)solvation, polymorphism and temperature dependent 
solubility will be different for each diastereomeric salt and can even invert the outcome of 
the resolution.
77 As will be discussed in §1.5, small amounts of structural related 
compounds can drastically influence the outcome of the resolution. 
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Scheme 1.18 Most frequently used acidic resolving agents.
74  
It is estimated that the chance of success of a typical resolution experiment by 
diastereomeric salt formation is only a disappointing 20–30%.
42,71 
1.5   Dutch Resolution
79 
In 1998, a group of Dutch researchers tried to make the screening process for resolution by 
diastereomeric salt formation faster by adding stoichiometric amounts of several resolving 
agents as a mixture to the racemate. They soon discovered that random combinations of 
resolving agents did not give good results. Only very insoluble salts can be selected using 
this method. However, when the researchers used structurally related and homochiral
80  
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resolving agents (family members) the outcome was different. Often, the combination of 
these resolving agents gave higher ee’s than with each of these resolving agents 
independently. Moreover, the chance of obtaining solid salts with significant diastereomeric 
excesses was increased from 20–30% to 90–95%.
71,81 
The reasons for the high success rate of Dutch Resolution are believed to be:  
•  Choice of the best resolving agent/racemate combination. With three resolving 
agents and one racemate, the least soluble combination of diastereomers will start to 
crystallize, hereby reducing the chance of encountering a salt that will not form 
crystalline salts. 
•  Solid solution behavior of the family members. Solid solution behavior means that 
the crystal lattice does not distinguish much between the several family members that 
can fit inside the crystal lattice of the salt that is precipitating. Hence, the composition 
of the crystal depends largely on the composition of the surrounding solution. A solid 
solution is less soluble than each separate salt and thus will produce crystals in stead of 
a clear solution. The isolated crystals usually show a non-stoichiometric ratio in the 
resolving agents although these were added stoichiometric. 
•  Peachey-Pope type resolution. In a Peachey-Pope resolution, instead of one 
equivalent resolving agent, one-half equivalent of resolving agent is used and 
supplemented with one-half equivalent of an achiral (low-cost) acid or base like 
hydrochloric acid or sodium hydroxide to make the system neutral. The achiral 
supplement should give very soluble salts with the racemate so these will not 
crystallize and ruin the resolution. The less soluble salt will start to crystallize and will 
consume most of the resolving agent thus leaving only small amounts of resolving 
agent for the more soluble diastereomer which, in an ideal case, will not crystallize. 
The same principle applies to Dutch resolution. When three resolving agents are used, 
usually, one of these is incorporated the most in the least soluble diastereomer. The 
concentration of this resolving agent in the solution is subsequently lowered and thus 
the more soluble diastereomer of this resolving agent cannot crystallize. 
•  Nucleation inhibition. When a family of three resolving agents is used, sometimes 
only two are incorporated in the crystal lattice. It was found that when a resolving 
agent is not incorporated in the crystal lattice, this does not mean this compound can be 
left out without altering the outcome of the resolution. Small amounts of compounds 
that resemble the resolving agent (or racemate) can inhibit the nucleation of the more 
soluble (unwanted) diastereomer. 
 
Nucleation inhibition has been further investigated and was found to be very effective for 
the improvement of a classic resolution by diastereomeric salt formation. By addition of  
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only a few percent of a structurally related additive, significant improvements were found. 
This type of resolution was named Second Generation Dutch Resolution.
82,44a  
Furthermore, Reverse Dutch Resolution has been reported
83 where family members of a 
racemate have been resolved simultaneously with one resolving agent. 
1.6   Aim and Outline of This Thesis 
The focus of this thesis is the improvements of resolutions of racemates by crystallization 
and a better understanding of the role of additives/impurities. Furthermore, application of 
grinding of crystals in resolutions will be addressed. A better understanding will be useful 
in laboratory scale and industrial scale. 
Chapter 2 covers the theoretical aspects of resolutions by crystallization including phase 
diagrams, crystal growth, nucleation and the inhibition of nucleation. 
Chapter 3 deals with the resolution by diastereomeric salt formation and the improvements 
thereon with additives that can act as nucleation inhibitors and growth inhibitors. For the 
first time, >95% de was achieved by addition of only 1% additive in a diastereomeric salt 
formation. On a relative large scale, the resolution was performed successfully even after 
seeding with the more soluble diastereomeric salt. The resolution was even further 
improved by the use of half-equivalent of resolving agent and grinding of the formed 
crystals. 
Chapter 4 is concerned with the effect of additives on resolutions by diastereomeric salt 
formation, which do not show great improvement of the resolution. Furthermore, a classical  
resolution was improved by abrasive grinding of the crystals in the presence of an additive. 
Also, the crystallization of optically pure phencyphos in the presence of other racemic 
cyclic phosphoric acid shows a stereoselective incorporation of the latter in high yields. 
In Chapter 5 a new concept of deracemization to optical purity by abrasive grinding is 
given. The stereoselective incorporation of other amino acid derivatives in the precipitating 
amino acid derivative poses a new pathway to homochirality in nature. 
In Chapter 6 the resolution of phencyphos is described for which the original resolving 
agent was no longer available for a low price. A new method was found and has been 
adopted on large scale to yield 2.5 moles of each enantiomer each day. 
Chapter 7 of this thesis is dedicated to some ideas which might be researched further in the 
future. 
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Resolution by Crystallization 
 
 
 
 
 
In this chapter the theoretical aspects of resolutions by crystallization are 
discussed. Nucleation, crystal growth, nucleation inhibition and polymorphism are 
considered. Furthermore, several resolution-by-crystallization techniques are 
highlighted and explained by means of ternary phase diagrams. A proper 
understanding of the crystallization process under investigation enhances the 
chance of success and can save time and money.  
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2.1   Introduction
1 
Lack of understanding in a resolution by crystallization can result in low yields, lengthy 
recrystallizations, frustration and even isolation of the undesired enantiomer. Although 
prediction of the outcome of a crystallization process by computer has been performed with 
increasing success,
2 computing times are still longer (and more expensive) than performing 
the actual experiment in a laboratory. 
2.2   Crystal Growth from Solution 
Crystallization from solution starts with nucleation. Nucleation can be divided in two 
categories: primary and secondary. Primary nucleation is the process in which crystals form 
spontaneously from a supersaturated solution. On the other hand, one speaks of secondary 
nucleation when a supersaturated medium is put in contact with an appropriate surface on 
which the supersaturated compound can crystallize. Examples are seeding, twinning 
(crystallization of the supersaturated compound on the crystal surface of another 
compound) and grinding of existing crystals of the supersaturated compound. John Mullin,
4 
a highly recognized expert, remarks that the difference between primary and secondary 
nucleation is sometimes not made clear in the literature. We feel, however, that the 
definition given here is clear. 
2.2.1  Primary Nucleation 
To focus on primary nucleation, it is difficult to observe the actual nucleation process since 
the nuclei are too small to observe with any instrument. When a solution of a compound at 
a certain temperature (Figure 2.1a) is cooled, a supersaturated solution forms. It has been 
suggested that very small aggregates, each consisting of a few molecules, form in the 
supersaturated solution as is depicted in Figure 2.1b.
3 
The small aggregates then grow in the solution or dissolve again as is shown in Figure 2.1c. 
When the aggregates/nuclei attain a critical size, they can grow into actual crystals. This 
critical size is determined by the relationship between the volume energy term: ∆GV of a 
crystal versus the surface area energy term: ∆GS of this crystal. For a spherical nucleus the 
total free energy difference ∆G can be calculated with Equation 2.1.
4a  
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Figure 2.1 Crystallization from a supersaturated solution. The X-shaped 
figures represent molecules that can form aggregates. 
Where ∆G is the overall free energy difference, r is the radius of the nucleus, γ is the 
interfacial tension (surface energy) and ∆Gv is the free energy difference of the 
transformation per unit volume.  
v V S G r r G G G ∆ + = ∆ + ∆ = ∆
3 2
3
4
4 π γ π  
Equation 2.1 Calculation of free energy from the radius of a spherical 
nucleus. 
The graph in Figure 2.2 depicts the development of the free energy difference of the surface 
term, the volume term and the total free energy difference as a function of the radius of the 
nucleus. 
When the crystal has a radius smaller than rc, the critical radius, it is energetically more 
favorable for the nucleus to re-dissolve, as can be told from the graph (line: - - -). For larger 
sizes than rc, growth of the nucleus into a crystal is more favorable. Of course, if the 
nucleus shape resembles the final crystal shape, Equation 2.1 cannot be entirely valid 
because crystals are never perfect spheres. However, for explanation purposes this picture 
is useful.  
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Figure 2.2 Free energy difference diagram for nucleation of a spherical 
nucleus with radius r. 
2.2.2  Polymorphism
5 
Often (if not always), aggregates with different molecule packings are formed 
simultaneously. These aggregates will grow into different crystals, known as polymorphs. 
Polymorphism is defined as the ability of a compound to exist in more than one crystal 
form. This means that the internal arrangement of the atoms is different although the 
chemical composition is the same (e.g. solvates, as explained in §2.3.4, are not 
polymorphs).  
Polymorphism is caused, among other things, by the molecule’s ability to change 
conformation, display hydrogen bonding and π-π interactions. The polymorph with the 
lowest solubility is by definition the most stable. This, however, can be temperature 
dependent as is shown in Figure 2.3 in which the solubility curves of three polymorphs of a 
compound are given. Form III is the most soluble and thus the least stable polymorph at 
every temperature and it thus has a monotropic relation with forms I and II. Form I is the 
most stable polymorph above Ta but below Ta form II is the most stable form. This means 
that form I has a so called enantiotropic relation with form II. 
Fast cooling, as indicated with the horizontal arrow, will produce all forms I-III.
6 The 
formation of a less stable crystal is known as Ostwald’s rule of stages: “An unstable system 
does not necessarily transform into the most stable state, but into one which closely  
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resembles its own, resulting in the smallest loss of energy”.
7 This is exemplified in Figure 
2.4 where form A is the most stable. However, when fast cooling is applied, form B will 
represent the majority of crystals in this kinetically driven crystallization. There are many 
exceptions to the rule of stages and thus it should not be considered a law.
8  
 
Figure 2.3 The theoretical dependence of solubility and stability as a 
function of temperature for a compound that can exist in three 
polymorphic forms. 
Polymorphism is very common in organic compounds. To quote Walter McCrone: “Those 
who study polymorphism are rapidly reaching the conclusion that ALL compounds, organic 
or inorganic, can crystallize in different forms or polymorphs. In fact, the more diligently 
any system is studied, the larger the number of polymorphs discovered.” 
9 
 
Figure 2.4 Thermodynamic (––) and kinetically (---) driven 
crystallization.  
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Very fast cooling might lead to amorphous material or even oil formation. In amorphous 
material the solids show a random orientation of the compound in contrast with crystals 
which show a very well defined repetitive packing of molecules.  
By slurrying a mixture of polymorphs in a saturated solution, the most stable polymorph at 
a temperature below Ta (form II in this case) will eventually be the only polymorph left 
(vertical arrow in Figure 2.3). The most stable polymorph will consume the other 
polymorphs via a dissolution and crystal growth process known as ‘ageing’.
10 However, if 
the formation of this polymorph is inhibited due to small impurities (nucleation inhibition, 
see also §2.2.3) the second most stable polymorph will form. However, by seeding with the 
most stable form or removal of the impurity, the whole system will produce the most stable 
polymorph. Also a change of solvents can produce different polymorphs (kinetically).
11 A 
good example is the crystallization of the simplest amino acid, glycine. This can crystallize 
in three different forms by the interaction of the solvents on the growing aggregates 
(nucleation inhibition): α (from water), β (from EtOH or MeOH) and γ (from acids or 
bases).
6,12 Prolonged stirring of the unstable polymorph will eventually result in the most 
stable polymorph. 
2.2.2.1  (Dis)appearing Polymorphs 
A famous example of so called ‘disappearing polymorphs’ is the production by Abbott of 
Ritonavir, a HIV protease inhibitor,
13 as shown in Scheme 2.1. This drug was discovered in 
1992, commercialized in 1996, and produced as polymorph I. However, in 1998 a second, 
more stable, form II appeared unexpectedly. The plant was unable to produce the less 
stable form I and the problem spread to other sites across the world. The biggest problem 
with this new polymorph was the 5-6 fold lower solubility. The new polymorph could now 
not provide high enough concentrations of the drug in the patients’ body. A decomposition 
compound was suspected to be the cause of the appearance of form II. The workup 
procedure was altered to produce polymorph I again by dehydration of a hydrate.
14 The 
estimated costs: US$ 1 billion. 
2.2.2.2  Polymorphism in Chocolate
15 
Polymorphic transitions in chocolate are one of the most famous examples. Chocolate 
(actually one of the ingredients: cocoa butter) is known to be able to crystallize in six 
different polymorphs: form I (least stable) to form VI (most stable). Form V, which does 
not melt at room temperature but does so in the mouth, is the desired form (melting range 
of 34.0°C–36.3°C)
16 and can be obtained by a process called ‘tempering’. In this  
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methodology, the chocolate, which contains a mixture of polymorphs I to V,
17 is heated to 
~29°C to melt the lower melting forms I-IV and the higher melting form V is retained. This 
mixture is then slowly cooled while it is well mixed to allow secondary nucleation to take 
place. The whole batch of chocolate will become small crystals of the desired form V. If the 
cooling is too fast also forms I-IV will form via primary nucleation, resulting in a poor 
(low melting) quality of chocolate. 
HN
O
O
S
N
OH
H
N
O
HN O
N
Me
N
S
Ritonavir  
Scheme 2.1 Ritonavir, a HIV protease inhibitor. 
Furthermore, when chocolate is not handled correctly or stored too long, the most stable 
form VI is formed. This polymorph is formed by partly melting and recrystallizing. The 
formation of this form VI often leads to a white dusty surface which is called ‘bloom’. 
Bloom is the migration of cacao butter to the surface of the chocolate where it crystallizes. 
The formation of bloom can be prevented by addition of other fats to the cocoa butter, 
which inhibit the nucleation of form IV.
18 
2.2.3  Nucleation Inhibition 
By the addition of small amounts of a compound that can partly incorporate in the crystal 
lattice, the nucleation of the crystallization can be prevented kinetically. In the cartoon in 
Figure 2.5a a solution of a compound (X-shaped) crystallizes in the presence of an additive 
(fish shaped). In Figure 2.5b two clusters of different polymorphs have formed. The 
additive blocks further growth of the top cluster by steric hindrance or crystal forming 
incompatibility (e.g. lack of hydrogen bonding capabilities). However, the bottom 
polymorph does not suffer from this. Thus, in Figure 2.5c the top polymorph has 
redissolved and the bottom polymorph can grow without disturbance.
19 This crystal does 
not distinguish much between the compound that it’s made of and the additive and thus  
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forms a solid solution as discussed further in §2.3.2. Would the bottom polymorph have 
been inhibited also, this crystallization would have resulted in a clear solution instead of a 
suspension of crystals. 
 
Figure 2.5 The effect of a nucleation inhibitor. The X-shaped figures 
represent molecules and the fish-shaped figures represent a nucleation 
inhibitor. 
Nucleation inhibition was first shown in the Dynamic Kinetic Resolution (DKR) of 
(±)-narwedine. A relatively large amount of (+)-galanthamine and/or (+)-epigalanthamine 
(epimers at the alcohol carbon) had been used to prevent the crystallization of 
(+)-narwedine as shown in Scheme 2.2.
20 The product of this resolution, (–)-narwedine, 
was used in the total synthesis of (–)-galanthamine. 
By racemizing the narwedine in the solution, Barton and Kirby were able to isolate more 
than 50% yield. It is clear from Scheme 2.2 that galanthamine with the same absolute 
configuration as narwedine inhibits the nucleation of the latter with the same absolute 
configuration and thus produces narwedine of the opposite configuration. This is in essence 
the “rule of reversal” as later postulated by Lahav based on the study of the crystallization 
behavior of amino acids.
21 
As discussed in §1.5, small amounts of structurally related additives are also used in a 
resolution by diastereomeric salt formation in the Second Generation Dutch Resolution 
protocol.
22  
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Scheme 2.2 Resolution of narwedine aided by the addition of 
(epi)galanthamine. 
2.2.4  Crystal Growth and Habit Modifiers 
The effect of an additive, next to nucleation inhibition, can also be on the crystal growth 
process. Changing the growth of certain faces of a crystal without a change in crystal lattice 
(polymorph) results in a change of appearance (morphology) of a crystal: habit 
modification. Since the smallest faces of a crystal are the fastest growing ones, blockage of 
these faces will make them bigger. An example is the addition of a habit modifier to 
crystallizing sodium chloride in water as shown in Figure 2.6. The cubic crystal on the right 
is sodium chloride grown in pure water and the left crystal is sodium chloride grown from 
water with some formamide as impurity.
24 
Not only achiral crystals may be modified. Addition of small amounts of optically pure 
impurities can cause the blockage of certain faces of optically pure crystals.
23   
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Figure 2.6 NaCl crystals grown from pure water (right) and water with 
some formamide.
24 
2.3   Phase Diagrams: a Necessary Evil on the Path to 
Salvation/Solvation 
The behavior of a mixture of two crystalline compounds and a solvent can be visualized 
and explained by means of a ternary phase diagram. A ternary phase diagram shows how 
this mixture of components behaves thermodynamically. Any attempt at a kinetic analysis 
must be done with great care. 
In Figure 2.7a a phase diagram is depicted. The scale of phase diagrams is usually in mole 
fractions or mole percentages. Each apex represents a pure compound (or solvent). The 
sides of the triangle represent mixtures of the two compounds that are at the ends of the 
side. For instance, point X represents a 1:1 mixture of (R) and (S) without any solvent. 
Point Y in the phase diagram represents a 1:1:1 mixture of all three components. Line Z’ is 
a dilution line and represents a constant (R):(S) ratio of 1:3 with a varying amounts of 
solvent. Point Z has the same ratio of (R):(S) but without solvent.  
The phase diagram in Figure 2.7b represents a diastereomeric salt in its solvent. In this 
diagram, p represents the less soluble salt with solubility p’ and n represents the more 
soluble salt with solubility n’. Presuming ideal solubility without dissociation, the solubility 
line (p’-E) of salt p runs parallel to line (S-n).
25 For the n salt the solubility line runs from 
n’ to E parallel to line (S-p). Point E represents a mother liquor that is saturated in both n  
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and  p and is called the eutectic. The parallelogram shaped area above the eutectic 
(E,p’,S,n’) represents under-saturated mixtures of p and n in the solvent. 
 
Figure 2.7 Theoretical ternary phase diagrams. 
The triangle (n,n’,E) represents the cases in which n has crystallized but p is under-
saturated. The triangle (p,p’,E), of course, represents the cases in which p has crystallized 
but n is under-saturated. For example, if one would have a mixture of composition A in 
equilibrium, this will consist of a mother liquor with composition A’ and the solids would 
be pure p. In the same manner, a mixture with composition D, would have a mother liquor 
with composition D’ and solids of pure n. A change in concentration at constant 
temperature will not alter the amount of phases but will only change the composition of the 
mother liquor (along line (n’,E)) and the amount of material in the solid phase. 
In triangle (n,p,E) both diastereomers have crystallized. The composition of the mother 
liquor in the presence of the solid phases of p and n will be fixed at a constant temperature. 
Changing the concentration within triangle (n,p,E) will not alter the composition the 
mother liquor, the composition of the n salt nor the composition of the p salt. Mixtures with 
composition  B or C would both have a mother liquor with composition E  and both 
mixtures will consist of a mixture of crystals of n and crystals of p. Although the ratio of n 
and p in B’ and C’ will be different. 
2.3.1  Construction of a Ternary Phase Diagram 
Although the construction of a ternary phase diagram is quite laborious and requires at least 
a racemate and one pure (or properly enriched) enantiomer, it can give more insight if the 
crystallization needs to be optimized or compared to other resolutions. In principle, the 
determination of the composition of the mother liquors is sufficient to make a phase 
diagram (these will furnish the solubility lines). However, important details will be missed  
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if the composition of the solids and/or system compositions are not taken into account, for 
instance end-solid solution formation and hydrate/solvate formation (as described in 
§2.3.4). These can be found when the method of “wet solids” is used.
1c  
Let us start with the theoretical ternary phase diagram in Figure 2.8. One begins with a 
known mixture of compounds in a known amount of solvent (starting composition: s) 
which is allowed to stir in a sealed flask for a sufficient amount of time (couple of days) at 
a fixed temperature so that the thermodynamic equilibrium has been reached. The mixture 
is then filtered, the amount of solvent is determined in the mother liquor by distillation and 
the composition of the solids in the residue is determined (by weighing and e.g. chiral 
HPLC to determine the ee), furnishing point m.  
The solids on the filter are then sucked ‘dry’ without evaporating the remaining solvent. 
The amount of solvent is determined in the wet filter cake by drying and the composition of 
the resulting solids is determined, delivering point w. By extrapolation of the tie line 
through the points m, s and w one arrives at point p: the composition of the crystals. 
 
 
Figure 2.8 Theoretical ternary phase diagram construction by the 
method of wet solids. 
Point p can also be found by a quick washing of the solids after filtration and then a 
determination of the ee. Although this method may be more convenient, one might miss 
solvate/hydrate formation and will introduce some error by the unwanted dissolution of 
some of the material by the washing step.  
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2.3.2  Conglomerates, Racemic Compounds and Solid 
Solutions
1c 
Enantiomers can crystallize separately: each in a single crystal or together in one crystal as 
depicted in Figure 2.9. 
 
Figure 2.9 Crystal packing of enantiomers and diastereomers. 
When a racemate crystallizes into two separate crystals of opposite handedness this is 
called a conglomerate. It is estimated that only 5–10% of all racemates crystallize as a 
conglomerate. More common (90–95%) is the formation of a racemic compound in which a 
racemate crystallizes in an ordered fashion. Rare (1%) is a solid solution where a crystal 
does not distinguish between (R)- and (S)-enantiomers. This crystal is then randomly 
packed and thus its overall ee depends on the ee of the mother liquor it was crystallized 
from. Typical ternary phase diagrams for these different crystallization behaviors are given 
in Figure 2.10. 
 
Figure 2.10 Theoretical ternary phase diagrams for different crystal 
packings of enantiomers.  
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2.3.2.1  Finding Conglomerates 
The resolution by direct crystallization can only be performed on conglomerates (see 
Chapter 1.4.3.3). There are several analytical methods for finding conglomerates, some of 
which are given below: 
•  DSC If the melting point difference between the pure enantiomer and the racemate 
is at least 20
oC a conglomerate might be expected.
1c  
•  IR/NIR/Raman/UV/Solid state NMR/XRPD The spectra of the racemate and 
pure enantiomer should be the same for conglomerates. 
•  Solubility Slurring crystals with ~5% ee in a minimal volume of an appropriate 
solvent will give 0% ee (eutectic composition) for conglomerates. Eutectics of 
racemic compounds will always be >0% ee (see also Figure 2.10).
26 
•  SHG (Second Harmonics Generation) This method only requires the racemate 
and is explained below. 
SHG depends on non-linear optics in which the two photons are combined in a crystal to 
produce diffuse light with twice the energy (λ/2) of the irradiated light: the SHG signal.
27 If 
the sample has crystallized in a non-centrosymmetric space group, as conglomerates do in 
95% of investigated cases, a SHG signal is produced. The intensity of the SHG signal 
depends on the symmetry class to which a crystal belongs. If the compound has crystallized 
in a centrosymmetric space group, no SHG signal is produced. Racemic compounds are 
known to crystallize predominantly in centrosymmetric space groups. Since some 
conglomerates can crystallize in a centrosymmetric space group, and some racemic 
compounds in a non-centrosymmetric space group, some crystals absorb the irradiated or 
the SHG photons, leading to false conclusions in an estimated 10% of cases. However, 
SHG only requires a racemate, is fast, (usually) non-destructive and thus makes it an ideal 
screening method. 
A typical SHG setup is depicted in Figure 2.11 where photons are delivered by a pulsed 
Nd:Yag laser (1064nm). The photons pass through an energy adjustment device to prevent 
decomposition of the sample. Subsequently, the photons pass through a filter that removes 
light from laser flash lamps. The sample container contains powdered crystals and is 
irradiated. The diffused light from the sample is then collected in a spectrophotometer via 
an optical cable and analyzed for a (usually weak) SHG signal with double the energy 
compared to the photons of the laser: 532nm.  
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Figure 2.11 SHG setup. 
2.3.3  Phase Diagrams and Diastereomers 
The situation with diastereomers is similar but not identical to that with enantiomers. When 
a diastereomeric salt is formed from a racemate and an optically pure resolving agent, 
similar crystal packings are formed as well. The most commonly observed type is the 
eutectic, which is comparable with conglomerates. Also addition compounds can be formed 
with different ratios of diastereomers, comparable with racemic compounds. Usually these 
are 1:1, however, other ratios have been found. For example, from (R)-1-phenylethyl amine 
and (S)-mandelic acid it is known that a 1:3 salt can form.
28  
 
 
Figure 2.12 Theoretical ternary phase diagrams for different crystal 
packings of diastereomers.  
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Also, randomly divided solid solutions can be formed in diastereomeric salt formation. 
However, addition compounds and solid solutions are not very common in diastereomers. 
Note that a solid solution is not the same as an end-solid solution (as discussed in §2.3.4) 
which often occur in eutectic mixtures. The phase diagrams for these types of 
crystallization behaviors are given in Figure 2.12. 
2.3.4  End Solid Solutions, Solvates and Hydrates 
Often, the resolution efficiency of a diastereomeric salt formation is lower than one would 
expect from the solubility difference of the two diastereomers which form an eutectic. A 
close examination of separate crystals will reveal the incorporation of some of one 
diastereomer in the other diastereomer crystal. This phenomenon is known as a end solid 
solution (or terminal solid solution) behavior and is very common in diastereomer 
mixtures.
30 As with (full) solid solutions, the percentage of incorporated ‘wrong’ material 
corresponds with the concentration of the latter in the surrounding mother liquor.  
Figure 2.13a depicts a diastereomer with an end solid solution for the less soluble salt. 
Starting with composition a, the mother liquor will have composition a1 and the solids 
would have composition a2. On crystallizing the solids in an certain amount of solvent, this 
will give a suspension of composition b. Note that the ee remains the same (dotted line). 
After equilibration, the mother liquor (b1) is removed and this will result in solids of 
composition b2. Another recrystallization delivers c2, which is still not >99% de.  
 
Figure 2.13 Theoretical ternary phase diagrams of an end solid solution 
and of a solvate.  
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It is clear that isolation of material with >99% de requires multiple recrystallizations with 
serious loss of material.
29 Hence, the efficiency of a resolution does not only depend on the 
position of the eutectic point, but maybe even more, on the extent of the end solid solution. 
The resolution of a pair of diastereomers with a poor eutectic point but without end solid 
solutions can be performed in more dilute solutions and can provide in principle >99% de 
in a single crystallization, perhaps with equally (low) yields as with an end solid solution 
forming pair of diastereomers and a eutectic point with high ee, but with less work. 
When performing a resolution by diastereomeric salt formation, often a solvate or hydrate 
is formed. This is often missed since the salts are usually not specifically analyzed for this. 
However, the presence of a solvate or hydrate will have profound effect on the outcome of 
a resolution. Figure 2.13b depicts the ternary phase diagram for the case that the more 
soluble diastereomer crystallizes as the solvate. 
Starting from a, the solids will have composition a2. Point a2 is on the line (S,n) because 
the solids contain some solvent. Furthermore, starting from b, the solids will have 
composition  b2. However, when the solids are dried, the solvent is removed but the 
composition of the solids remain unchanged (b3). The triangle (p,n,n·solvent) contains 
saturated solution, p-crystals, n-crystals, and n-solvate. 
2.3.5  Binary versus Ternary Phase Diagrams
5,30 
Melting point phase diagrams (binary phase diagrams) are easier to construct than ternary 
ones. These can be constructed by Differential Scanning Calorimetry (DSC) which requires 
several mixtures of enantiomers or diastereomers and is a relative fast method. Binary 
phase diagrams are often used to predict the outcome of a resolution by diastereomeric salt 
formation. 
However, the results can be distorted or even completely invalid for a resolution at room 
temperature for a number of reasons: 
•  Polymorphic transition by heating/melting. 
•  Decomposition during heating. 
•  Temperature dependent stability of polymorphs (enantiotropic relation). 
•  Temperature dependent stability of racemic compounds.
31 
•  The extent of end solid solution behaviour can change with temperature. 
•  Grinding of the samples (necessary for DSC measurements) can cause 
significant changes in the sample. 
•  Hydrate and solvate formation are not taken into account.  
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The formation of solvates and hydrates should not be underestimated. Out of 46,460 
structures in the Cambridge Structural Database (CSD) there are 9,464 (20%) solvates from 
which 61.4% are with water.
5 
Therefore, it is better to spend a bit more time to construct a ternary phase diagram which 
can be trusted rather than use less time to construct a binary phase diagram that might not 
represent the system under investigation. 
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Chapter 3 
 
Resolution of Racemates by Diastereomeric 
Salt Formation with the Aid of Nucleation 
Inhibitors. 
 
 
 
 
 
In this chapter
* the resolution of (±)-1-(3-methoxy-phenyl)ethylamine with 
(S)-mandelic acid is described. This resolution was aided by the addition of 
nucleation inhibitors and was performed both on test tube and large scale. 
 
* Parts of this chapter were also published in Angew. Chem. Int. Ed. 2008, 47, 1287–1290 
and Tetrahedron Asymm. 2009, 20, 1363–1364.  
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3.1   Introduction 
Optically pure 1-phenylethylamine and phencyphos are frequently used resolving agents 
and for these compounds nucleation inhibitors have been described and proven to be 
effective.
1,2 
(S)
NH2
(S)
O
P
O
O HO
(S)-1-Phenylethylamine (S)-Phencyphos  
Scheme 3.1 Resolving agents for which nucleation inhibitors have been 
designed. 
However, for other resolving agents like mandelic acid only one example of a successful 
nucleation inhibitor has been described.
1 For other frequently used resolving agents like 
dihydrochalcone-3-sulfonic acid, tartaric acid, cinchonidine and O,O’-dibenzoyl tartaric no 
effective nucleation inhibitors have been developed.  
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O
O
 
Scheme 3.2 Commonly used acidic and basic resolving agents.  
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3.2   Resolution with Optically Pure Mandelic Acid 
The resolution of a racemate with mandelic acid, improved by addition of a nucleation 
inhibitor should, ideally, meet to the following requirements:  
•  Chemically and configurationally stable racemate. 
•  Fast diastereomeric excess (de) determination by chiral HPLC or chiral GC, preferably 
without derivatization or liberation of the salts. 
•  Salts that precipitate with eutectic behavior without end-solid solution formation. 
•  Sufficient solubility difference between both diastereomeric salts. 
 
1-Phenylethylamine derivatives were chosen as racemates because of our experience with 
these compounds, wide variety of low cost starting materials and for their chemical 
stability. The 1-phenylethylamine derivatives can be synthesized by the Leuckart-Wallach 
reaction as depicted in Scheme 3.3.
3 
O
R
HCO2H
HCONH2
∆
NH
R
O
NH2
R
± ±
HCl
H2O, ∆
12 3  
Scheme 3.3 Lauckart-Wallach synthesis of phenylethylamines. 
Via reductive amination of acetophenones 1  with formic acid and formamide, formyl 
protected amines 2 were isolated and subsequently deprotected by boiling the latter in 
aqueous hydrochloric acid to furnish compounds 3 after workup. 
3.2.1  Screening for Possible Candidates 
The efficiency of resolutions of several 1-phenylethylamine (PEA) derivatives with 
mandelic acid (MA) have been published,
4 and the results of these resolutions are depicted 
in Table 3.1. Unfortunately, no experimental details were given (i.e. solvent, concentration) 
so repetition of these experiments can lead to different results. However, these published 
results might give a fast insight in which diastereomeric salt pair could give the best results. 
The racemates that have >95% de in the first salts must have eutectic behavior without a 
large end-solid solution. The racemates which have a low de might also be improved by 
addition of a nucleation inhibitor. Moreover, a solvate or hydrate might be present which  
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will give different results after a change of solvent. After consideration, the racemates with 
R = H, 2-Me and 3-MeO (entries 1, 2 and 5) were chosen for further research because these 
were most promising. 
Table 3.1 Resolution of PEA derivatives with MA.
4 
Entry R  Yield  (%)  de (%)  S-factor
a 
1  H 38 99  0.75 
2  2-Me 36  100  0.72 
3  2-MeO 35  81  0.57 
4  3-Me 47  12 0.11 
5  3-MeO 35  99  0.69 
6  4-Me 44  4 0.04 
7  4-MeO 85  0  0.00 
8  4-Cl 17  3 0.01 
a Resolution efficiency: S-factor = Yield × de × 2.
5 
 
Because any improvement of a resolution with a reasonable high de in the precipitated salts 
by addition of a nucleation inhibitor is difficult to observe, the resolution should be 
performed at a high concentration. However, a clear solution should be obtained at reflux 
temperature since nucleation inhibitors cannot inhibit crystals that have already formed. At 
a high concentration, the more soluble diastereomer can crystallize to a large extent at room 
temperature and thus give a high yield and poor de.  
Small scale (1 mmol) experiments were carried out on the 1-phenylethylamines with one 
equivalent of (S)-MA by heating the mixture in an appropriate amount of solvent until 
complete dissolution was obtained at reflux temperature. The mixtures were allowed to cool 
to room temperature without stirring and crystals were collected the next day. The results 
are depicted in Table 3.2. Obviously, the results in the table are not the same as the 
literature values in Table 3.1. Different solvents, concentrations and other factors will lead 
to different results.   
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The resolution of racemic 1-phenylethylamine (entry 1, Table 3.2) is too good for 
experiments to find an effective nucleation inhibitor since the de is already quite high and 
thus improvements will only be marginal.  
Table 3.2 Resolution of PEA derivatives with MA (1 mmol scale) without 
stirring and controlled cooling. 
Entry R  Solvent  Yield  (%)  de (%)  S-factor
c 
1
a  H MEK
d (10 mL)  48  83  0.80 
2
b  2-Me  EtOAc (2 mL)  54  23  0.25 
3
b  3-MeO MEK
d (15 mL)  65  9  0.11 
a Commercially available. 
b See experimental section for preparation. 
c Resolution 
efficiency: S-factor = Yield × de × 2.
5 
d 2-butanone. 
 
In principle, the resolution of racemic 1-(2-methyl-phenyl)ethylamine (entry 2) is suitable 
for an improvement by addition of a suitable nucleation inhibitor but an experimental 
restriction was the requirement of liberation and derivatization before chiral HPLC 
analysis. Thus, 1-(3-methoxy-phenyl)ethylamine (entry 3) was chosen as an ideal racemate 
for the resolution with MA as depicted in Scheme 3.4, since it gave high yield, low de and 
required no derivatization or even liberation before the determination of the de by chiral 
HPLC thus allowing a non-laborious workup. 
(S) CO2H
OH
MeO
NH2
less soluble salt: (S),(S)
+ 
more soluble salt (R),(S) MEK
MA
3MeOPEA  
Scheme 3.4 The resolution of (±)-3MeOPEA with (S)-MA. 
When the resolution was performed by magnetic stirring and controlled cooling, the salts of 
(±)-1-(3-methoxy-phenyl)ethylamine (3MeOPEA) with (S)-MA were isolated in 72% yield 
and 10% de, nearly identical with scouting experiments reported in Table 3.2, entry 3 (see 
also entry 1 in Table 3.3).  
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3.2.2  Nucleation Inhibitors Based on the Resolving Agent 
Various additives, structurally related to MA, were tested in 2-butanone (MEK) as solvent 
and the results are given in Table 3.3. In all cases 6 mol% of acid was used with 94 mol% 
of (S)- or (R)-MA in order to keep the ratio of acid to base stoichiometric and the system 
thus neutral. For example, in the case of the double acid in entry 5 (Table 3.3) 3 mol% of 
this compound was used.  
In entry 1, Table 3.3 the de of the isolated solids in the blank resolution is 10%, which 
means that 55% of the solids consists of the less soluble salt and 45% of the more soluble 
salt. If a nucleation inhibitor were able to block only the more soluble salt, the resolution 
would furnish instead of the 72% yield in entry 1, the pure less soluble salt in 72% × 0.55 = 
40% yield. 
Powerful nucleation inhibition effects were seen. These are well illustrated with O-acetyl 
mandelic acid (entry 2a). Instead of synthesizing both enantiomers of each additive, the 
other enantiomer of the resolving agent was chosen to resolve the racemate according to the 
Marckwald principle.
6  As can be seen from entries 2a/b, 3b/c and 4a/b, the combination of 
the same absolute configuration of the nucleation inhibitor with that of the resolving agent 
leads to high de’s in the precipitated salts and thus a strong nucleation inhibition effect. 
These stereochemical correlations parallel the “rule of reversal” postulated by Lahav et al 
as described in section 2.2.3.
7  
The additive used in entry 3a is racemic and works nearly as well as the optically pure 
additive in entry 3b. Of course, of the 6% racemic additive used in entry 3a, half consists of 
(S)-enantiomer, which is an excellent nucleation inhibitor. However, the optically pure 
additive in entry 6a shows strong nucleation inhibition whereas the racemate in 6b shows 
only minor nucleation inhibition effects. Most likely, the amount of the additive with the 
same absolute configuration as the resolving agent is too low to still be an effective 
nucleation inhibitor. Moreover, HPLC analysis of the precipitated salts show that some of 
this additive is incorporated in the less soluble salts, which makes its concentration in the 
solution lower and thus less effective as a nucleation inhibitor.  
As described before,
2 bifunctional additives based on 1-phenylethylamine show great 
potential as nucleation inhibitors. In entry 5, it is seen that also bifunctional mandelic acid 
derivatives can act as nucleation inhibitors. This inhibitor even inhibits the crystallization 
and/or growth of the less soluble diastereomeric salt as revealed by the low yield.  
Other chiral and achiral acids that do not resemble mandelic acid closely do not work as 
nucleation inhibitors as can be seen in entries 9, 15, 28, 29 and 30. Also the multi-
functional acids in entries 27 and 28 do not work efficiently as nucleation inhibitors.  
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Bulky groups in place of the alpha-proton of mandelic acid also did not give any 
improvement of the resolution as denoted in entries 14, 16, 20 and 23. 
The use of esters (entries 7 and 31), which cannot form salts, do not lead to any 
improvement in the resolution. Apparently, ability to form salts is crucial for effective 
nucleation inhibition in this system. 
The additives have a great variance in structure and also in effectiveness. Based on the 
results in Table 3.3, we might conclude that O-substituted mandelic acids with the same 
absolute configuration show potential as nucleation inhibitors. This is most likely because 
of end-capping of the hydrogen bonding network in the embryo after which this cannot 
grow further. Also, para-substituted mandelic acids with the same absolute stereochemistry 
work fine as nucleation inhibitors. Most substituents on the para-position of the phenyl ring 
effectively block the nucleation of the more soluble crystal because of sterics, charge and 
hydrogen bonding abilities. Why the (R)-p-methyl mandelic acid in entry 17 and the p-nitro 
mandelic acid in entry 10 do not work is unknown. 
Table 3.3 Results of resolutions of racemic 1-(3-methoxy-
phenyl)ethylamine with mandelic acid with 6 mol% of additives 
resembling the resolving agent. 
Entry Additive 
(R)- or 
(S)-MA 
mol% 
MA 
mol% 
NI 
Yield 
(%) 
de 
(%) 
S-
factor
e 
additive 
in salt 
1  None  R/S  100 - 72  10  0.14  - 
2a
a  (S) CO2H
OAc
 
S  94 6 42  97  0.81  <0.1% 
2b
a  ”  R  94 6 70  12  0.17 n.d.
f 
3a
b 
CO2H
OH
 
S  94 6 36  95  0.68 1% 
3b
b 
(S) CO2H
OH
 
S  94 6 42  95  0.80  <0.1% 
3c
b  ”  R  94 6 68  15  0.20 n.d.
f  
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Entry Additive 
(R)- or 
(S)-MA 
mol% 
MA 
mol% 
NI 
Yield 
(%) 
de 
(%) 
S-
factor
e 
additive 
in salt 
4a
a  (S) CO2H
OMe
 
S  94 6 40  96  0.77  <0.1% 
4b
a  ”  R  94 6 63  11  0.15 n.d.
f 
5
c  HO2C
OH
CO2H
OH
 
R  94 3 16  93  0.30  <0.1% 
6a
a  (R)
Br
CO2H
OH
 
R  94 6 40  93  0.73 4% 
6b
a 
Br
CO2H
OH
 
R  94 6 46  32  0.30 3% 
7
c  (R)
O
Br
O
O
 
R  100 6 67  12  0.15 n.d.
f 
8
c  (S) CO2H
OAc
Br  
S 
94 
 
6 31  99  0.61  <0.1% 
9
a 
(S) CO2H
OH
 
S  94 6 69  13  0.18 n.d.
f 
10
c 
O2N
CO2H
OH
 
S  94 6 60  26  0.31 2% 
11
c  CO2H
OH
 
S  94 6 66  13  0.17 n.d.
f 
12
c  CO2H
OH
 
S  94 6 26  94  0.48  <0.1%  
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Entry Additive 
(R)- or 
(S)-MA 
mol% 
MA 
mol% 
NI 
Yield 
(%) 
de 
(%) 
S-
factor
e 
additive 
in salt 
13
a 
(R) CO2H
OH
 
R  94 6 67  15  0.20 n.d.
f 
14
a 
CO2H H3C
OH
⋅0,5 H2O  
S  94 6 48  18  0.16  <0.1% 
15
a 
OBz
(R) HO2C
(R) CO2H
OBz
 
R  94 3 63  22  0.27 n.d.
f 
16
a 
CO2H
OH  
R  94 6 63  16  0.20 n.d.
f 
17
d  (R) CO2H
OH
 
R  94 6 64  15  0.19  <0.1% 
18
a  CO2H
OH
Br
 
R  94 6 63  19  0.23  <0.1% 
19
a  CO2H
Me
 
R  94 6 62  14  0.17 n.d.
f 
20
a  OH
CO2H
 
S  94 6 56  20  0.22 n.d.
f 
21
a  CO2H
OH Cl
 
S  94 6 52  15  0.15 n.d.
f 
22
a  CO2H
OH
Cl  
R  94 6 33  95  0.62 6%  
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Entry Additive 
(R)- or 
(S)-MA 
mol% 
MA 
mol% 
NI 
Yield 
(%) 
de 
(%) 
S-
factor
e 
additive 
in salt 
23
a 
(R)
CF3
CO2H
OMe
 
R  94 6 46  32  0.29 n.d.
f 
24
c  CO2H
OH
PhO
 
R  94 6 61  26  0.32 n.d.
f 
25
a  CO2H
OH
BnO  
R  94 6 35  95  0.67 3% 
26
a  CO2H
OH
 
R  94 6 66  12  0.16 n.d.
f 
27
a  HO2CC O 2H   R  94 3 68  10  0.14 n.d.
f 
28
a 
CO2H
OH HO2C
HO2C
 
R  94 2 67  25  0.30 n.d.
f 
29
a  CO2H HO   R  94 6 65  14  0.19 n.d.
f 
30
a 
CO2H
OH
 
R  94 6 66  19  0.25 n.d.
f 
31
a  (R) CO2Me
OH
 
R  100 6 74  10  0.15 n.d.
f 
a Commercially available. 
b Prepared according to literature.
8 
c See experimental section for 
preparation. 
d Prepared according to literature.
9 
e Resolution efficiency: S-factor = Yield × de × 
2.
5 
f not determined. 
 
3.2.3  Nucleation Inhibitors Based on the Racemate 
Inhibition should also apply to the racemate to be resolved. However, until now, no 
example with an increased S-factor has been found to validate this expectation.
1 We had 
previously observed high activity of certain bifunctional amines as inhibitors of  
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1-phenylethylamine as resolving agent.
2 Some of these compounds have been investigated 
as inhibitors in the resolution of (±)-3MeOPEA by (S)-MA. The results are shown in Table 
3.4. As can be concluded from the table, both more than one amine moiety per molecule 
and steric bulk (see entry 15) seem to be necessary to give a significant change in yield, de 
and S-factor. The tris amine in entry 7 even shows some inhibition of the less soluble salt 
similar to the bis acid in entry 5 in Table 3.3. 
Since none of the mono functionalized amines work, it is impossible to make claims about 
the use of optically pure additives based on the to be resolved material (entries 4 and 5 or 
11a and 11b) and its relation to the rule of reversal. The only enantio pure amine that was 
tested and has proven to be an effective nucleation inhibitor is the chiral bis-amine in 
entries 6a and 6b. The additive works equally well in both resolutions based on the 
Marckwald principle. It seems that the absolute configuration of bi-functional additives is 
of less importance in this system. 
Table 3.4 Results of resolutions of racemic 1-(3-methoxy-
phenyl)ethylamine with mandelic acid with 6 mol% of additives 
resembling the racemate. 
Entry Additive 
(R) or 
(S)-MA 
mol% 
3MeO
PEA 
mol%  
NI 
Yield 
(%) 
de 
(%) 
S-factor
e 
additive 
in salt 
1  None  R/S  100 - 72  10  0.14  - 
2
a 
NH2 NH2
 
S  94 3  32  96  0.61  <0.1% 
3
a 
NH2
NH2  
S  94 3  35  89  0.63  <0.1% 
4
b  (S)
NH2
 
S  94 6  43  23  0.20  <0.1%  
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Entry Additive 
(R) or 
(S)-MA 
mol% 
3MeO
PEA 
mol%  
NI 
Yield 
(%) 
de 
(%) 
S-factor
e 
additive 
in salt 
5
b  (R)
NH2
 
S  94 6  46  14  0.13  <0.1% 
6a
a 
(R)
NH2
(R)
NH2
 
S  94 3  32  97  0.62  <0.1% 
6b
a  ”  R  94 3  31  96  0.60  <0.1% 
7
c 
NH2 NH2
NH2  
S  94 2  27  95  0.51 4% 
8
c 
NH2 NH2
 
1,3-BAPB 
S  94 3  42  97  0.82 5% 
9
c 
NH2
OH  
S  94 6  75  12  0.18 n.d. 
10
b  (S)
(S)
NH2
NH2  
R  94 3  73  11  0.17 n.d. 
11a
a  (R)
NH2
MeO
 
R  94 6  69  12  0.17 n.d. 
11b
a  ”  S  94 6  69  13  0.17 n.d 
12
d 
NH2
MeO  
R  94 6  67  11  0.16 n.d.  
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Entry Additive 
(R) or 
(S)-MA 
mol% 
3MeO
PEA 
mol%  
NI 
Yield 
(%) 
de 
(%) 
S-factor
e 
additive 
in salt 
13
d 
NH2
 
R  94 6  69  19  0.27 n.d. 
14
c 
HN
MeO
(R)
OMe
 
S  94 6  64  10  0.12  <0.1% 
15
b 
NH2 H2N
 
S  94 3  69  13  0.15 1% 
16
b 
NH2
Br  
S  94 6  61  15  0.17 2% 
17
b 
H2N
 
R  94 6  69  14  0.20 n.d. 
18
c 
H2N
NH2
 
1,4-BAPB 
S  94 3  Additive  insoluble 
a Prepared according to literature.
10 
b Commercially available. 
c See experimental section for 
preparation. 
d Prepared according to literature.
8 
e Resolution efficiency: S-factor = Yield × de × 2.
5 
f 
not determined 
 
A remarkable observation is that an achiral bis-amine can be an extremely effective 
inhibitor. In entry 8 the results with 1,3-bis-[2-amino-2-propyl]benzene (1,3-BAPB) are 
given. Under the conditions of the resolution 1,3-BAPB is probably doubly protonated.  
The C2 conformation with the ammonium groups located up and down is chiral as depicted 
in Scheme 3.5. 
Both steric factors and charge repulsion could favor this conformation. Unfortunately an 
attempt to test this idea of a chiral conformation by use of 1,4-BAPB (entry 18), which  
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cannot have such a chiral conformation, was foiled by the total insolubility of the bis (S)-
MA salt in MEK. 
H3N NH3
 
Scheme 3.5 Possible chiral conformation of 1,3-BAPB. 
3.2.4  Nucleation Inhibition in Ternary Phase Diagrams 
A graphic representation in the form of a ternary phase diagram of the resolution of 
(±)-3MeOPEA with (S)-MA makes it possible to understand and predict the outcome of a 
normal resolution and of nucleation inhibitor enhanced resolutions also. 
 
Figure 3.1 Thermodynamic phase diagram of 3-MeOPEA-(S)-MA. The 
points in the diagrams represent the start compositions and the mother 
liquor compositions.  
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To determine the thermodynamic ternary phase diagram, suspensions were made with 
varying compositions of the (S)-MA salt of (R)- and (S)-3MeOPEA and treated like a 
typical resolution experiment as described in the experimental section. However, the 
mixtures were stirred at 20°C for 2 additional days to ensure that thermodynamic 
equilibrium had been reached.  The composition of the mother liquors was determined and 
with the method of algebraic extrapolation the compositions of the solids were determined.
6 
The phase diagram showed no end-solid solution behavior for either diastereomer (not 
shown). The compositions were plotted in a ternary phase diagram, depicted in Figure 3.1. 
Because of the poor solubility of the diastereomeric salts in MEK, only the top 2% of the 
phase diagram is shown. 
The maximum theoretical yield can be determined from the eutectic composition with 
Equation 3.1.
11 
 
% 100
1
5 . 0
max ×
−
−
=
eu
eu
x
x
y  
Equation 3.1 Resolvability from the eutectic value. 
Where: 
 y max   =  maximum yield of the isolated solids. 
 x eu    =  molar fraction of the more soluble diastereomer at the eutectic. A value of 
0.5 is racemic, 1.0 and 0.0 are the optically pure opposite enantiomers. 
The eutectic in Figure 3.1 lies at xeu = 0.29 (= 42% ee). This means the maximum yield in a 
thermodynamically driven resolution at an appropriate concentration is 30%,
12 provided 
that the material to be resolved is racemic. This means that by increasing the concentration 
of the salts and by addition of a small amount of nucleation inhibitor as denoted in Table 
3.3 and Table 3.4 where up to 97% de with 42% yield were found, the space-time yield 
should increase by 3–4 fold. In other words: a reactor of a certain volume can give 3 to 4 
times more product in the same period of time. 
Since the phase diagram in Figure 3.1 is determined after a couple of days stirring at 20°C 
and the small scale resolutions in Table 3.3 and Table 3.4 were performed in an overnight 
experiment, a phase diagram was constructed (not shown) under the same conditions as the 
small scale experiments. When the phase diagrams from this and the previous experiment 
were superimposed, no significant differences were found. It may be concluded that after a  
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normal resolution experiment as described above, thermodynamical equilibrium has been 
reached. 
A phase diagram was constructed for the case that 1% (S)-MA was replaced by 1% 
(S)-O-acetylmandelic acid (a strong nucleation inhibitor, see Table 3.3, entry 2). The results 
are depicted in Figure 3.2 which is a representation of the top 2% of the full phase diagram. 
 
Figure 3.2 Kinetic phase diagram of 3MeOPEA-(S)-MA with 1% 
(S)-O-acetylmandelic acid. The points in the diagrams represent the start 
compositions and the mother liquor compositions. 
In the phase diagram it is clear that the solubility of the less soluble diastereomer is not 
affected (lines A–C) because the compositions of the mother liquors is on its solubility line. 
However, at higher fractions of the more soluble diastereomer (lines D and E), the mother 
liquor is supersaturated in the more soluble diastereomer but does not crystallize. Thus, the 
composition of the mother liquor follows the elongated solubility line of the less soluble 
diastereomer (dotted line). At even higher fractions of the more soluble diastereomer (lines 
F–J), the effect becomes less pronounced and the system returns towards thermodynamic 
equilibrium (solubility line of the more soluble diastereomer) but does not reach it in this 
time frame.  
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3.2.5  Upscaling of the Resolution 
A larger scale resolution with 1,3-BAPB as additive (entry 8, Table 3.4) was examined. 
Starting from 40 gram of (±)-3MeOPEA-(S)-MA salt, a resolution in MEK with 0.5% and 
1.0% of the 1,3-BAPB-2(S)-MA salt as additive was performed and compared to a blank 
resolution (without additives) with the same concentration as the small scale resolutions 
from entry 1 in Table 3.3. In Figure 3.3 the blank resolution is shown. Sampling started one 
hour after the temperature reached 20°C (T0). The blank resolution illustrates that the de’s 
of the mother liquor and of the unwashed solids do not change much in time. 
 
Figure 3.3 Large scale resolution without nucleation inhibitor. The solids 
were sucked dry but not washed. Lines are provided as a guide for the 
eye. 
However, when 0.5 mol% of the 1,3-BAPB-2(S)-MA salt was added before the mixture 
was cooled to 20°C, the first sample of isolated solids after one hour at 20°C had >90% de 
as depicted in Figure 3.4. Note that the solids, collected by filtration, were not washed and 
hence, contain some mother liquor, lowering the measured de. However, a second sample 
after another hour had only 10% de in the collected solids and this percentage remained 
constant in time. Analysis by HPLC (not shown) established that after one hour, the 1,3-
BAPB was for the greater part incorporated in the precipitated less soluble salt. The 
resulting low concentration of additive in the mother liquor made the system unstable and 
in the next hour the more soluble salt also precipitated with incorporation of the rest of the 
additive leaving the system in thermodynamic equilibrium.   
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Figure 3.4 Large scale resolution with 0.5mol% 1,3-BAPB. The solids 
were sucked dry but not washed. Lines are provided as a guide for the 
eye. 
However, when 1.0 mol% 1,3-BAPB was used, the more soluble diastereomeric salt 
remained dissolved for at least 5 days as shown in Figure 3.5.
13 Analysis by HPLC 
established that only 0.38 % of the additive was still present in the mother liquor, the rest 
was incorporated in the precipitated less soluble salts. After these 5 days, the solids were 
collected, washed and dried to give the (S)-3MeOPEA-(S)-MA in 43% yield and 96% de 
(S-factor=0.83) which is in agreement with the small scale experiment in entry 8, Table 3.4. 
Apparently at least 0.5% additive is consumed during crystallization.
14 Obviously, also the 
mother liquor shows more enrichment: 79% de with additive compared to 53% de in the 
blank resolution (see Figure 3.3), which is very useful if the other enantiomer is required 
also. 
The latter experiment was repeated but when the mixture reached 20°C, the mixture was 
seeded with 670 mg of fine crystals of the less soluble (R)-3MeOPEA-(S)-MA salt. This 
seeding should stimulate the growth and secondary nucleation of the unwanted 
diastereomer. The mixture was mechanically stirred continuously and samples were taken 
regularly. The washed solids had ~95% de throughout the experiment (not shown) and after 
22 days the solids were isolated by filtration and washing. This yielded the less soluble (S)-
3MeOPEA-(S)-MA salt in yields and high de’s similar to the experiment that was not 
seeded with the more soluble diastereomer. Apparently, 1,3-BAPB is not only an excellent 
nucleation inhibitor, but also a highly effective growth inhibitor.  
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Figure 3.5 Large scale resolution with 1.0 mol% 1,3-BAPB. The solids 
were sucked dry but not washed. Lines are provided as a guide for the 
eye. 
3.3   Pope-Peachey and Nucleation Inhibitors 
In principle, a classical resolution requires only one-half equivalent of resolving agent for 
the less soluble diastereomer to crystallize, which is called the Marckwald method or the 
method of half-quantities.
6 However, since the solubility of the free racemate is not always 
high enough in the chosen solvent and double salts are more likely to form in such a 
resolution, Pope and Peachey
15 proposed a method where the remaining racemate is 
neutralized with one-half equivalent of an achiral acid or base. Replacing half of the 
relatively expensive resolving agent by a low-cost acid or base is economically very 
attractive.  
In a classical resolution, the concentration of the resolving agent thus is twice as high as in 
Pope-Peachey method and thus is the solubility of the less soluble diastereomer salt by the 
Pope-Peachey method twice as high as in a classical resolution. Note that the crystallization 
of the less soluble diastereomer still can occur although its solubility will be also doubled. 
To obtain the same solubility as in a classical resolution, half of the solvent should be taken 
or a solvent should be chosen in which the diastereomeric salt dissolves less well. 
The Pope-Peachey method was applied to the resolution of (±)-3MeOPEA with (S)-MA 
which, as shown in §3.2.2, is aided by addition of (S)-AcMA as depicted in Scheme 3.6.  
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Several achiral acids were screened with both racemic 3MeOPEA as with optically pure 
3MeOPEA. Acetic acid (AcOH) was an ideal candidate since this did not gave crystalline 
salts even after prolonged standing and thus will not crystallize during the resolution. The 
oily salts with AcOH dissolved smoothly in toluene and ether (Et2O). Because of the high 
boiling point of toluene, the salts of (±)-3MeOPEA with (S)-MA dissolve at reflux 
temperature but dissolve poorly at room temperature and thus can produce high yields. At 
room temperature the salts of (±)-3MeOPEA with (S)-MA dissolve less well in Et2O. 
However, because of the low boiling point of Et2O and subsequent low solubility at this 
temperature, Et2O could not be used in the resolution. However, the low solubility of the 
diastereomeric salts in Et2O at room temperature made it an ideal solvent to wash the 
isolated crystals. 
OAc
CO2H
OH
CO2H
(S)-MA
(S)-AcMA
MeO
NH2
(±)-3MeOPEA
, HOAc
 
Scheme 3.6 Pope-Peachey resolution by addition of an additive. 
In the first experiments, one-half equivalent AcOH, one-half equivalent of (S)-MA, varying 
amounts of (S)-AcMA (replacing the AcOH) as a nucleation inhibitor and one equivalent of 
racemic 3MeOPEA were combined with 10 mL toluene in reactor tubes, heated to reflux 
(dissolution), and the reactor tubes were stirred for 30 minutes at 70°C and subsequently 
cooled to 20°C at 0.1°C·min
-1. The results are shown in Table 3.5. 
Clearly, 1% (S)-AcMA (entry 4) prevents the nucleation of the more soluble diastereomer 
(R)-3MeOPEA,(S)-MA. This will keep the concentration of (S)-MA in solution higher, 
which will allow more of the less soluble diastereomer to crystallize. This results in nearly 
the same yield but much higher de’s. When less (S)-AcMA was added, the nucleation of the 
more soluble diastereomer could not be inhibited effectively and hence, a lower de was 
obtained. Note that the de’s found with these low concentrations of inhibitor are still 
somewhat higher than in the blank resolution in entry 1.  
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Table 3.5 Pope-Peachey resolution with varying amounts of (S)-AcMA 
with slow cooling starting at 70°C. 
Entry %(S)-AcMA % AcOH  yield (%)
a  de (%)
a S-factor
b 
1  none 50.0  47  53  0.51 
2  0.01 49.99  46  56  0.50 
3  0.1 49.9 47  61 0.56 
4  1.0 49.0 43  97 0.83 
a Results are averages of duplicate experiments.
b S-factor = yield × de × 2.
5 
 
During these first experiments it was noticed that crystals started to form in the 
equilibration period of 30 minutes at 70°C. In later experiments, the mixtures were 
equilibrated at 100°C for 30 minutes and subsequently cooled to 20°C at 0.1°C·min
-1. In 
these experiments it was observed that primary nucleation started at 89°C–84°C. This 
slower primary nucleation gave strikingly different results as given in Table 3.6.  
Table 3.6 Pope-Peachey resolutions with varying amounts of (S)-AcMA 
with slow cooling starting at 100°C. 
Entry %(S)-AcMA % AcOH  yield (%)
a  de (%)
a S-factor
b 
1  none 50.0  42–43  92–99  0.79–0.83 
2  0.05 49.95  41–42  98–99  0.81–0.83 
3  0.1 49.9  41–42  99  0.81–0.83 
4  0.5 49.5  41–42  99  0.81–0.83 
5  1.0 49.0  41–42  98–99  0.81–0.82 
a Results are the extremes of triplicate experiments.
b S-factor = yield × de × 2.
5 
 
The high de’s in the triplicate experiments without nucleation inhibitor (entry 1) may be 
explained by the slow primary nucleation together with fast secondary nucleation by the 
grinding action of the magnetic stirrer. The larger crystal surface generated by the grinding 
action of the magnetic stirrer will consume the supersaturation faster than the same  
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experiment without grinding. This will give more crystal mass of the less soluble 
diastereomer, which consumes (S)-MA from the solution and hereby producing a lower 
supersaturation of the more soluble diastereomer. Apparently, the metastable zone width in 
the blank resolution of entry 1 is large enough to prevent the primary nucleation of the 
more soluble diastereomer most of the time.  However, addition of very small amounts of 
nucleation inhibitor does make the process more reproducible (entries 2–5). 
The experiment with the lowest de (92%), started to crystallize at 84°C whereas the 
experiments with >98% de started to crystallize above 85°C. Screening Pope-Peachey 
resolutions in a test tube without a proper cooling program will, most likely, result in far 
from optimal (but thermodynamically driven) results. 
All samples were washed with 2 × 2 mL Et2O instead of 1 × 1 mL MEK in the classical 
resolution experiments described in §3.2. Better removal of the mother liquor explains the 
slightly higher de’s found in these experiments (99% de versus 97% de). 
The combination of small amounts of nucleation inhibitors, slow primary nucleation, 
secondary nucleation by the grinding action of the magnetic stirrer and a Pope-Peachey 
resolution clearly is an economical method to yield more product with less resolving agent. 
If the resolving agent needs to be recycled, only the precipitated salts need to be liberated 
since the mother liquor contains only small amounts of resolving agent. Note that the 
experiments with increased de are strictly kinetic in nature. When these experiments are left 
to stand for a prolonged time (hours, years or even centuries), the experiments will 
eventually give the same results as the experiment in Table 3.5, entry 1 as this is the 
thermodynamical outcome of this resolution. 
3.4   Experimental Section 
General Information: Reagents were obtained from commercial sources and used without 
further purification.  
Chiral HPLC analysis of 1-(3-methoxy-phenyl)ethylamine (3MeOPEA) salts was carried 
out on a Crownpak CR(-) column with an aqueous solution of HClO4 (pH 2) as eluent at 
20°C and 0.6 mL·min
-1. UV-VIS detection was performed at 192 nm. The salts were 
dissolved in eluent and injected as such. (R)-3MeOPEA Rf: 39.59 min, (S)-3MeOPEA Rf: 
42.98 min. When 1,3-bis(2-amino-2-propyl)benzene (1,3-BAPB) was used as additive, its 
percentage (against the sum of areas under both 3MeOPEA peaks) in the precipitated salts 
and mother liquors was measured with the same HPLC conditions (1,3-BAPB Rf: 9.17 
min).  
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RP-HPLC analysis of other additives was performed by comparing a solution of the 
precipitated salts with a solution of the additive. The separation was performed on a Zorbax 
Extend C18 (4.6 × 50 mm, 3.5 µm) column, mobile phase: Solution A: Solution B = 95:5 
(3 min) → (5 min) → 0:100 (4 min). Solution A: 9,65 g NH4Ac; 2250 mL H2O; 150 mL 
MeOH; 100 mL Acetonitrile, Solution B: 9.65 g NH4Ac; 250 mL H2O; 1350 mL MeOH; 
900 mL acetonitrile, at 1.0 mL·min
-1 and 22°C. Mass detection: API-ES. Amounts were 
determined relative to the area under the 3MeOPEA or MA peak without internal standard. 
1H-NMR and 
13C-NMR spectra were recorded on a Varian Mercury 300MHz machine. 
Chemical shifts are denoted in δ (ppm) and are referenced to the residual protic solvent. 
The coupling constant J is denoted in Hz. Splitting patterns are denoted as follows: 
s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet) and bs (broad singlet). 
Mass spectra were recorded by API-ES (electron spray ionization) by dissolving the 
samples in MeOH and injecting the solution as such. Mobile phase: acetonitrile : 0.1% 
formic acid in water 50 : 50 (1 min), flow: 0.2 mL·min
-1, injection volume: 5 µL. 
Resolutions with additives as described in §3.2: A typical resolution experiment was 
performed by charging a Kimble reactor tube (Ø 25 × 150 mm) with a PTFE coated egg-
shaped magnetic stirring bar (19 mm × 10 mm), 2.5 mL 0.13 M (±)-3MeOPEA in 
2-butanone (MEK) and 2.5 mL 0.13M (S)- or (R)-mandelic acid (MA) in MEK. This 
mixture was stirred and after some minutes, crystals started to form. When additives were 
used, an equimolar amount of (±)-3MeOPEA or MA was 
replaced by a solution of the additive so the whole system 
remained neutral and of equal volume. 
The suspension was heated to dissolution and placed in a 
Reactiv8 computer controlled reactor station as depicted in 
Figure 3.6 and stirred magnetically at 600 rpm and 70°C 
for 30 min. Then the tubes were cooled to 20°C at 
0.1°C·min
-1 and kept at 20°C for an additional 8 hours. 
The formed crystals were collected on pre-weighed 
disposable filters and washed with 1.0 mL MEK. The 
solids were subsequently dried in vacuo and weighed and 
the de of the salts was determined. 
The eutectic composition lies at 71 mol% of the more soluble (R),(S)-diastereomer in 
methylethyl ketone (MEK).  The solubility of the less soluble (S),(S)-diastereomer is 
4.2 mmol·L
-1 and that of the (R),(S)-diastereomer 8.4 mmol·L
-1. 
Figure 3.6 Reactiv8, 
computer controlled 
reactor station  
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Pope-Peachey resolutions with (S)-AcMA as described in §3.3: A typical Pope-Peachey  
resolution experiment was performed by charging a Kimble reactor tube (Ø 25 × 150 mm) 
with a PTFE coated egg-shaped magnetic stirring bar (19 mm × 10 mm), (±)-3MeOPEA 
(322 mg, 2.13 mmol, 1.0 eq), (S)-MA (162 mg, 1.06 mmol, 0.5 eq), AcOH (63 mg, 1.06 
mmol, 0.5 eq) in toluene (10 mL). This mixture was stirred and after some minutes, crystals 
started to form. When additives were used, an equimolar amount of AcOH and toluene 
were replaced by a solution of (S)-AcMA (41.35 mg·10 mL
-1 toluene) so the whole system 
remained neutral and of equal volume. 
The suspension was heated to reflux (dissolution) and placed in a Reactiv8 computer 
controlled reactor station as depicted in Figure 3.6 and stirred magnetically at 600 rpm and 
70°C (Table 3.5) or 100°C (Table 3.6) for 30 min. Then the tubes were cooled to 20°C with 
0.1°C·min
-1 and kept at 20°C for an additional 8 hours. The formed crystals were collected 
on pre-weighed disposable filters and washed with 2 × 2.0 mL Et2O. The solids were dried 
in vacuo, weighted and subsequently the de of the salts was determined. 
Large scale resolutions with and without 1,3-BAPB: A mixture of (±)-3MeOPEA 
(19.66 g, 130 mmol, 1.0 eq), (S)-MA (19.78 g, 130 mmol, 1.0 eq) and MEK (2.00 L) was 
mechanically stirred in a thermostated double jacketed 2 L flask at 20°C and the mixture 
was allowed to crystallize. At this point, 0.5 mol% or 1.0 mol% of 1,3-BAPB-2(S)-MA 
could be added: 323 mg or 646 mg respectively. The mixture was heated to 70°C and then 
stirred at this temperature for 30 minutes resulting in complete dissolution of the salts, the 
mixture was then cooled at 0.1°C·min
-1 to 20°C. When the mixture reached 20°C, samples 
of ~0.6 mL were taken hourly and the solids were collected and sucked dry. The evaporated 
mother liquor and filter cake were analyzed by chiral HPLC for de and amount of additive. 
From both de’s, the yield can be calculated.
16 Note that small amounts of mother liquor are 
still present in the solids and hereby lowering and fluctuating the de (and thus the yield) of 
the later. Proper washing of the filter cake of the salts obtained after 5 days from the 
resolution with 1.0% additive furnished 17.1g (43%) of salts with 96% de and contained 
1.4% 1,3-BAPB compared to 3MeOPEA. 
 (±)-1-(2-Methylphenyl)ethylamine. A mixture of 2-methyl acetophenone 
(24.9g, 186 mmol, 1.0 eq), formamide (110 mL) and formic acid (45 mL) 
was heated to reflux for 2 h. Once the formation of CO2 ceased, the 
mixture was cooled to room temperature before it was poured out in water 
(350  mL) and extracted with TBME (3 × 50 mL). The combined organic layers were 
washed with brine (25 mL), dried (Na2SO4) and concentrated in vacuo. The residue was 
heated to reflux in 10% HCl (250 mL) overnight and subsequently allowed to cool to room 
temperature. The reaction mixture was washed with TBME (3 × 50 mL) and then basified 
to pH 10 with conc. NaOH. The mixture was extracted with TBME (3 × 50 mL) and the 
NH2 
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combined organic layers were washed with brine (25 mL), dried (Na2SO4) and 
concentrated. This yielded a yellow oil with was further purified by distillation (0.03 mbar 
at 75°C) to furnish the title compound (15.5g, 62% yield) as a colorless oil. 
1H-NMR 
(300MHz, CDCl3): δ= 1.37 (d, J=6.6 Hz, 3H), 1.67 (bs, 2H), 2.37 (s, 3H), 4.37 (q, J=6.6 
Hz, 1H), 7.13 (d, J=0.9 Hz 1H), 7.15 (d, J=1.2 Hz, 1H), 7.20-7.27 (m, 1H), 7.48 (d, J=7.5 
Hz, 1H)  ppm. 
13C-NMR (75MHz, CDCl3): δ=  19.0, 24.5, 46.8, 124.0, 124.2, 126.4, 130.3, 
134.3, 145.6 ppm. MS (EI): m/z= 119 [M-NH3+H
+]. 
(±)-1-(3-Methoxyphenyl)ethylamine.  A mixture of 3-methyl 
acetophenone (100 mL, 726 mmol, 1.0 eq), formamide (440 mL) 
and formic acid (190 mL) was heated to reflux for 2h. After CO2 
evolution stopped, the mixture was cooled to room temperature 
before it was poured out in water (1 L) and extracted with TBME (3 × 150 mL). The 
combined organic layers were washed with brine (100 mL), dried (Na2SO4) and 
concentrated in vacuo. The residue was heated to reflux in 10% HCl (1.0L) overnight and 
subsequently allowed to cool to room temperature. The reaction mixture was washed with 
TBME (3 × 100 mL) and then basified to pH 10 with conc. NaOH. The mixture was 
extracted with TBME (3 × 150 mL) and the combined organic layers were washed with 
brine (100 mL), dried (Na2SO4) and concentrated. This yielded a brown oil which was 
further purified by distillation (0.006 mbar at 90°C) to furnish the title compound (66.5g, 
61% yield) as a colorless oil. 
1H-NMR (300MHz, CDCl3): δ= 1.38 (d, J=3.6 Hz, 3H), 1.55 
(bs, 2H), 3.81 (s, 3H), 4.09 (q, J=6.3, 1H), 6.75-6.79 (m, 1H), 6.90-6.91 (m, 2H), 6.93-7. 
ppm. 
13C-NMR (75MHz, CDCl3): δ= 25.9, 51.5, 55.4, 111.6, 112.3, 129.7, 149.9, 160.0 
ppm. MS (EI): m/z= 135[M-NH3+H
+]. 
(±)-2-{3-[carboxy(hydroxy)methyl]phenyl}-2-
hydroxyacetic acid. A mixture of isophthalaldehyde 
(1.14 g, 8.5 mmol, 1.0 eq), ZnI2 (54 mg, 0.17 mmol, 0.02 
eq) and I2 (43 mg, 0.17 mmol, 0.02 eq) were stirred in 
CH2Cl2 (20 mL). To this mixture was added trimethylsilyl 
cyanide (2.72 mL, 20.4 mmol, 2.4 eq) dropwise upon which the reaction mixture started 
boiling. The reaction mixture was kept at 40°C overnight. The mixture was subsequently 
allowed to cool to room temperature and was carefully treated with sat. NaHCO3 (20 mL). 
CO2 gas was formed. WARNING: the aqueous layer contains the toxic sodium cyanide. 
The aqueous layer was extracted with CH2Cl2 (2 × 20 mL) and the combined organic layers 
were washed with brine (20 mL), dried (Na2SO4) and concentrated to dryness. This 
delivered 2.76 g (65%) (±)-2-(3-{cyano[(trimethylsilyl)oxy]methyl}phenyl)-2-
[(trimethylsilyl)oxy]acetonitrile as a brown oil which was used without further purification. 
1H-NMR (300MHz, CDCl3): δ= 0.24 (s, 18H), 5.52 (s, 2H), 7.48-7.49 (m, 3H), 7.49 (s, 1H) 
NH2
MeO
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ppm. 
13C-NMR (75MHz, CDCl3): δ= 0.0, 63.5, 119.1, 124.3, 127.4, 129.9, 137.5 ppm. MS 
(EI): m/z=350 [M+NH4
+]. 
A solution of the cyanohydrin (1.92 g, 5.77 mmol, 1.0 eq) in dioxane (10 mL) was treated 
with 10% HCl (10 mL) and subsequently heated to 60°C for 6 hours after which the 
dioxane was removed by distillation. The residue was brought to pH 12 with conc. NaOH 
and washed with TBME (2 × 20 mL). The aqueous layer was filtered, brought to pH 1 with 
conc. HCl and washed with TBME (2 × 20 mL). The aqueous layer was concentrated to 
dryness and the residue stirred in acetone and filtered. The filtrate was concentrated to 
dryness to furnish 1.01 g (78%) of the title compound as a brown solid. 
1H-NMR (300MHz, 
DMSO-d6): δ= 5.03 (s, 2H), 6.90 (bs, 4H), 7.30-7.34 (m, 3H), 7.48 (s, 1H) ppm. 
13C-NMR 
(75MHz, DMSO-d6): δ= 72.99, 125.54, 126.83, 126.86, 128.68, 140.77, 140.78, 174.71 
ppm. MS (EI): m/z=225 [M-H
+], 451 [2M-H
+]. 
(R)-5-(4-bromophenyl)-2,2-dimethyl-1,3-dioxolan-4-one. 
To an ice-cooled solution of  (R)-4-bromomandelic acid
9 (25 
g, 108 mmol, 1.0 eq) in acetone (50 mL) was added 
concentrated H2SO4 (6.34 mL, 119 mmol, 1.1 eq) dropwise in 
5 minutes thereby keeping the temperature below 22°C. After 
addition, Na2SO4 (3.5 g) was added to the mixture and stirring was continued for another 
4.5 hours after which the reaction mixture was carefully poured out in a mixture of sat. 
NaHCO3 (350 mL) and ice (250 g). The resulting mixture was extracted with CH2Cl2 (1 × 
100 mL + 2 × 50 mL). The combined organic layers were washed with brine (50 mL), dried 
(Na2SO4) and concentrated to yield 15.4 g (53%) of the title compound as a yellow oil. 
1H-NMR (300MHz, CDCl3): δ= 1.67 (s, 3H), 1.71 (s, 3H), 5.34 (s, 1H), 7.35  (d, J=8.7 Hz, 
2H), 7.54 (d, J=8.4 Hz, 2H) ppm. 
13C-NMR (75MHz, DMSO-d6): δ= 26.1, 27.2, 75.1, 
111.2, 123.0, 128.0, 131.8, 133.5, 170.9 ppm. MS (EI): m/z= 229 [M+H2O-CH3(CO)CH3-
H
+]. 
(S)-2-(4-bromophenyl)-2-(acetyloxy)acetic acid. ( S)-4-
bromomandelic acid
9 (500 mg, 2.16 mmol, 1.0 eq) was 
suspended in CH2Cl2 (10 mL). Acetyl chloride (0.19 mL, 2.60 
mmol, 1.2 eq) and Et3N (0.33 mL, 2.38 mmol, 1.1 eq) were added dropwise and the 
resulting mixture was stirred for another hour after which the reaction mixture was poured 
out in ice water (10 mL) and extracted with CH2Cl2 (2 × 10 mL). The combined organic 
layers were washed with 1M HCl (10 mL) and brine (10 mL), subsequently dried (Na2SO4) 
and concentrated to dryness. This yielded 530 mg (90%) of the title compound as a white 
solid. 
1H-NMR (300MHz, DMSO-d6): δ= 2.11 (s, 3H),  5.80 (s, 1H), 7.41 (d, J=8.4Hz, 
O
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2H), 7.61  (d, J=8.4 Hz, 2H), 12.90 (bs, 1H) ppm. 
13C-NMR (75MHz, DMSO-d6): δ= 21.1, 
74.1, 123.0, 130.4, 132.3, 134.5, 170.2, 170.4 ppm. MS (EI): m/z= 271 [M-H
+]. 
(±)-4-nitromandelic acid. A mixture of 4-nitrobenzaldehyde 
(2.57 g, 17 mmol, 1.0 eq), ZnI2 (54 mg, 0.17 mmol, 0.01 eq) 
and I2 (43 mg, 0.17 mmol, 0.01 eq) were stirred in CH2Cl2 
(20 mL). To this mixture was added trimethylsilyl cyanide (2.72 mL, 20.4 mmol, 1.2 eq) 
dropwise upon which the reaction mixture started boiling. The reaction mixture was kept at 
40°C overnight. The mixture was subsequently allowed to cool to room temperature and 
was carefully treated with sat. NaHCO3 (20 mL) under expulsion of CO2 gas. WARNING: 
the aqueous layer contains the toxic sodium cyanide. The aqueous layer was extracted with 
CH2Cl2 (2 × 20 mL) and the combined organic layers were washed with brine (20 mL), 
dried (Na2SO4) and concentrated to dryness. This delivered 2.76 g (65%) (±)-2-(4-
nitrophenyl)-2-[(trimethylsilyl)oxy]acetonitrile as a brown oil which was used without 
further purification. 
1H-NMR (300MHz, CDCl3): δ= 0.27 (s, 9H), 5.58 (s, 1H), 7.66 (d, 
J=9.0 Hz, 2H), 8.27 (d, J=9.0 Hz, 2H) ppm. 
13C-NMR (75MHz, CDCl3): δ= -0.1, 62.9, 
118.4, 124.4, 127.4, 143.1, 148.7 ppm. MS (EI): m/z=177 [M+H
+]. 
A solution of the cyanohydrin (2.76 g, 11.0 mmol, 1.0 eq) in dioxane (10 mL) was treated 
with 10% HCl (10 mL) and subsequently heated to 60°C for 6 hours after which the 
dioxane was removed by distillation. The residue was brought to pH 12 with conc. NaOH 
and washed with TBME (2 × 20 mL). The aqueous layer was filtered, brought to pH 1 with 
conc. HCl and extracted with TBME (2 × 20 mL). The combined organic layers were 
washed with brine (20 mL), dried (Na2SO4) and concentrated to dryness to furnish 1.29 g 
(57%) of the title compound as an orange solid. 
1H-NMR (300MHz, DMSO-d6): δ= 3.90 
(bs, 1H), 5.23 (s, 1H), 6.10 (bs, 1H), 7.69 (d, J=9.0 Hz, 2H), 8.20 (d, J=8.7 Hz, 2H) ppm. 
13C-NMR (75MHz, DMSO-d6): δ= 72.4, 124.0, 128.4, 147.6, 148.3, 173.8 ppm. MS (EI): 
m/z=196 [M-H
+], 393 [2M-H
+].  
(±)-2-hydroxy-2-(naphthalen-1-yl)acetic acid. A mixture of 
1-naphthaldehyde (2.31 mL,   17 mmol, 1.0 eq), ZnI2 (54 mg, 0.17 
mmol, 0.01 eq) and I2 (43 mg, 0.17 mmol, 0.01 eq) were stirred in 
CH2Cl2 (20mL). To this mixture was added trimethylsilyl cyanide (2.72 
mL, 20.4 mmol, 1.2 eq) dropwise upon which the reaction mixture 
started boiling. The reaction mixture was kept at 40°C overnight. The mixture was 
subsequently allowed to cool to room temperature and was carefully treated with sat. 
NaHCO3 (20 mL). CO2 gas evolved. WARNING: the aqueous layer contains the toxic 
sodium cyanide. The aqueous layer was extracted with CH2Cl2 (2 × 20 mL) and the 
combined organic layers were washed with brine (20 mL), dried (Na2SO4) and concentrated 
CO2H
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to dryness. This delivered 3.63 g (83%) (±)-2-(naphthalen-1-yl)-2-[(trimethylsilyl)oxy]-
acetonitrile as a brown oil which was used without further purification. 
1H-NMR (300MHz, 
CDCl3): δ= 0.19 (s, 9H), 6.04 (s, 1H), 7.47 (t, J=7.8 Hz, 1H), 7.51-7.63 (m, 2H), 7.69 (d, 
J=7.2 Hz, 1H), 7.89 (d, J=8.1 Hz, 1H), 8.16 (d, J=8.7 Hz, 1H) ppm. 
13C-NMR (75MHz, 
CDCl3): δ= 0.1, 63.0, 119.4, 123.4, 125.3, 125.7, 126.6, 127.3, 129.2, 130.2, 130.7, 131.6, 
134.2 ppm. MS (EI): m/z= 229 [M-HCN+H
+]. 
A solution of the cyanohydrin (3.63 g, 14.2 mmol, 1.0 eq) in dioxane (10 mL) was treated 
with 10% HCl (10 mL) and subsequently heated to 60°C for 6 hours after which the 
dioxane was removed by distillation. The residue was brought to pH 12 with conc. NaOH 
and washed with TBME (2 × 20 mL). The aqueous layer was filtered, brought to pH 1 with 
conc. HCl and extracted with TBME (2 × 20 mL). The combined organic layers were 
washed with brine (20 mL), dried (Na2SO4) and concentrated to dryness to furnish 1.88 g 
(65%) of the title compound as a yellow solid. 
1H-NMR (300MHz, DMSO-d6): δ= 5.65 (s, 
1H), 6.10 (bs, 1H), 7.45-7.59 (m, 4H), 7.84-7.94 (m, 2H), 8.25-8.28 (m, 1H) ppm. 
13C-NMR (75MHz, DMSO-d6): δ= 71.7, 125.3, 126.0, 126.3, 126.4, 126.7, 128.9, 129.1, 
131.3, 134.1, 137.0, 175.0  ppm. MS (EI): m/z=201 [M-H
+].  
(±)-2-hydroxy-2-(naphthalen-2-yl)acetic acid. A mixture of 
2-naphthaldehyde (2.66 g, 17 mmol, 1.0 eq), ZnI2 (54 mg, 0.17 
mmol, 0.01 eq) and I2 (43 mg, 0.17 mmol, 0.01 eq) were stirred 
in CH2Cl2 (20mL). To this mixture was added trimethylsilyl 
cyanide (2.72 mL, 20.4 mmol, 1.2 eq) dropwise upon which the 
reaction mixture started boiling. The reaction mixture was kept at 40°C overnight. The 
mixture was subsequently allowed to cool to room temperature and was carefully treated 
with sat. NaHCO3 (20 mL). CO2 gas was formed. WARNING: the aqueous layer contains 
the toxic sodium cyanide. The aqueous layer was extracted with CH2Cl2 (2 × 20 mL) and 
the combined organic layers were washed with brine (20 mL), dried (Na2SO4) and 
concentrated to dryness. This delivered 3.41 g (78%) (±)-2-(naphthalen-2-yl)-2-
[(trimethylsilyl)oxy]acetonitrile as a brown oil, which was used without further 
purification. 
1H-NMR (300MHz, CDCl3): δ= 0.25 (s, 9H), 5.64 (s, 1H), 7.50-7.56 (m, 3H), 
7.83-7.92 (m, 4H) ppm. 
13C-NMR (75MHz, CDCl3):  δ= 0.07, 64.15, 119.43, 123.91, 
125.98, 127.00, 127.19, 128.05, 128.50, 129.36, 133.24, 133.82, 133.84 ppm. MS (EI): 
m/z= 229 [M-HCN+H
+]. 
A solution of the cyanohydrin (3.41 g, 13.4 mmol, 1.0 eq) in dioxane (10 mL) was treated 
with 10% HCl (10 mL) and subsequently heated to 60°C for 6 hours after which the 
dioxane was removed by distillation. The residue was brought to pH 12 with conc. NaOH 
and washed with TBME (2 × 20 mL). The aqueous layer was filtered, brought to pH 1 with 
OH
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conc. HCl and extracted with TBME (2 × 20 mL). The combined organic layers were 
washed with brine (20 mL), dried (Na2SO4) and concentrated to dryness to furnish 1.07g 
(40%) of the title compound as a yellow solid. 
1H-NMR (300MHz, DMSO-d6): δ= 5.28 (s, 
1H), 6.10 (bs, 1H), 7.52-7.65 (m, 3H), 7.91-8.01 (m, 4H) ppm. 
13C-NMR (75MHz, DMSO-
d6): δ= 71.7, 125.3, 126.0, 126.3, 126.4, 126.7, 128.9, 129.1, 131.3, 134.1, 137.0, 175.0  
ppm. MS (EI): m/z=201 [M-H
+]. 
(±)-3-phenoxymandelic acid. A mixture of 
3-phenoxybenzaldehyde (3.37 g, 17 mmol, 1.0 eq), ZnI2 
(54 mg, 0.17 mmol, 0.01 eq) and I2 (43 mg, 0.17 mmol, 
0.01 eq) were stirred in CH2Cl2 (20mL). To this mixture 
was added trimethylsilyl cyanide (2.72 mL, 20.4 mmol, 1.2 eq) dropwise upon which the 
reaction mixture started boiling. The reaction mixture was kept at 40°C overnight. The 
mixture was subsequently allowed to cool to room temperature and was carefully treated 
with sat. NaHCO3 (20 mL). CO2 gas was formed. WARNING: the aqueous layer contains 
the toxic sodium cyanide. The aqueous layer was extracted with CH2Cl2 (2 × 20 mL) and 
the combined organic layers were washed with brine (20 mL), dried (Na2SO4) and 
concentrated to dryness. This delivered 4.65 g (92%) (±)-2-(3-phenoxyphenyl)-2-
[(trimethylsilyl)oxy]acetonitrile as a brown oil, which was used without further 
purification. 
1H-NMR (300MHz, CDCl3): δ= 0.20 (s, 9H), 5.44 (s, 1H), 6.98-7.03 (m, 3H), 
7.08-7.19 (m, 3H), 7.31-7.37 (m, 3H) ppm. 
13C-NMR (75MHz, CDCl3): δ= -0.1, 63.4, 
116.6, 119.1, 119.5, 120.9, 124.0, 130.0, 130.5, 138.3, 156.7, 158.2 ppm. MS (EI): m/z= 
315 [M+NH4
+]. 
A solution of the cyanohydrin (4.48 g, 15.1 mmol, 1.0 eq) in dioxane (10 mL) was treated 
with 10% HCl (10 mL) and subsequently heated to 60°C for 6 hours after which the 
dioxane was removed by distillation. The residue was brought to pH 12 with conc. NaOH 
and washed with TBME (2 × 20 mL). The aqueous layer was filtered, brought to pH 1 with 
conc. HCl and extracted with TBME (2 × 20 mL). The combined organic layers were 
washed with brine (20 mL), dried (Na2SO4) and concentrated to dryness to furnish 3.10g 
(84%) of the title compound as a brown solid. 
1H-NMR (300MHz, DMSO-d6): δ= 5.02 (s, 
1H), 5.90 (bs, 1H), 6.88-6.93 (m, 1H), 6.97-7.02 (m, 2H), 7.04-7.06 (m, 1H), 7.09-7.19 (m, 
2H), 7.30-7.40 (m, 3H) ppm. 
13C-NMR (75MHz, DMSO-d6): δ= 72.0, 116.5, 117.7, 118.8, 
121.7, 123.6, 129.8, 130.1, 142.4, 156.5, 156.7, 173.8 ppm. MS (EI): m/z=243 [M-H
+]. 
(±)-1-[3,5-bis(1-aminoethyl)phenyl]ethan-1-amine.  To a solution of 1,3,5-
triacetylbenzene (5.00 g, 24.5 mmol, 1.0 eq) in pyridine (90 mL) was added hydroxylamine 
hydrochloride (17.0 g, 245 mmol, 10 eq) portionwise. The temperature rose to 34°C upon 
addition. The reaction mixture was heated to 75°C. After 30 minutes, the reaction mixture 
CO2H
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was allowed to cool to room temperature. The mixture was 
parted between water (3 × 50 mL) and EtOAc (400 mL). The 
organic layer was washed with brine (50 mL), dried (Na2SO4), 
concentrated and the last traces of pyridine were removed by co-
distillation with toluene (3x). This furnished 6.0 g (98%) N-(1-
{3,5-bis[1-(hydroxyimino)ethyl]phenyl}ethylidene)-
hydroxylamine. 
1H-NMR (300MHz, DMSO-d6): δ= 2.17 (s, 
9H), 7.88 (s, 3H), 11.27 (s, 3H) ppm. 
13C-NMR (75MHz, DMSO-d6): δ= 11.6, 122.8, 
137.2, 152.6 ppm. MS (EI): m/z= 191 [M-NH3+H
+]. 
The trisoxime (1.0 g, 4.01 mmol, 1.0 eq) was suspended in MeOH (50 mL) and Pd/C (10% 
Pd, 60 mg) was added carefully. The mixture was hydrogenated at ambient pressure. After 
2 days, 
1H-NMR showed complete conversion and the suspension was filtered over a path 
of Celite. The filtrate was concentrated to yield 0.70 g (85%) of the title compound as a 
colorless oil. 
1H-NMR (300MHz, CDCl3): δ= 1.39 (d, J=6.6Hz, 9H), 1.52 (bs, 6H), 4.12 (q, 
J=6.6Hz, 3H), 7.20 (s, 3H) ppm. 
13C-NMR (75MHz, CDCl3): δ= 25.8, 51.4, 121.6, 148.3 
ppm. MS (EI): m/z= 208 [M+H
+], 191 [M-NH3+H
+]. 
1,3-bis(2-amino-2-propyl)benzene (1,3-BAPB).  At 200°C and 
0.02mbar CeCl3·7H2O was dried for 2 hours to a white powder. 
Dry CeCl3 (11.5 g, 46.8 mmol, 6 eq) was suspended in fresh THF 
(250 mL) and heated to reflux for 1 hour. The suspension was 
cooled to -60°C and a solution of MeLi (~1.6M in Et2O, 29 mL, 
46.8 mmol, 6 eq) was added over 5 minutes which resulted in a yellow suspension. After 20 
minutes, a solution of 1,3-dicyanobenzene (1.0 g, 7.80 mmol, 1.0 eq) in fresh THF (20 mL) 
was added over 1 minute. The now orange suspension was allowed to warm to room 
temperature and after 3 hours the reaction mixture was poured out in water. The resulting 
mixture was brought to pH 10 with conc. NaOH and was subsequently parted with EtOAc 
(3 × 200 mL) and solids were removed during the first extraction and discarded. The 
combined organic layers were washed with brine (100 mL), dried (Na2SO4) and 
concentrated to yield a brown oil which was purified by column chromatography over silica 
with a gradient of 1M NH3 in MeOH and CH2Cl2. This yielded 0.78 g (52%) of the pure 
title compound. 
1H-NMR (300MHz, CDCl3): δ= 1.51 (s, 12H), 1.66 (bs, 4H), 7.25-7.37 (m, 
3H), 7.67-7.69 (m, 1H) ppm. 
13C-NMR (75MHz, CDCl3): δ= 33.1, 52.7, 121.0, 122.7, 
128.1, 150.3 ppm. MS (EI): m/z= 159 [M-2NH3+H
+], 176 [M-NH3+H
+]. 
1,4-bis(2-amino-2-propyl)benzene (1,4-BAPB).  T h e  
compound was prepared in a similar way as the procedure for 
1,3-BAPB. This yielded the pure title compound in 0.60 g 
H2N
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(40%) as white solid. 
1H-NMR (300MHz, CDCl3): δ= 1.42 (s, 12H), 1.52 (bs, 4H), 7.39 (s, 
4H) ppm. 
13C-NMR (75MHz, CDCl3): δ= 32.9, 52.2, 124.6, 148.3 ppm. MS (EI): m/z= 159 
[M-2NH3+H
+], 176 [M-NH3+H
+]. 
(±)-1-[4-(1-aminoethyl)phenyl]ethan-1-ol. A solution of (±)-
1-(4-bromophenyl)ethan-1-amine (2.0 mL, 14.0 mmol, 1.0 eq) 
in CH2Cl2 (20 mL) was treated with Boc2O (3.66 g, 16.8 mmol, 
1.2 eq) and the temperature rose from 18°C to 27°C with gas evolution. After 10 minutes a 
suspension forms. After 90 minutes the reaction mixture was concentrated and the residue 
was stirred in Et2O (10 mL). The solids were collected by filtration and dried on air. This 
yielded 3.52 g (84%) of (±)-tert-butyl-N-[1-(4-bromophenyl)ethyl]carbamate as a white 
solid. 
1H-NMR (300MHz, CDCl3): δ= 1.36-1.43 (m, 12H), 4.71 (bs, 1H), 4.75-4.83 (m, 
1H),  7.16 (d, J=8.7Hz, 2H), 7.43 (d, J=8.4Hz, 2H) ppm. 
13C-NMR (75MHz, CDCl3): δ= 
22.7, 28.5, 49.8, 49.7, 120.9, 127.7, 131.7, 143.4, 155.1 ppm. MS (EI): m/z= 183 
[M-NH2Boc+H
+], 322 [M+Na
+]. 
The bromide (3.5 g, 11.7 mmol, 1.0 eq) was dissolved in THF (25 mL) and cooled to 
-78°C. A solution of n-BuLi (2.5M in hexane, 10.3 mL, 25.6 mmol, 2.2 eq) was added 
dropwise so the temperature was kept below -65°C. On addition, a very thick suspension 
was formed and extra THF (5 mL) was added to keep the reaction mixture stirable. Next, 
acetaldehyde (1.65 mL, 29.3 mmol, 2.5 eq) was added to the suspension in one portion 
upon which the internal temperature rose to -44°C and a clear solution was formed. The 
reaction mixture was allowed to warm to room temperature and was subsequently parted 
between water (20 mL) and EtOAc (2 × 50 mL). The combined organic layers were washed 
with brine (20 mL), dried (Na2SO4) and concentrated to a colorless oil which was stirred in 
CH2Cl2 (20 mL). The resulting solids were removed by filtration and the filtrate was 
concentrated. The resulting oil was purified by column chromatography over silica with 
25:75 EtOAc:heptanes as eluent. The compound with Rf 0.22 proved to be the desired (±)-
tert-butyl N-{1-[4-(1-hydroxyethyl)phenyl]ethyl} carbamate. This compound was isolated 
as a colorless oil (2.85 g, 92%). 
1H-NMR (300MHz, CDCl3): δ= 1.40-1.50 (m, 12H), 4.78 
(bs, 1H), 4.86-4.92 (m, 1H), 7.27 (d, J=9.0Hz, 2H) ppm. 
13C-NMR (75MHz, CDCl3): δ= 
22.7, 25.2, 28.5, 49.9, 70.0, 79.5, 125.7, 126.0, 143.3, 144.9, 155.2 ppm. MS (EI): m/z= 288 
[M+Na
+]. 
The Boc protected amine (500 mg, 1.89 mmol, 1.0 eq) was suspended in CH2Cl2 (20 mL) 
and trifluoroacetic acid (0.84 mL, 11.3 mmol, 6 eq) was added after which the reaction 
mixture became a clear solution and was heated to reflux for 2 days. 
1H-NMR showed 
complete conversion. The reaction mixture was concentrated and stirred at room 
temperature in a mixture of THF (3 mL) and 1M NaOH (6 mL) for 2. Then the THF was 
HO NH2 
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removed by distillation and the aqueous mixture was extracted with EtOAc (2 × 20 mL). 
The combined organic layers were washed with brine (10 mL) and concentrated to yield 
250 mg (80%) of the title compound as a white solid. 
1H-NMR (300MHz, CDCl3): δ= 1.37 
(d, J=6.6Hz, 3H), 1.49 (d, J=6.3Hz, 3H), 1.80 (bs, 3H), 4.10 (q, J=6.6Hz, 1H), 4.88 (q, 
J=6.3Hz, 1H), 7.29-7.36 (m, 4H) ppm. 
13C-NMR (75MHz, CDCl3): δ= 25.3, 25.4, 51.0, 
69.7, 125.7, 125.8, 126.5, 145.0 ppm. MS (EI): m/z= 131 [M-NH3-H2O+H
+], 149 [M-
NH3+H
+]. 
[(1R)-1-(3-methoxyphenyl)ethyl][(±)-1-(3-
methoxyphenyl)ethyl]amine. A mixture of (R)-1-(3-
methoxyphenyl)ethan-1-amine (0.895 g, 5.92 mmol, 1.0 
eq), 3-methoxyacetophenone (0.816 mL, 5.92 mmol, 
1.0 eq), Ti(O
iPr)4 (5.3 mL, 17.8 mmol, 3.0 eq) was 
stirred for 20 minutes and became warm to the touch. 
Pd/C (10% Pd, 120 mg) was added and a hydrogen atmosphere was applied by a balloon 
overnight. The reaction mixture was basified with 1M NaOH (25 mL), EtOAc (20 mL) was 
added and the resulting mixture was filtered over a pad of Celite. The aqueous layer was 
extracted with more EtOAc (2 × 10 mL). The combined organic layers were washed with 
brine (20 mL), dried (Na2SO4) and concentrated to dryness. The title compound was 
isolated as a colorless oil (1.43 g, 85%). RP-HPLC analysis of the material revealed an 1:10 
mixture of diastereomers. 
1H-NMR (300MHz, CDCl3): δ= 1.28 (d, J=6.6Hz, 6H), 3.51 (q, 
J=6.6Hz, 1H), 3.82 (s, 6H), 6.75-6.83 (m, 6H), 7.22-7.28 (m, 2H) ppm. 
13C-NMR (75MHz, 
CDCl3): δ= 25.01, 55.27, 55.30, 112.21, 112.30, 112.36, 112.39, 119.21, 129.48, 147.66, 
159.90 ppm. MS (EI): m/z= 286 [M+H
+]. 
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16  Determination of the yield from the compositions of both solids and mother liquor 
  determined by chiral HPLC: 
 Where:       
 a     = mass  solids  precipitated 
  b      =  mass material in the mother liquor 
 R start / Sstart  =  mass of (R) / (S) enantiomer at the start of the experiment 
 R sf / Ssf    =  fraction of (R) / (S) enantiomer in the precipitated salts (range: 0-1) 
 R MLf / SMLf  =  fraction of (R) / (S) enantiomer in the mother liquor (range: 0-1) 
  Yield    =  percentage of the precipitated solids. 
  
  The overall composition is divided between the crystallized material and the material in 
  the mother liquor: 
  MLf sf start R b R a R × + × = Î 
sf
MLf start
R
R b R
a
× −
=     ( 3 . 2 )  
  MLf sf start S b S a S × + × =            ( 3 . 3 )  
  When equations 3.2 and 3.3 are combined, equation 3.4 is derived: 
  MLf
sf
sf MLf
sf
sf start
start S b
R
S R b
R
S R
S × +
× ×
−
×
=       (3.4) 
  The fraction of total material in solids and mother liquor is, of course, 1:
  sf sf S R − =1          ( 3 . 5 )  
  MLf MLf S R − =1            ( 3 . 6 )  
  When equations 3.4, 3.5 and 3.6 were combined, equation 3.7 was derived. 
  MLf
sf
MLf sf
sf
sf
sf
sf start
start S b
S
S S b
S
S b
S
S R
S × +
−
×
+
−
×
−
−
×
=
1 1 1
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  Î  
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MLf sf
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sf
MLf
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sf start
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S
S S
S
S
S
S
S R
S
b
−
×
+
−
−
−
×
−
=
1 1
1
             ( 3 . 7 )  
When ‘a’ and ‘b’ are calculated from the chiral HPLC data, the yield can be determined: 
  % 100 ×
+
=
b a
a
Yield            ( 3 . 8 )  
When the ee of the mother liquor and the solids both approach 0%, then the equations 
above are not useful to determine the yield since the error will be large.     
Chapter 4 
 
The Effect of Additives 
 
 
 
 
 
In this chapter the resolutions of racemates by diastereomeric salt formation which 
are modified by additives are described. Polymorphic transitions and nucleation 
inhibition have been observed. Furthermore, generation of supersaturation by 
abrasive grinding followed by dissolution of small particles and resolution by 
solid-solution formation of cyclic phosphoric acid families is described also.  
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4.1   Introduction 
Crystallization of mixtures of compounds, closely related in structure lead to behavior that 
differs from that of mixtures without these additives as shown in first
1 and second
2 
generation Dutch Resolution. These compounds can be effective nucleation inhibitors
3, 
habit/growth modifiers
4 and polymorph inhibitors,
5 all of which are of great interest to the 
chemical industry. 
As described in Chapter 3, a resolution by diastereomeric salt formation (hereafter called 
resolution) can benefit from the addition of certain molecules which resemble either the 
resolving agent or the racemate. In Chapter 3 the main focus was on the resolution with 
mandelic acid. For other frequently used resolving agents like tartaric acid (TA) and 
O,O’-dibenzoyl tartaric acid (DBTA) (see Scheme 4.1), additives have not been described. 
However, for DBTA
1 a family of resolving agents is available, which can be tested as 
additives. 
OH
(R)
(R)
HO2C
CO2H
OH
L-TA
O
(R) (R)
CO2H
HO2C
O
L-DBTA
O
O
 
Scheme 4.1 Frequently used acidic resolving agents. 
In this section the design, synthesis and testing of these compounds as additives in 
resolutions with these resolving agents is described. 
4.2   Resolution of (±)-PEA with DBTA 
The resolution of racemic 1-phenylethylamine (PEA) with L-dibenzoyltartaric acid 
(DBTA), as shown in Scheme 4.2, was investigated. The resolution was performed in a 
mixture of isopropanol and water (4:1). The blank resolution (entry 1 in Table 4.1) 
proceeded reasonably but might be improved by the addition of nucleation inhibitors. 
Several additives that resembled the resolving agent, with the same absolute configuration, 
were tested.  
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+
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Scheme 4.2 Resolution of (±)-1-phenylethylamine with L-dibenzoyl 
tartaric acid. 
Table 4.1 Results of resolutions of (±)-PEA with L-DBTA with additives. 
Entry Additive %  additive
b Yield  (%)
a  de (%)
a S-factor
c 
1  none -  53  49  0.52 
2
d 
O
(R) (R)
CO2H
HO2C
O
O
O
Me
Me  
6 49  57  0.56 
3
d 
O
(R) (R)
CO2H
HO2C
O
O
O
Me
Me
 
6 55  41  0.45 
4
d 
O
(R) (R)
CO2H
HO2C
O
O
O
OMe
MeO  
6 49  59  0.57 
a All results are averages of duplicates. 
b Less L-DBTA was added to compensate for the 
acid groups of the additives so the system was kept neutral and of equal volume. 
c S-factor = 
yield × de × 2.
7 
d Commercially available. 
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No large improvements were seen with these additives. The additive in entry 3 even shows 
a decrease in de. The samples were investigated with X-Ray Powder Diffraction (XRPD) 
and the results are given in Figure 4.1. The top two spectra represent the pure 
diastereomers, which were crystallized from the same solvent mixture. Careful examination 
of the XRPD spectra of these separate (S)-PEA,L-DBTA (less soluble) and (R),L (more 
soluble) diastereomers and the resolution without additives (blank) shows that the blank 
experiment does not contain these separate pure diastereomer crystals. This can be 
explained by either (end-)solid solution formation between the diastereomers or 
polymorphism. 
 
Figure 4.1 XRPD of solids obtained from single diastereomers and 
resolutions. 
The solids of the experiments with additives were investigated also. The XRPD spectra a, b 
and c correspond to entries 2, 3 and 4 in Table 4.1 respectively. On first glance there is no 
difference. However, small peak changes were found in spectrum b, highlighted with 
circles. This indicates incorporation of the additive in the crystals and/or polymorphism of 
one or both of the diastereomers. Indeed, HPLC analysis of the solids indicated the 
presence of the additive. Since the PEA salt of this additive does not crystallize at 20°C at 
the concentration used in this experiment, it must form a solid solution with one or both  
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crystallized diastereomers and hence, slightly alter the XRPD. However, with this 
information, the formation of a different polymorph cannot be ruled out.  
The other additives do not reveal a different XRPD than obtained in the blank experiment. 
The small increase in de in entries 2 and 4 can be explained by poor nucleation/growth 
inhibition and higher dilution since in the experiments with additives, 94% resolving agent 
was used compared to 100% in the blank resolution in entry 1.  
4.3   Resolution of (±)-PEA with TA 
The resolution of racemic 1-phenylethylamine (PEA) with tartaric acid (TA) is depicted in 
Scheme 4.3. This had been described as a low cost experiment which chemistry students 
could perform.
6 According to the article, the resolution was performed with D-TA and 
delivered (–)-PEA in a good yield and high ee after liberation. However, repeating this 
experiment delivered the opposite enantiomer, (+)-PEA in a similar yield and ee. Most 
likely, the author made a typing error. Moreover, since the experiment is described to be a 
low cost experiment, it seems illogical to use the more expensive D-TA than the low cost 
L-TA. The article also mentions that the formed salt is the “(–)-amine-(+)-hydrogen 
tartrate” which is consistent with the positive optical rotation of L-TA. 
The author mentioned that most students obtained (S)-PEA in more than 95% ee after 
liberation of the crystals. This indicates that the least soluble diastereomeric salt does not 
form an end-solid solution (or at least not a large one). The yield of such a resolution could 
be improved by the addition of nucleation inhibitors if the concentration were to be 
increased. 
NH2
(±)-PEA
Less soluble salt: (S),L
+
More soluble salt: (R),L
OH
(R)
(R)
HO2C
CO2H
OH
L-TA
 
Scheme 4.3 Resolution of (±)-1-phenylethylamine with L-tartaric acid. 
The resolution in the article was performed in boiling methanol. This furnishes the 
diastereomeric salt in 32% yield and 95% de (S-factor: 0.61)
7 which is not a bad resolution 
as such. However, higher yields could be obtained either by further cooling or utilization of  
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a higher boiling solvent since the solubility increases at higher temperatures. A phase 
diagram was constructed for (±)-PEA and L-TA in the higher boiling ethanol in stead of 
methanol, at 20°C (black) and 70°C (grey) as shown in Figure 4.2.  
 
Figure 4.2 Top 6% of the ternary phase diagram for the L-tartaric acid 
salt of (±)-1-phenylethylamine at 20°C (black)  and 70°C (grey). 
As can be seen from the phase diagram, the solubility of the racemic material is more than 
four fold higher at 70°C than at 20°C. Furthermore, starting from point A at 70°C delivered 
nearly pure (S),L when filtered at 70°C which tells us that (nearly) no end-solid solution is 
formed. No large differences in end-solid solution formation are expected at 20°C. An 
additive that inhibits the more soluble diastereomer successfully then should furnish solids 
with high de’s.  
Point B represents a racemic mixture that is saturated in (S),L at 70°C. Thus starting from a 
racemic mixture, the highest concentration at which a clear solution is obtained at 70°C is 
point B. When this mixture is then cooled to 20°C, point B is located in the region where 
only (S),L is supersaturated and will start to crystallize. Since the more soluble diastereomer 
(R),L is not saturated, it will not crystallize and hence, cannot be inhibited by additives. 
Since only the nucleation of the more soluble diastereomer has to be inhibited, the starting 
point does not necessarily need to be located above point B where both the more and the 
less soluble diastereomers are under-saturated. Each mixture between point B and C 
represent mixtures in which the more soluble diastereomer is under saturated but the less 
soluble diastereomer has crystallized at thermodynamic equilibrium. Since only the more 
soluble diastereomer needs to be inhibited it needs to be dissolved at the start of the cooling  
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program. The less soluble diastereomer however, may have crystallized at the start of the 
cooling program since it does not need to be inhibited. Thus a resolution with an effective 
nucleation inhibitor and starting from a mixture located between points B and C could 
deliver pure (S),L and will produce higher yields than a mixture with lower concentrations. 
A downside to this procedure is that the operator of the resolution now cannot visually 
inspect whether the more soluble diastereomer has dissolved. However, the phase diagram 
has shown that this is the case at point A and thus an ideal starting point for the resolution 
aided with a nucleation inhibitor and furnishes 80% yield and 19% de (S-factor: 0.30) as 
given in Table 4.2, entry 1.  
The experiments in Table 4.2 are performed with D-TA and not with L-TA which only 
means that the least soluble diastereomer is (R),D and the more soluble diastereomer is 
(S),D. If an additive would work as a nucleation inhibitor on the more soluble (S),D 
diastereomer, this would give 100% de and 48% yield (S-factor: 0.95) of the less soluble 
(R),D diastereomer.  
It is clear that the addition of additives did not result in the expected >95% de. Only the bi-
functional additive in entry 5 and the mixtures in entries 10 and 11 gave a reasonable 
increase in resolution efficiency. Combinations of additives in entries 10 and 11 do not 
seem to give higher efficiencies than the bi-functional additive in entry 5 alone. 
Since the phase diagram in Figure 4.2 indicated that there was no end-solid solution present 
it is strange to see that some of the additives give an effect on the resolution but >95% de 
was never found. This might be explained by poor nucleation inhibition performance or by 
polymorphism. To investigate this, the crystals of some of the resolutions were investigated 
by XRPD 
First, the blank experiment was compared to the separate diastereomers, (S),L (less soluble) 
and (R),L (more soluble) which shows that the blank experiment is indeed the “sum” of its 
separate diastereomers and thus does not form a measurable end-solid solution. 
The XRPD spectra a–d corresponds to entries 8–11 in Table 4.2 respectively. The duplicate 
experiment in entry 11 gave two different spectra which are shown in Figure 4.3 as d1 and 
d2. Strikingly, all of the experiments with additives have completely different XRPD 
spectra than the resolution without additives (blank) even though the increase in de was 
minimal. This means that all the additives effectively block the nucleation of both 
diastereomers present in the blank experiment. For experiments a,  b,  c and d2 this is 
visually most evident in the peak at 2θ: 6.0º but also other peaks are different than the blank 
experiment. The spectrum d1 shows even other polymorphs than all the other experiments.  
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Table 4.2 Results of resolutions of (±)-PEA with L-TA aided by additives. 
Entry Additive
a %  additive
b Yield  (%) de (%)  S-factor
c 
1  none -  80  19  0.30 
2
d 
NH2 NH2
 
3 64  21  0.27 
3
e 
OH
(R)
(S)
HO2C
CO2H
OH  
6 74  26  0.38 
4
e 
OH
(R) HO2C
CO2H
 
6 74  32  0.47 
5
e 
NH2 NH2
 
3 52  64  0.67 
6
e 
(S)
(R)
HO2C CO2H
O
 
6 73  26  0.37 
7
e 
OH
HO2C  
12 72  29  0.42 
8
f 
OAc
(S)
(S)
HO2C
CO2H
OAc  
6 72  22  0.32 
9
f 
OAc
(S)
(S)
HO2C
CO2H
OH  
6 72  21  0.30 
10  entry 5 + entry 8  3 + 6  55  59  0.65 
11  entry 5 + entry 9  3 + 6  47  60  0.56 
a All results are averages of duplicates. 
b Less (±)-PEA and/or L-TA were added to 
compensate for the additives acidic or basic groups so the system was kept neutral and of 
equal volume. 
c S-factor = yield × de × 2.
7 
d Synthesis described in chapter 3.                       
e Commercially available. 
f Synthesis described in the experimental section. 
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It may be concluded that although the effect of an additive does not result in an impressive 
increase in resolution efficiency, it can have an effect on the polymorph in which the 
diastereomers crystallize. Perhaps a mixture of carefully chosen additives can prevent the 
nucleation of less stable polymorphs also and thus give an increase in resolution efficiency. 
 
Figure 4.3 XRPD of the solids collected after resolution experiments. 
4.4   Dissolution by Abrasive Grinding 
Addition of glass beads and an additive to a stirred suspension of crystals can have 
profound effects as will be made clear in this section and Chapter 5. 
4.4.1  Dissolution of Diastereomers in Saturated Mixtures 
Nucleation inhibitors can make excellent growth inhibitors as shown in §3.2.5. In that 
section, seeding of the less soluble (R)-3MeOPEA-(S)-MA did not result in crystal growth 
because of the presence of only 1.0 mol% of 1,3-BAPB. This achiral additive inhibits not 
only the nucleation of the more soluble salt but also blocks the growth of seeds of the more 
soluble salt.   
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Depicted in Scheme 4.4 is the crystallization of a diastereomeric salt. Crystallizations take 
place by forming aggregates in solution (pathways ax/y) which can re-dissolve (bx/y). When 
these aggregates grow to a certain critical size they form crystals (cx/y) which is know as 
primary nucleation. Once crystals have formed, these can grow further via pathway ex/y 
(secondary nucleation). 
 
Scheme 4.4 Resolution of (±)-3MeOPEA with (S)-MA aided by 
1,3-BAPB. 
If an additive (1,3-BAPB in Scheme 4.4) functions as a nucleation and a growth inhibitor 
only for the more soluble diastereomer, it blocks pathways ax and/or cx and ex but leaves 
pathways ay, cy and ey, which describe the crystallization of the less soluble salt, untouched. 
Of course, had the additive been added after the more soluble salt crystallized, it cannot 
spontaneously re-dissolve the more soluble diastereomeric salt (pathways bx and dx). When 
a supersaturated mixture containing a nucleation inhibitor that does not function as a 
growth inhibitor, thus only blocks pathways ax and cx, is seeded with crystals of the less 
soluble diastereomer, crystal growth of the seeds will take place via pathway ex.   
The Gibbs-Thomson relationship states that extremely small particles have a higher 
solubility than larger particles.
8 However, small particles suspended in their own saturated 
solution undergo Ostwald ripening. In this process, larger particles grow by consuming 
smaller particles via the liquid phase.
9 Thus, if crystals are grown in suspension, they have 
to be milled continuously to keep the average crystal size small. Higher milling efficiencies  
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will then give smaller particles and thus higher concentrations of the dissolved compound. 
It must be noted that a noticeable increase in solubility is difficult to achieve. However, if 
the Ostwald ripening process could be blocked by an effective additive, even relatively 
slow milling will, in time, produce extremely small particles with a certain higher solubility 
and could dissolve all material in the solid phase if the mass of particles is not too high.   
Furthermore, smaller particles dissolve faster than their larger counterparts since the surface 
to volume ratio is larger. This phenomenon is important in the washing step of the filter 
cake during the isolation.
10 
This grinding procedure was applied to the resolution in Scheme 4.4 where the more 
soluble diastereomer has already crystallized and the additive (that only affects the more 
soluble diastereomer) is added once the thermodynamic equilibrium has been achieved. 
Abrasive grinding of the solids should not affect the concentration of the less soluble 
diastereomer in solution (not via pathway by and dy) much but should dissolve some or all 
of the more soluble diastereomer via pathways bx  and d x  and simultaneous blocking 
pathways ax, cx and ex. 
Four experiments were performed in which the effects of abrasive grinding and the additive 
were tested. Every experiment contained an egg-shaped magnetic stirrer and a suspension 
of both more and less soluble diastereomer. This mixture was crystallized overnight and the 
de of the solid phase was 58-68% after washing (t0). Experiment 1 was left unaltered. Glass 
beads were added to experiment 2. To experiment 3, 3 mol% of 1,3-BAPB·2(S)-MA was 
added and experiment 4 was charged with both glass beads and 3 mol% 
1,3-BAPB·2(S)-MA. All four flasks were then stirred at 900 rpm. Samples were taken 
regularly and the de’s were determined of the washed solids and the mother liquors 
(without washings).  The results for the solids are given in Figure 4.4, and the results for the 
mother liquors are given in Figure 4.5. 
The experiments which only grind the available crystals (exp 2 and to a lesser degree, exp 
1) do not show a significant increase in de in the mother liquor as expected. However, a 
decrease in de in the solids phase was observed. This can be explained by some loss of 
mother liquor via the capillary space between the stopper and the ground glass joint by the 
strong stirring action which was accompanied with some spattering of the suspension and 
air pressure differences over the time of the experiment. This was confirmed by some solid 
salts on the top of the joint that remained after evaporation of the solvent. 
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Figure 4.4 Progression of the de of the solid phases. Lines are provided 
as a guide for the eye. 
 
 
Figure 4.5 Progression of the de of the mother liquors. Lines are 
provided as a guide for the eye.  
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The mother liquors of experiments 3 and 4, which both contain the growth inhibitor, show 
an increase in de from 45% to approximately 65%. The solid phase from experiment 3 
shows a slight increase in de but the grinding action of the magnetic stirred alone is not 
enough to produce the extremely small crystals needed in this experiment. However, should 
the concentration of this experiment be lowered, the grinding action of the magnetic stirrer 
alone could be enough to produce complete dissolution of the more soluble diastereomer. 
This was not further investigated 
In experiment 4, where the grinding action does produce extremely small particles, washing 
of the filter cake dissolved the remainder of small particles and gave the pure less soluble 
diastereomer within 14 days. Considering that both mother liquors of experiments 3 and 4 
have the same de’s but the solids of experiment 4 have higher de’s than experiment 3 must 
be the result of crystal size. The difference in these experiments is thus solely the result of 
faster dissolution of smaller crystals during the washing step. 
Abrasive grinding experiments with this additive were performed at higher concentrations 
also. At the start of the experiment (t0) the precipitated solids had 23% de and the mother 
liquor had 45% de. Then, the additive and the glass beads were added and after 5 days the 
de of the solids was constant at ~40% and the mother liquor at 60% de. Doubling the 
amount of glass beads and increasing the stirring rate from 900 rpm to 1500 rpm increased 
the de of the solids from 40% to 60%. Furthermore, the de in the mother liquor increased 
from 60% to 66%. An attempt to reduce the crystal size even further by sonication (see also 
§5.4) was foiled by the heat generation of the ultrasonic device. Even when the ultrasonic 
bath was kept at 20°C by means of a thermostat, the internal temperature could not be kept 
constant. Since the solubility of the diastereomer is increased by heating, the idea of 
grinding the salts by sonication was abandoned. 
Other successful nucleation inhibitors from §3.2, as depicted in Scheme 4.5, were examined 
using this procedure. However, addition of these compounds gave de’s similar to as the 
experiment without additives (experiment 2).  
 
(S) CO2H
OH
Br
(S) CO2H
OAc NH2 NH2
(S)-4BrMA 1,3-BAEB (S)-OAcMA  
Scheme 4.5 Successful nucleation inhibitors.  
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4.4.2  Dissolution of Enantiomers in Saturated Mixtures 
Dissolution of compounds in a saturated mixture by grinding is not restricted to 
diastereomers. However, as can be concluded from the previous paragraph, not every good 
nucleation inhibitor makes a good growth inhibitor.  
Two racemic conglomerates, Ala-Schiff and Phg-Schiff (depicted in Scheme 4.6 and 
described in §5.6), were suspended in MeCN with some DBU (to racemize the 
conglomerates in solution) in such a concentration that both materials had crystallized. 
Deracemization as described in §5.6 was achieved by addition of glass beads and grinding 
by sonication a sufficient amount of time to give a mixture from which the washed solids 
were analyzed by chiral HPLC. The ratio between the total area under the Ala-Schiff peaks 
and the Phg-Schiff peaks was 36:64 at the start of the experiment and when both 
enantiomers were completely deracemized (>99% ee) the ratio was 2:98 at the end of the 
experiment. Both enantiomers were enriched in the (R)-enantiomer.
11 
Me
N
Me
CONH2
Me
N CONH2
Ala-Schiff Phg-Schiff  
Scheme 4.6 Amino acid based conglomerates. 
The Phg-Schiff in solution proved to be an excellent growth inhibitor for the Ala-Schiff 
crystals, producing small crystals of the latter which were dissolved in the washing step 
similar as described in §4.4.1.
12 The small amount Ala-Schiff (2% in area) which was still 
present might either be crystallized in its own crystal lattice or co-crystallized in the 
Phg-Schiff crystals as observed in similar experiments in §5.6.2. The experiments described 
below help in understanding the observations.  
It was believed that the addition of D- or L-alanine, a close family member of Ala-Schiff 
and perhaps of Phg-Schiff also, could provoke faster deracemization of both imines 
towards the opposite enantiomer of the additive. The additive will then block the growth of 
crystals with the same handedness as the additive and thus will allow the growth of the 
opposite enantiomer to proceed unhindered. This phenomenon is known as the rule of 
reversal.
4a Addition of (R)-alanine to a suspension of (±)-Ala-Schiff under deracemizing  
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conditions indeed delivered (S)-Ala-Schiff in >99% ee. In a similar fashion, (S)-alanine 
delivered (R)-Ala-Schiff in >99% ee. However, addition of (S)-alanine to (±)-Phg-Schiff 
under deracemizing conditions delivered (S)-Phg-Schiff in >99% ee instead of the expected 
(R)-Phg-Schiff. Also, addition of (R)-alanine delivered (R)-Phg-Schiff in >99% ee under 
these conditions. These observations seem to contradict the rule of reversal. However, since 
three of the groups attached to the chiral centers of alanine and Phg-Schiff are different, this 
observation is not so surprising. If a suspension of (±)-Ala-Schiff and (±)-Phg-Schiff was 
treated with (S)-alanine under deracemizing conditions this should deliver (R)-Ala-Schiff 
and (S)-Phg-Schiff if the two compounds crystallized in separate crystal lattices and deliver 
(S)-Ala-Schiff and (S)-Phg-Schiff if a solid solution was formed. The experiment with 
(S)-alanine indeed gave Ala-Schiff and Phg-Schiff as the (S)-enantiomers. Likewise, 
addition of (R)-alanine gave both Schiff bases in the (R)-enantiomers. In both cases the 
ratio of the area under the peaks of both Ala-Schiff enantiomers and the area under the 
peaks of both Phg-Schiff enantiomers was 2:98 (the ratio at the start of the experiment was 
36:64). These findings demonstrate that indeed Phg-Schiff is an effective growth inhibitor 
for Ala-Schiff and that some Ala-Schiff is incorporated enantioselective in the crystals of 
Phg-Schiff.  
4.5   Simultaneous Resolution with Cyclic Phosphoric 
Acids 
In Dutch Resolution, a mixture of structurally closely related compounds (family members) 
is used to resolve a racemate.
1 Two or three resolving agents are used which are often 
incorporated in the precipitated salts as a solid solution.  
Also a mixture of racemic family members can be resolved with one resolving agent. The 
racemates often form a solid solution or end solid solution between two or three of the 
components in the precipitated salts. These components usually show high ee’s with the 
same absolute configuration. This process is named Reversed Dutch Resolution.
13  
The solid solution formation of the components in the precipitated salts means that usually 
reasonable amounts (>10%) of these components are co-crystallized, depending on the 
composition of the mother liquor, of course. In §5.6.2 it is described that when a mixture of 
amino acid derivative were co-crystallized in the presence of an excess of a conglomerate 
amino acid derivate, up to 1.22% of the amino acids were incorporated in the crystallized 
conglomerate. The reason for this low incorporation compared to the solid solution 
formation in (Reversed) Dutch Resolution is that the crystal lattice of the conglomerate can 
distinguish between the conglomerate and the other amino acid derivatives because of  
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relatively large differences. This has been observed before and was confirmed by computer 
aided calculations.
14 
If a solution of several structurally closely related racemates (family members) were to be 
co-crystallized in the presence of an excess of an optically pure family member, a mixture 
should crystallize with the same absolute configuration and with high ee’s.
15 
4.5.1  Phencyphos 
Seven structurally closely related racemic cyclic phosphoric acids 4.2–4.8 (see Scheme 4.7) 
were saturated in a water/methanol mixture and then (R)-phencyphos (4.1) hydrate was 
added to the solution in such a concentration that a solution was obtained at reflux 
temperature but the hydrate of (R)-4.1 crystallized when cooled to room temperature. Since 
the other phosphoric acids were not supersaturated at room temperature, these will not 
crystallize. The crystals that were collected after cooling, however, contained large 
quantities of the other phosphoric acids 4.2–4.8 but in variable amounts and all with high 
enantiomeric excesses with the same absolute configuration as the parent (R)-4.1 as denoted 
in Table 4.3. Note that in the assignment of the absolute configuration, the priority of the 
phenyl group changes when a heavy atom is present on the ortho position as is the case 
with compounds 4.2, 4.4, 4.7 and 4.8. This means that, for example, (R)-4.1 and (S)-4.4 
actually have the same spatial configuration. These results are analogous to the results 
described in §5.6.2. 
O
P
O
Me Me
OH O
R
R=
OMe
Me
Cl
Cl
Cl
OBn
Br
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4.5 4.6 4.7 4.8
 
Scheme 4.7 Cyclic phosphoric acids.  
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The isolated solids however, were very finely divided and only filterable over fine filters 
(P4). The (R)-4.1·H2O crystals grown from aqueous solutions that only contain (R)-4.1, 
however, consist of long needles and are collected with ease over a P2 filter. Apparently, 
the additives 4.2–4.8 block the growth of the (R)-4.1·H2O crystals and then more primary 
nucleation will take place, resulting in more fine crystals. This experiment was repeated 
with (S)-4.1 resulting in approximately the same incorporation but of opposite handedness. 
Surprisingly, approximately 30% wt. of the crystal content is not the parent phosphoric acid 
4.1. Thus 70%  wt. determines the absolute configuration of the other co-crystallized 
30% wt. 
Table 4.3 Compositions of co-crystallized phosphoric acids with 
optically pure phencyphos (4.1) hydrate from water-methanol as solvent. 
Phosphoric acid  ee (%)
a,c 
Composition 
(% wt.)
a 
ee (%)
b,c 
Composition 
(% wt.)
b 
4.1  99.8 (S)  70.1  99.9 (R)  71.0 
4.2  94.3 (R)
d 6.6 84.2  (S)
d 10.5 
4.3  98.0 (S) 1.7 71.3  (R) 1.8 
4.4  96.8 (R)
d 11.8 93.9  (S)
d 3.3 
4.5  95.0 (S) 4.0 92.9  (R) 1.9 
4.6  90.2 (S) 2.0 83.3  (R) 0.6 
4.7  46.3 (R)
d 2.2 82.7  (S)
d 3.9 
4.8  79.8 (R)
d 1.5 74.9  (S)
d 6.8 
a Single experiment with an excess of (S)-PP·H2O. 
b Single experiment with an excess of 
(R)-PP·H2O. 
c The letter in parenthesis gives the absolute configuration. These were 
determined by the elution order of chiral HPLC which showed excellent correlation for 
phosphoric acids with known absolute configurations: 4.1,4.2 and 4.4. This however, does 
not necessary need to be true for the other phosphoric acids. 
d The priority of the phenyl 
group has changed due to a heavy atom on the ortho position. This means that, for example 
(R)-4.4 has the same spatial configuration as (S)-4.1. 
 
An attempt to repeat this experiment in pure MeOH did not produce the large quantities of 
4.2–4.8 incorporated in the now anhydrous 4.1. The hydrate formation seems to give an  
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advantageous crystal lattice in which the other phosphoric acids fit better. Since the 
phosphoric acids 4.2–4.8 are under-saturated they should remain dissolved, apparently form 
a solid solution or an end solid solution with the crystallized (R)- or (S)-4.1·H2O. 
4.5.2  Anicyphos and Chlocyphos 
Anicyphos (4.2) and chlocyphos (4.4) were both incorporated in large quantities in the 
phencyphos (4.1) hydrate resolution described above. Since both enantiomers of anicyphos 
and chlocyphos were available optically pure these were tested also with a mixture of the 
other racemic phosphoric acids.  
Under the same conditions as described above, (S)- and (R)-anicyphos were crystallized in 
the presence of a saturated solution of racemic 4.1 and 4.3–4.8. The results are shown in 
Table 4.4. 
Table 4.4 Compositions of co-crystallized phosphoric acids with 
optically pure anicyphos (4.2). 
Phosphoric acid  ee (%)
a,c 
Composition 
(% wt.)
a 
ee (%)
b,c 
Composition 
(% wt.)
b 
4.1  - n.d.
d - n.d.
d 
4.2  99.8 (R)  96.7  99.8 (S)  97.2 
4.3  - n.d.
d - n.d.
d 
4.4  >99.9 (R) 2.0  95.4  (S) 1.6 
4.5  - n.d.
d - n.d.
d 
4.6  86.0 (S)
e 0.7 91.0  (R)
e 0.6 
4.7  69.8 (R) 0.4 86.2  (S) 0.4 
4.8  90.4 (R) 0.2 78.6  (S) 0.2 
a Single experiment with an excess of (R)-anicyphos (4.2). 
b Single experiment with an 
excess of (S)-anicyphos (4.2). 
c The letter in parenthesis gives the absolute configuration. 
These were determined by the elution order of chiral HPLC which showed excellent 
correlation for phosphoric acids with known absolute configurations: 4.1, 4.2 and 4.4.   
d n.d.: not detected 
e The priority of the phenyl group has changed due to a lighter atom on 
the ortho position. This means that (R)-4.2 has the same spatial configuration as (S)-4.6.  
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Although the incorporation of the other cyclic phosphoric acids in anicyphos (4.2) is low, 
all incorporated phosphoric acids in the crystallized 4.2 have the same spatial configuration 
with high ee’s  
Even though anicyphos is one of the most incorporated compounds in the phencyphos (4.1) 
hydrate crystals, the anicyphos (4.2) does not incorporate significant amounts of 
phencyphos as show in Table 4.4. This might indicate that anicyphos forms an end solid 
solution in phencyphos hydrate crystals and not a full solid solution. This observation is 
remarkable because one would expect that smaller molecules (4.1 in this case) should 
incorporate more readily in the crystal lattice of a larger molecule (4.2 in this case) than 
visa versa. Since 4.1 forms a hydrate from the aqueous solvent mixture, this crystal lattice 
might provide more room for larger molecules to incorporate by removal of one molecule 
of water.
15 
Table 4.5 Compositions of co-crystallized phosphoric acids with 
optically pure chlocyphos (4.4, in the grey bar). 
Phosphoric acid  ee (%)
a,c 
Composition 
(% wt.)
a 
ee (%)
b,c 
Composition 
(% wt.)
b 
4.1  - n.d.
d 11.5  (R)
e 1.0 
4.2  - n.d.
d 11.3  (S) 1.2 
4.3  - n.d.
d - n.d.
d 
4.4  >99.9 (R)  98.8  >99.9 (S)  93.7 
4.5  - n.d.
d 7.2  (S)
e 0.9 
4.6  18.0 (S)
e 0.2 0.4  (S)
e 1.1 
4.7  87.8 (R) 1.0 39.0  (S) 1.5 
4.8  - n.d.
d 32.5  (S) 0.7 
a Single experiment with an excess of (R)-chlocyphos (4.4). 
b Single experiment with an 
excess of (S)-chlocyphos (4.4). 
c The letter in parenthesis gives the absolute configuration 
which were determined by the elution order of chiral HPLC which showed good correlation 
for phosphoric acids with known absolute configurations: 4.1, 4.2 and 4.4. 
d n.d.: not 
detected. 
e The priority of the phenyl group has changed due to the lighter atom on the ortho 
position. This means that (R)-4.4 has the same spatial configuration as (S)-4.6. 
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Under the same conditions as described above, (R)- and (S)-chlocyphos (4.4) were 
crystallized in the presence of a saturated solution of racemic 4.1–4.3 and 4.5–4.8. The 
results from these crystallizations are given in Table 4.5. 
In the experiment with (R)-chlocyphos (4.4), some unexpected results were obtained. The 
enantioselectivity of this experiment is not as good as other experiments in this chapter. 
This might be because of a poor washing of the filter cake and poor separation of the 
mixture of phosphoric acids with preparative HPLC (see experimental section), which 
causes overlap of peaks in the chiral HPLC of the individual phosphoric acids and thus 
makes the ee determination of such low ee’s combined with low amounts (~1%) unreliable. 
As with anicyphos (4.2), chlocyphos (4.4) was incorporated in large amounts in the 
crystallizing phencyphos (4.1) hydrate, shown in Table 4.3. However, as can be seen from 
Table 4.5 phencyphos (4.1) is not significantly incorporated in the crystallizing chlocyphos 
(4.4), nor are other cyclic phosphoric acids. This behavior is typical for an end solid 
solution. Higher incorporation percentages may be found when a mixture is crystallized 
which have a full solid solution relationship such as described in §6.3. 
4.6   Experimental Section 
General Information: Reagents were obtained from commercial sources and used without 
further purification.  
1H-NMR and 
13C-NMR spectra were recorded on a Varian Mercury 300MHz machine. 
Chemical shifts are denoted in δ (ppm) and are referenced to the residual protic solvent. 
The coupling constant J is denoted in Hz. Splitting patterns are denoted as follows: 
s (singlet), d (doublet), m (multiplet) and bs (broad singlet). 
Mass spectra were recorded by API-ES (electron spray ionization) by dissolving the 
samples in MeOH and injecting the solution as such. Mobile phase: Acetonitrile : 0.1% 
formic acid in water 50 : 50 (1 min), flow: 0.2 mL·min
-1, injection volume: 5 µL. 
Procedure for the dissolution of diastereomers by abrasive grinding as described in 
§4.2 . A typical resolution experiment was performed by charging a Kimble reactor tube (Ø 
25 × 150 mm) with a PTFE coated egg-shaped magnetic stirring bar (19 mm × 10 mm), 2.5 
mL 0.1106 M (±)-PEA in IPA:H2O (4:1) and 2.5 mL 0.1106M L-dibenzoyl tartaric acid 
(DBTA) in IPA:H2O (4:1). This mixture was stirred and after some minutes, crystals started 
to form. When additives were used, an equimolar amount of L-DBTA was replaced by a 
solution of the additive so the whole system remained neutral and of equal volume.  
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The suspension was heated to dissolution and placed in a Reactiv8 computer controlled 
reactor station as depicted in Figure 3.6 in Chapter 3 and stirred magnetically at 600 rpm 
and 70°C for 30 min. Then the tubes were cooled to 20°C at 0.1°C·min
-1 and kept at 20°C 
for an additional 8 hours. The formed crystals were collected on pre-weighed disposable 
filters and washed with 1.0 mL IPA:H2O (4:1). The solids were subsequently dried in vacuo 
and weighed and the de of the salts was determined. 
Chiral HPLC analysis of 1-phenylehylamine (PEA) salts was carried out on a Crownpak 
CR(-) column with an aqueous solution of HClO4 (pH 2) as eluent at 20°C and 
0.6 mL·min
-1. UV-VIS detection at 200 nm. The salts were dissolved in eluent and 5 µL 
were injected as such. (R)-PEA Rf: 24.87 min, (S)-PEA Rf: 37.77 min.  
Procedure for the dissolution of diastereomers by abrasive grinding as described in 
§4.3 .  A typical resolution experiment was performed by charging a Kimble reactor tube 
(Ø 25 × 150 mm) with a PTFE coated egg-shaped magnetic stirring bar (19 mm × 10 mm). 
The tube was placed in a Reactiv8 computer controlled reactor station as depicted in Figure 
3.6 in Chapter 3 and stirred magnetically at 600 rpm at 70°C and further charged with 
2.5 mL 0.30 M (±)-PEA in EtOH and 2.5 mL 0.30M L-tartaric acid (TA) in EtOH. After 
some minutes, crystals started to form at 70°C. When additives were used, an equimolar 
amount of (±)-PEA and/or L-TA was replaced by a solution of the additive(s) so the whole 
system remained neutral and of equal volume. 
The suspension was kept at 70°C for another 30 min. Then the tubes were cooled to 20°C at 
0.1°C·min
-1 and kept at 20°C for an additional 8 hours. The formed crystals were collected 
on pre-weighed disposable filters and washed with 1.0 mL EtOH. The solids were 
subsequently dried in vacuo and weighed and the de of the salts was determined. 
Chiral HPLC was performed with the procedure described above. 
(2R,3R)-dibenzyl 2,3-diacetoxysuccinate and (2R,3R)-dibenzyl 
2-acetoxy-3-hydroxysuccinate. A solution of (2R,3R)-dibenzyl 
2,3-dihydroxysuccinate (5.0 g, 15.1 mmol, 1.0 eq) in pyridine (50 
mL) was treated with acetic anhydride (2.13 mL, 22.7 mL, 
1.5 eq) and stirred for two days before it was concentrated to dryness. The mixture was 
purified by automated column chromatography with EtOAc:heptanes. The diacetylated 
compound eluded first shortly followed by the monoacetyl compound. The pure fractions 
were combined and concentrated to deliver 2.38 g (38%) of the diacetylated compound as a 
colorless oil: (
1H-NMR (300MHz, DMSO-d6): δ= 1.91 (s, 6H), 5.12 (d, J=12.6Hz, 2H), 
5.24 (d, J=12.3Hz, 2H), 5.71 (s, 2H), 7.20-7.37 (m, 10H) ppm. 
13C-NMR (75MHz, DMSO-
d6): δ= 19.9, 67.1, 70.3, 128.2, 128.4, 128.5, 135.2, 165.3, 169.1 ppm. MS (EI): m/z= 437 
[M+Na
+]) and 2.31 g (41%) of the mono-acetylated compound as a colorless oil which 
OH/OAc
(R)
(R)
OAc
BnO2C
CO2Bn 
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crystallized on standing to produce white crystals (
1H-NMR (300MHz, DMSO-d6): δ= 1.92 
(s, 3H), 4.76 (dd, J1=6.9Hz, J2=3.0Hz , 1H), 5.04-5.23 (m, 4H),  6.26 (d, J=6.3Hz, 1H), 
7.30-7.37 (m, 10H) ppm. 
13C-NMR (75MHz, DMSO-d6): δ= 20.1, 66.3, 66.6, 69.9, 73.4, 
127.7, 128.1-128.5 (m), 135.4, 135.7, 166.6, 169.6, 169.9 ppm. MS (EI): m/z= 395 
[M+Na
+]).  
(2R,3R)-2,3-diacetoxysuccinic acid. A mixture of (2R,3R)-
dibenzyl 2,3-diacetoxysuccinate (1.0 g, 2.41 mmol, 1.0 eq), EtOH 
(25 mL) and Pd/C (10% Pd, 100 mg) was hydrogenated at 
atmospheric pressure. A 
1H-NMR sample taken after 1.5 hours 
revealed complete conversion. The reaction mixture was filtered over Celite and 
concentrated to dryness. This yielded the product as a colorless oil (598 mg, 96%). 
1H-
NMR (300MHz, DMSO-d6): δ= 2.08 (s, 6H), 4.20 (bs, 2H), 5.49 (s, 2H) ppm. 
13C-NMR 
(75MHz, DMSO-d6): δ= 20.3, 70.7, 167.2, 169.4 ppm. MS (EI): m/z= 233 [M-H
+]. 
(2R,3R)-2-acetoxy-3-hydroxysuccinic acid. The above procedure 
was repeated for (2R,3R)-dibenzyl 2-acetoxy-3-hydroxysuccinate. 
Yield: 511 mg (99%) as a colorless oil. 
1H-NMR (300MHz, 
DMSO-d6): δ= 2.06 (s, 3H), 4.54 (s, 1H), 5.22 (s, 1H)  ppm. 
13C-
NMR (75MHz, DMSO-d6): δ= 20.4, 69.8, 73.4, 168.4, 169.7, 172.0 ppm. MS (EI): m/z= 
191 [M-H
+]). 
Procedure for the dissolution of diastereomers by abrasive grinding as described in 
§4.4.1. Four new 250 mL round bottom flasks were each charged with a new PTFE coated 
egg-shaped stirring bar (2.5 cm × 1.0 cm), (±)-3MeOPEA (907 mg, 6 mmol, 1.0 eq), 
(S)-MA (913 mg, 6 mmol, 1.0 eq) and 2-butanone (12.06 g, 15 mL). The flasks were 
stoppered and stirred for a couple of hours to ensure complete crystallization of both 
diastereomeric salts. Then the suspension was further diluted with 2-butanone (108.81 g, 
total: 150 mL). The resulting suspension was stirred at 900 rpm overnight. Samples were 
taken from the mother liquor and the solids (P4). The latter was washed with some 2-
butanone and the washings were discarded. Glass beads (20 g) were added to flasks 2 and 
4. Flasks 3 and 4 were each charged with 1,3-BAPB·2(S)-MA (89 mg, 0.18 mmol, 0.03 eq) 
and the stirring was continued at 900 rpm. Samples of mother liquor and washed solids 
were taken three times a week in a manner as described above. The methods for chiral 
HPLC analysis and the procedures to synthesize the compounds are described in the 
experimental section of Chapter 3.  
In the experiments which use either (S)-4BrMA-(±)-3MeOPEA, (S)-OAcMA-(±)-
3MeOPEA or (±,±)-1,3-BAEB
16·2(S)-MA, 0.18 mmol of these compounds replaced the 
0.18 mmol of 1,3-BAPB·2(S)-MA 
OAc
(R)
(R)
OAc
HO2C
CO2H
OH
(R)
(R)
OAc
HO2C
CO2H 
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Procedure for the dissolution of enantiomers by abrasive grinding as described in 
§4.4.2.  A new scintillation vial (20 mL) was charged with 10 g solids glass beads (Ø 2 
mm), 0.36 g (±)-Phg-Schiff and/or 0.39 g (±)-Ala-Schiff and 3.6 g MeCN. Depending on 
the experiment, no alanine, 10 mg D-alanine or L-alanine was added. The bottom part (~1 
cm) of the stoppered vial was placed in a ultrasonic cleaning bath (Bandelin Sonorex, RK 
106, 35 kHz) which was kept at 20°C by a thermostat (Huber, ministat cc) and was 
sonicated in the middle of the bath for 5 minutes. Subsequently, fresh 
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 0.20 g) was added and the sonication was 
continued. After 3 days, samples were taken by filtration (P4), sucked dry and washed with 
some TBME. The filter cake was analyzed according to Method 1 which is described in the 
experimental section in Chapter 5 as is the synthesis of (±)-Phg-Schiff and (±)-Ala-Schiff. 
Procedure for the resolution of multiple phosphoric acids by co-crystallization as 
described in §4.5.1.  To a 50:50 mixture of water and MeOH (~6 mL) was added sufficient 
racemic phosphoric acids 4.2–4.8 to result in a suspension in which all phosphoric acids 
were saturated. The mixture was heated to reflux and allowed to cool to room temperature 
overnight. The solids were removed by filtration (P4). Two tubes were charged with 
2.5 mL filtrate each. One tube was charged with enough (S)-4.1·H2O and the other with 
enough (R)-4.1·H2O to result in a thin suspension when heated to reflux and was filtered 
hot. The filtrates were reheated to dissolution and allowed to cool to room temperature 
overnight with stirring. The solids were collected by filtration (P4). The composition of the 
mother liquor was 367 mg phosphoric acid mix per mL solvent mixture for the tube 
containing (S)-4.1 and 396 mg phosphoric acid mix per mL solvent mixture for the tube 
containing (R)-4.1. The composition of the filter cake was determined and compensated for 
the amount of residual mother liquor. The filter cake from the tube containing (R)-4.1 gave 
151 mg phosphoric acid mix per mL solvent mixture. The filter cake from the tube 
containing (S)-4.1 gave 155 mg phosphoric acid mix per mL solvent mixture. The mixtures 
of phosphoric acids in the filter cakes were separated by HPLC: column: Luna PFP (4.6 × 
100 mm, 3 µm). Mobile phase: solution A: solution B = 95:5 (0 min) in 30 min to 60:40 
(0 min) in 10 min to 0:100 (0 min). Solution A: 9.65 g ammonium acetate; 2250 mL H2O; 
150 mL MeOH; 100 mL acetonitrile, solution B: 9.65 g ammonium acetate; 250 mL H2O; 
1350 mL MeOH; 900 mL acetonitrile. Flow: 1.0 mL·min
-1. Detection: 215 nm. Mass 
detection: API-ES (electron spray ionization) positive and negative. The samples were 
measured against a mixture of the phosphoric acids with known concentrations and weight 
percentages given in Table 4.3. 
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Table 4.6 Retention times of phosphoric acids analyzed by chiral HPLC. 
The absolute configurations of compounds 4.1, 4.2 and 4.4 are known 
and given in the table. The absolute configurations of the other 
compounds are established by the elution order. 
Phosphoric acid 
Absolute 
configuration and 
Rf  first peak (min) 
Absolute 
configuration and  
Rf second peak (min) 
4.1  know: (S)-(+): 7.18   know: (R)-(–): 8.15 
4.2  know: (R)-(+): 7.33  know: (S)-(–): 9.57 
4.3  expected (S): 7.61  expected (R): 8.49 
4.4  know: (R)-(+): 7.12  know: (S)-(–): 7.59 
4.5  expected (S): 7.26  expected (R): 8.58 
4.6  expected (S): 7.62  expected (R): 17.58 
4.7  expected (R): 7.01  expected (S): 7.49 
4.8  expected (R): 6.88  expected (S): 14.61 
    
The experiments described in §4.5.2 were performed in a similar fashion. For the anicyphos 
(4.2) experiments in Table 4.4, a saturated solution of 4.1, 4.3–4.8 was made and for the 
chlocyphos (4.4) experiments in Table 4.5 a saturated solution of 4.1–4.3, 4.5–4.8 was 
made.  
The separated peaks were collected, concentrated and each analyzed by chiral HPLC: 
Chiralpak QN-AX column with MeOH:AcOH 97:3 + 0.25g NH4OAc/100 mL as mobile 
phase at room temperature and 1.5 mL·min
-1. UV-VIS detection at 254 nm. The retention 
times for each of the components are given in Table 4.6. For compound 4.4, the priority of 
the phenyl group has changed due to the chlorine on the ortho position. This means that 
(R)-4.2 and (R)-4.4 have the same spatial configuration as (S)-4.1. Since the compounds 
with known configurations (4.1, 4.2 and 4.4) elude in the same order with respect to the 
spatial configuration, it is expected that the compounds 4.3 and 4.5–4.8 will elude in the 
same order also. Note that the priority of the phenyl group of compounds 4.7 and 4.8 has 
changed in the same manner as compounds 4.2 and 4.4. 
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Chapter 5 
 
Deracemization by Abrasive Grinding 
 
 
 
 
 
In this chapter
* the resolution of racemates that crystallize as conglomerates by 
means of racemization in the liquid phase and simultaneous grinding of the solid 
phase is described. Also mixtures of amino acid derivatives have been resolved in 
similar experiments using a crystalline conglomerate. The other amino acid 
derivatives co-crystallized with the same absolute configuration. This approach 
could be a feasible pathway for the origin of homochirality in nature. 
 
* Parts of this chapter have been published in: J. Am. Chem. Soc. 2008, 130, 1158–1159,  
Angew. Chem. Int. Ed. 2008, 47, 6445–6447 and Angew. Chem. Int. Ed. 2009, 48, 3278–
3280.  
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5.1   Introduction 
Direct resolution by crystallization of racemic mixtures, induced by seeding or by adding 
tailor-made additives, forms an attractive alternative to the separation by forming 
diastereomeric salts.
1 Unfortunately, the overall yield in a single resolution step is low and 
limited to 50% of each enantiomer and in practice usually lower. Combining a direct 
resolution with racemization in the solution would lead to a total enantiomeric 
transformation.
2 Complete resolution in a single operation would be of great practical use.  
Examples have been very limited, however.  
Viedma
3 recently demonstrated the inexorable and random emergence of solid-phase single 
chirality for the intrinsically achiral inorganic compound NaClO3 or NaBrO3, initially 
present as a racemic mixture of two enantiomorphic solid phases in equilibrium with the 
achiral aqueous phase (Figure 5.1a). Grinding the slurry of crystals with glass beads 
promotes dynamic dissolution / crystallization processes that result in the conversion of one 
solid enantiomorph into the other via the solution. Larger crystals grow by consuming 
smaller crystals via the saturated solution due to the fact that a small surface to volume ratio 
is energetically favorable. This process is known as Ostwald ripening
4 and is also seen in 
ice-cream, which forms large ice crystals over time at relative high temperatures and 
making the ice-cream less smooth. In ice-cream, this process is halted to a large extent by 
freezing the ice at -18°C.
5 
 
Figure 5.1 a) Suspension of an achiral compound crystallizing in mirror 
imaged space groups. b) Suspension of a conglomerate, racemizing in the 
liquid phase. 
The grinding action of the glass beads gives smaller crystals which dissolve faster than 
large crystals since the surface to volume ratio is larger for smaller crystals. Had Viedma  
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not ground his crystals this deracemization process would also have taken place, however, 
much slower.
6 
The conversion towards homochiral crystals relies on the fact that the solid-phase chiral 
identity of the intrinsically achiral NaClO3 or NaBrO3 is lost upon dissolution. Recently 
similar results have been reported with an achiral organic compound that also crystallizes as 
a conglomerate
7 as well as an achiral compound that forms left and right handed helices. 
During discussions with Prof. Donna Blackmond of Imperial College London, on the 
occasion of a lecture in Nijmegen, the idea arose to attempt to extend the Viedma 
observation to an intrinsically chiral organic compound that could be easily racemized,
8 a 
requisite for complete conversion, and which was also a conglomerate. This process is 
depicted in Figure 5.1b. It soon became apparent that DSM scientists, with their long 
experience with amino acids, could likely provide suitable candidates. It was decided by the 
Radboud University Nijmegen, DSM, Syncom and the Imperial College in London to 
collaborate in this challenging quest. 
5.2   Racemizable Conglomerate 
Amino acid amides can be readily racemized under basic conditions when they are 
converted into their corresponding imines with a functionalized benzaldehyde. Several 
benzaldehydes were tested with phenylglycinamide (Phg-NH2, 5.3) at DSM Geleen and 
imine 5.4 from o-tolualdehyde showed the same XRDP patterns for racemic and optically 
pure 5.4 which is consistent with conglomerate type behavior, necessary for testing this 
idea. The synthesis of 5.4 is known from literature
9 and is depicted in Scheme 5.1. 
H2N CO2H H2N CO2Me
SOCl2
MeOH
∆ H2N CONH2
NH3
H2O
72% over
 2 steps
N CONH2
Me
o-tolualdehyde
Na2SO4
CH2Cl2
73% 5.1 5.2 5.3
5.4
·HCl
 
Scheme 5.1 Synthesis of the imine of phenylglycinamide. 
Racemic phenylglycine (5.1) was allowed to react with MeOH and in situ generated HCl to 
deliver the HCl salt of methyl ester 5.2. This ester was subsequently allowed to react with 
aqueous ammonia to deliver primary amide 5.3. This material was treated with  
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o-tolualdehyde in the presence of a drying agent to remove the water. Compound 5.4 was 
recrystallized from MeCN to yield pure crystalline material. 
5.3   Deracemization by Abrasive Grinding
10 
The method of deracemization by abrasive grinding requires racemization in solution of 
compound 5.4. This can be accomplished with a base like 1,8-diazabicyclo[5.4.0]undec-7-
ene (DBU). Several conditions have been tested at DSM and the University of Nijmegen to 
find a good solvent, amount of solid glass beads, DBU-concentrations, stirring rates and 
amount of 5.4 in the solid phase.
11,18 Best results were obtained in MeCN as solvent and in 
general it may be concluded that more glass beads, higher DBU concentrations, faster 
stirring rates and lower amounts of 5.4 give faster deracemization. More than one hundred 
experiments were run in four individual laboratories
12 in new glassware and all experiments 
gave (R)-5.4 as final product as depicted in Figure 5.2 (blank). This can be explained 
because of small natural (S)-amino acid contaminations,
13 which direct the deracemization 
towards the enantiomer with opposite absolute configuration as dictated by the Rule of 
Reversal, postulated by Lahav.
14 
 
CO2H H2N
(R)
(R)-Phg  
Scheme 5.2 (R)-Phenylglycine. 
However, by addition of small amounts of an additive with a strong structural resemblance, 
(R)-phenylglycine (Phg), as depicted in Scheme 5.2, the deracemization could be steered 
towards (S)-5.4.
15 Addition of larger amounts of (S)-Phg makes the deracemization process 
faster as depicted in Figure 5.2. Of course, addition of (R)-Phg steered the deracemization 
towards (S)-5.4. The role of the additive is one of growth inhibition in which the 5.4 
crystals of opposite handedness are retarded in their growth. 
Addition of a small bias of one enantiomer of 5.4 provided this enantiomer optically pure 
faster than in unbiased systems as depicted in Figure 5.3. 
Furthermore, Monte Carlo computer simulations have been performed at the University of 
Nijmegen to elucidate the kinetics of the abrasive grinding and Ostwald ripening process.
16  
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Figure 5.2 Deracemization aided by (S) or (R)-phenylglycine. Lines are 
provided as a guide for the eye. 
 
Figure 5.3 Deracemization with small a small bias in the initial ee. Lines 
are provided as a guide for the eye.  
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5.4   Deracemization by Sonication 
Sonication is a way to break up particles in suspension by a process called cavitation. In 
this process, small bubbles are generated, grown in the vacuum created on passage of the 
sonic wave, and after a few cycles collapse. The collapsing locally generates extreme 
pressures (1000 bar), heat (5000 K) and heating and cooling rates (10
10 K·s
-1) in the further 
cool liquid. With the collapsing of a bubble, a liquid jet is generated which can erode a 
relative large particle. Moreover, the produced shock waves generate high velocity 
interparticle collisions.
17 In theory, sonication provides an attractive alternative for abrasive 
grinding by glass beads and magnetic stirring as described in §5.3 . 
A handheld sonicator (Hielscher, UP100H, 100W) with titanium sonotrode (Ø 3mm, 7 mm 
or 10 mm) was used to mill a suspension of  (±)-5.4 in MeCN with DBU which was placed 
inside a thermostated double jacketed vessel which kept the suspension at 20°C. 
Unfortunately, in overnight experiments brown solutions were found. Apparently, the local 
heat generated by the cavitation process from this relatively powerful device caused the 
decomposition of 5.4 (confirmed by HPLC analysis). Furthermore, prolonged use of this 
sonicator caused the titanium sonotrode to wear considerably, resulting in titanium 
contaminated reaction mixtures. 
Sonication in a thermostated bath-sonicator did not lead to this decomposition of the 
material. However, no significant size reduction of the crystals was observed by optical 
microscope. When glass beads were introduced to the suspension and then sonicated, fast 
deracemization was observed leading to >99% ee 5.4 within one day.
18 Apparently, the 
glass beads collided with each other crushing crystals between the beads effectively. Still, 
the direction of non-biased or non-deliberately contaminated mixtures produced solely 
(R)-5.4. Even faster deracemization was achieved by addition of more solid glass beads, 
more DBU and less 5.4 in the solid phase.  
5.5   Deracemization by Crystallization
19 
Nearly 70 years ago, during the second World war, Havinga demonstrated that 
conglomerate 1, which racemizes in solution and crystallizes as enantiopure crystals of 
opposite handedness deposited large single crystals of high enantiomeric purity on slow 
undisturbed crystallization from a supersaturated solution.
2a,b  The process is illustrated in 
Figure 5.4. An undersaturated solution (situation I) is cooled to a point where both 
enantiomers are slightly supersaturated (situation II). In a stochastic process, primary 
nucleation takes place, arbitrarily illustrated for the (S)-enantiomer (situation III). This (S)-
crystal consumes the supersaturation of the (S)-enantiomer in the surrounding liquid.  
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Because 1 racemizes in solution, the supersaturated (R)-enantiomer is consumed also by the 
growing (S)-crystal. This resolution can only be performed slowly, utilizing compounds 
with a large metastable zone width and on a small scale since one crystal has to consume 
the supersaturation of the surrounding liquid by diffusion. 
 
Figure 5.4 Deracemization of allylethylmethylanilinium iodide (1) by 
slow crystallization from chloroform as performed by Havinga. 
Kondepudi, in 1990, carefully analyzed an analogous process based on NaClO3, a 
conglomerate when crystalline.
2g Although intrinsically achiral, NaClO3 is packed in the 
chiral space group P213 upon crystallization. The proposed mechanism of this resolution is 
depicted in Figure 5.5. Starting with situation I where the NaClO3 is completely dissolved, 
the solvent is slowly allowed to evaporate to produce a supersaturated solution of NaClO3 
(situation II). In situation III, one enantiopure crystal of random handedness has formed 
(the D-enantiomer in this example). Other than the Havinga resolution, this first crystal is 
ground down by a magnetic stirrer, producing multiple crystals of the same handedness 
(secondary nucleation) with a larger combined surface than the single crystal.
20 A larger 
crystal surface leads to faster consumption of the supersaturation (situation III). Higher 
yields can be obtained by further evaporation of the solvent (situation IV).  Kondepudi 
found that if the solution is not stirred, the supersaturation is not consumed efficiently and 
primary nucleation of the other enantiomer will be observed also, resulting in a both 
enantiomeric crystals rather than a stochastic choice of a single chirality. Although this 
resolution should also be applicable to racemizing enantiomers that crystallize as 
conglomerates, the process is still relatively slow.  
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The scale of the experiment of Kondepudi was larger than that of Havinga, 120 mL and 
1 mL respectively. Most likely, if Havinga had performed his experiments on a ‘Kondepudi 
scale’, the diffusion might have been too slow and then multiple crystals of random 
handedness would have been formed as was also observed by Kondepudi when no stirring 
was applied. 
 
Figure 5.5 Kondepudi deracemization of achiral NaClO3 by evaporation 
and grinding. 
This process should also be applicable to the deracemization of (±)-5.4. However, 
evaporation of solvent under ambient atmosphere is a time consuming procedure. 
Furthermore, this has to be performed under an inert atmosphere since CO2 in the air will 
render DBU ineffective due to carbamate formation and hence disable the racemization in 
solution. An alternative approach is shown in Figure 5.6. An undersaturated solution (I) is 
cooled slowly to supersaturation of both enantiomers (II). One enantiomer then crystallizes 
first (III) and is immediately ground down. The large crystal surface readily consumes the 
supersaturation of both enantiomers via racemization in solution (IV). Primary nucleation 
cannot take place without supersaturation and upon further cooling, a large volume of 
crystals of single handedness is generated (V). 
It is not impossible to imagine that (R)- and (S)-crystals are formed nearly simultaneous. In 
that case, these will deracemize quickly via Ostwald ripening because of the small amounts 
of material present and the high racemization rate at elevated temperatures.  
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Figure 5.6 Havinga-Kondepudi resolution of the racemizable 
conglomerate 5.4 by cooling and grinding 
To a mixture of MeCN and DBU was added (±)-5.4 so that a suspension was still present at 
65°C but at 70°C a clear solution was obtained. The clear solution was subsequently slowly 
cooled to 20°C at a preset cooling rate combined with magnetic stirring at 1250 rpm in the 
presence or absence of solid glass beads. A sample was taken from the resulting suspension 
after reaching 20°C. Solids were collected and analyzed and the results denoted in Table 
5.1. 
The results show that, analogous to the results of Havinga and Kondepudi, deracemization 
takes place if the system is allowed to consume the supersaturation by secondary 
nucleation. The system that was ground with solid glass beads generates more crystal 
surface than the system with magnetic stirring only, which prohibits the primary nucleation 
even at faster cooling rates. Only at a cooling rate of 2.0°C·min
-1 the grinding/secondary 
nucleation/crystal growth/racemization in solution cannot keep up with the primary 
nucleation and solids were collected consisting of only 85% ee. However, repeated heating 
and cooling gave decomposition of the material as indicated by HPLC. These findings are 
similar to those found in §5.4 .  
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Table 5.1 Deracemization of 5.4 by crystallization and secondary 
nucleation. 
Entry 
cooling rate  
(ºC·min
-1) 
stirrer
a             
ee (%); (R)/(S)
c 
glass beads
b         
ee (%); (R)/(S)
c 
1  2.0 25;  (R) 85;  (R) 
2  1.0 76;  (R) >99;  (R) 
3  0.5 83;  (R) 99;  (R) 
4  0.05 >99;  (R) >99;  (R) 
a Magnetic stirring at 1250 rpm.
 b Magnetic stirring at 1250 rpm with solid glass beads
  
c enantiomeric excess and absolute configuration. 
 
Mixtures that did not produce enantiopure materials but which did create some ee in the 
solid phase will, of course, on prolonged stirring give enantiopure 5.4 as shown in §5.3. 
Also, deracemization of another conglomerate amino acid derivative, (±)-5.5, depicted in 
Scheme 5.4 and discussed further in §5.6.1, was complete within one day with this 
improved protocol. Addition of 4.6 mol% natural (R)-alanine (Ala) (depicted in Scheme 
5.2) to racemic 5.5 gave optical pure (S)-5.5 in the solid phase. Likewise, (S)-Ala delivered 
optical pure (R)-5.5, as would be expected from the rule of reversal. 
5.6   Deracemization and Co-crystallization 
It has been demonstrated previously
21 that under kinetic conditions, asparagine (see Scheme 
5.3), a conglomerate amino acid, can incorporate upon crystallization selectively one 
enantiomer of a certain other (racemic) amino acid. Also, when a mixture of twelve 
different amino acids were added to the crystallizing racemic asparagine, “about several 
percentages at most”
22 of these amino acids were incorporated into the crystal lattice. By 
collecting the first crystals that form, often an enantiomeric excess was found.  
The formation of enantiomerically enriched material from a racemic mixture can be 
explained by the fact that the crystallization of a compound from solution will take a certain 
amount of time with a statistic deviation. If two similar compounds with the same 
concentration (conglomerate forming racemate) are allowed to crystallize, of course, one 
enantiomer will crystallizes first. The second enantiomer will start to crystallize within 
seconds or minutes after the first crystallization event. If the mixture is stirred, the formed  
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crystals will be ground and secondary nucleation will take place, producing more crystals, 
which grow faster in mass than a single crystal does.
23 If the solids are collected 
immediately after a suspension is observed, often high enantiomeric excesses will be found 
in the solid phase.  
HO2C
NH2
(S)
O
NH2
L-Asparagine
HO2C
NH2
(S)
(R)
OH
L-Threonine  
Scheme 5.3 Natural occurring forms of amino acids asparagine and 
threonine. The racemates are conglomerates. 
These results were duplicated with another conglomerate amino acid, threonine (see 
Scheme 5.3) in water. Nine stirred and slightly supersaturated solutions of racemic 
threonine were allowed to crystallize. When crystals were observed, these were isolated by 
filtration and the ee was determined. All results are depicted in Figure 5.7.  
 
Figure 5.7 Emergence of kinetic symmetry breaking in threonine. 
Analogously to the results with asparagine, high ee’s (experiments 1 and 8) are found. 
However, when D- and L-threonine crystallize nearly simultaneously, low ee’s are found  
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(experiments 3–6 and 9), which is characteristic for these type of experiments. From nine 
experiments six deliver L-threonine and three D-threonine. This imbalance might be 
explained by the low amount of experiments, slight initial imbalance or chiral impurities. 
However, these speculations were not further investigated. 
The authors of the asparagine experiments fail to mention that if the mixture is allowed to 
proceed to equilibrium (within a couple of minutes) the ee of the crystallized amino acids 
will drop to zero. In contrast what the authors claim, without racemization in the solution, 
this procedure will not give high ee’s for a sufficient amount of time to “account for the 
predominance of L-amino acids on earth”. 
Because fast racemization of amino acids is difficult to accomplish without harsh 
conditions and decomposition of the material,
24 amino acids, structurally akin to compound 
5.4 were prepared. Imines from alanine, methionine, tryptophan and valine were prepared 
analogous to the synthetic route as depicted in Scheme 5.1. The synthesized amino acids 
are depicted in Scheme 5.4. 
5.6.1  Second Harmonic Generation
25 
The amino acid derivatives shown in Scheme 5.4 were subjected to Second Harmonic 
Generation (SHG) experiments.
26 Both compounds 5.4 and 5.5 showed the frequency 
doubling signal which indicate that these compounds are most likely to be conglomerates. 
For the other imines, no such signal was found and these compounds are thus most likely 
racemic compounds. 
N
R
CONH2 Me Me
S
Me
Me
NH
5.4
R=
5.5 5.6 5.7 5.8
Me
 
Scheme 5.4 Racemizable amino acid derivatives. 
Confirmation of the assignment of conglomerate behavior formation found by SHG was 
found when deracemization experiments were carried out by crystallization from solution. 
Of course, racemic compounds cannot deracemize under these conditions. It must be noted 
that the absence of deracemization in an experiment is not absolute proof for the absence of  
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a conglomerate; the deracemization might be very slow or hampered by twinning (epitaxy). 
The results of the experiments are shown in Table 5.2. 
Table 5.2 SHG and deracemization experiments of amino acid 
derivatives. 
Entry Racemate  SHG  signal
a  ee (%); (R)/(S)
b 
1 5.4  Yes >99  (R) 
2 5.5  Yes >99  (R) 
3 5.6  No 0 
4 5.7  No 0 
5 5.8  No 0 
a of the racemate.
   b enantiomeric excess and absolute configuration 
 
The results show excellent correlation between the SHG experiments and the 
deracemization experiments. It may be concluded that only 5.4 and 5.5 crystallize as 
conglomerates and can be racemized under the applied conditions. The other amino acid 
derivatives 5.6, 5.7 and 5.8 most likely do not crystallize as conglomerates. This, however, 
should be confirmed by more reliable techniques since SHG has an estimated accuracy of 
90%.  
Experiments have shown that the pure enantiomers of all these compounds, were 
completely racemized with DBU in MeCN overnight. Later, the conglomerate behavior of 
compounds  5.4 and 5.5 was confirmed by eutectic determination by crystallizing from 
enriched material without racemization and XRPD determinations of the racemate and the 
pure enantiomers.
27 
5.6.2  Deracemization with Multiple Compounds 
When solutions of each of the other racemic imines are mixed with an excess of 5.4 and the 
latter is crystallized by the dissolution and crystallization/grinding procedure, as described 
in §5.5, each experiment shows that the imine is incorporated with high enantiomeric 
excess into solid 5.4 and with the same absolute configuration (Figure 5.8, experiments 1–
4).   
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Figure 5.8 Enantiomeric excess of amino acid derivatives. Experiments 
1–4 represent crystallizations of under-saturated separate racemates 
5.5–5.8 in the presence of supersaturated racemic 5.4. Experiments 5–14 
represent the experiments with under-saturated mixtures of all racemates 
5.5–5.8 in the presence of supersaturated racemic 5.4. 
When these experiments were repeated with a solution of all four imines and with an excess 
of 5.4, the latter is isolated with very high enantiopurity. In contrast to the abrasive grinding 
experiments of 5.4 alone, the latter process appears to be nearly stochastic; 4 experiments 
go to (S) and 6 experiments go to (R).  Note that in the mixed experiments all five amino 
acid imines incorporated in the solid have identical absolute configurations although the 
particular configuration for the entire experiment appears to be random as depicted in 
Figure 5.8, experiments 5–14. 
The solids of experiments 5–14 were analyzed for content of imines incorporated into the 
crystallized 5.4 and the averages of these results are given in Table 5.3. 
Although 0.29 equivalents of each of the imines has been used in comparison to 5.4, only 
small amounts of these imines have co-crystallized. This observation is consistent with the 
Kojo experiments.
21,22 The low incorporation percentage is most likely a response to  small 
errors in the crystal lattice of 5.4. In comparison, in (First Generation) Dutch Resolution 
experiments a solid solution is often formed between the different family members of the 
resolving agents. The crystal lattice cannot distinguish between the resolving agents but  
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incorporates whatever available material fits in the crystal lattice and thus largely depends 
on the composition of the liquid phase.
28 Usually, high incorporation percentages are found 
because the starting composition of resolving agents is stoichiometric (e.g. 1:1 or 1:1:1). 
The difference between Dutch Resolution and these experiments can be explained by the 
fact that the family of resolving agents is more similar in structure and size than these 
imines.
29 
Table 5.3 Incorporation in the crystalline phase of 5.4. 
Entry racemate  composition  (%)
a average  ee
 (%)
b 
1 5.4  96.76 97 
2 5.5  0.81 86 
3 5.6  1.22 86 
4 5.7  0.22 66 
5 5.8  0.98 89 
a mass percentage. 
b always in the same absolute chiral configuration as 5.4. 
 
Since 5.5 is a conglomerate also, the incorporation of the other amino acid derivatives 
could be enantioselective as well. An experiment similar to that described above was 
performed with an excess of racemic 5.5 and 0.047 equivalents of each of the other imines 
described above. The composition of the isolated crystals of a single experiment is shown 
in Table 5.4. Analogously to the co-crystallization with 5.4, all components that co-
crystallize in the crystal lattice of 5.5 do so with the same absolute configuration. 
In these experiments, the average ee of each of the components is high. However, the 
compounds that are poorly incorporated (5.7 in the 5.4 experiments and 5.4 in the 5.5 
experiments) have low ee’s also. An explanation can be that small amounts of remaining 
mother liquor lower the ee to a larger extent of the component that is incorporated the least. 
As given in the experimental section, these experiments were carried out overnight and 
worked up the next morning without checking the deracemization in the solid phase. In 
contrast to the Kojo experiments, the ee of the excess conglomerate will become 100% 
upon longer stirring (Ostwald ripening). Furthermore, abrasive grinding only accelerates 
the Ostwald ripening (crystals with a smaller volume dissolve faster). If the mixture had not 
been ground, the same results would have been obtained most likely, but more slowly, of 
course.  
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Table 5.4 Incorporation in the crystalline phase of 5.5. 
Racemate composition  (%)
a  ee (%)
b 
5.4  0.67 36 
5.5  93.53 96 
5.6  2.24 73 
5.7  1.94 74 
5.8  1.62 75 
a mass percentage. 
b all compounds co-crystallized in the (S)-enantiomer. 
 
In nature, reasonable fast racemization of amino acids can be performed at high 
temperatures.
30 For instance, the water in the vicinity of thermal vents on the ocean floor 
may provide ideal circumstances. The combination of racemization and Ostwald ripening 
may pose a pathway to homochirality in nature. 
5.7   Experimental Section 
General Information: Reagents were obtained from commercial sources and used without 
further purification.  
For the chiral HPLC analysis of mixtures of: 2-(((2-methylphenyl)methylidene)amino)-2-
phenylacetamide (5.4), 2-(((2-methylphenyl)methylidene)amino)propanamide (5.5), 2-(((2-
methylphenyl)methylidene)amino)-4-(methylsulfanyl)butanamide (5.6), 3-(1H-indol-3-yl)-
2-(((2-methylphenyl)methylidene)amino)propanamide (5.7) and 3-methyl-2-(((2-
methylphenyl)methylidene)amino)butanamide (5.8) two methods have been used because 
of overlap of some peaks.  
Method 1: the separation was carried out on a  Chiralcel OJ-H (150 × 4.6mm) column with 
a gradient of heptane:EtOH as eluent at 20°C and 0.7 mL·min
-1: 95:5 (20 min) in 20 min to 
90:10 (10 min) in 20 min to 75:25 (40 min). UV-VIS detection was performed at 254 nm. 
The solids were dissolved in MeOH and injected as such. The areas under the peaks in the 
chromatogram were measured against a known sample so the percentage of each 
compound, relative to the total area under all peaks, could be determined. (S)-5.8 Rf: 14.52 
min, (R)-5.8 Rf: 20.28 min, (S)-5.5 Rf: 25.23 min, (S)-5.6 Rf: 30.39 min, (R)-5.5 & (R)-5.6  
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Rf: 38.81 min, (S)-5.4 Rf: 48.79 min, (R)-5.5 Rf: 64.39 min, (S)-5.7 Rf: 75.87 min, (R)-5.7 
Rf: 97.11 min. 
Method 2: the separation was carried out on a Chiralcel  AD-H  (150 × 4.6 mm) column 
with a gradient of heptane : EtOH as eluent at 20°C and 0.7 mL·min
-1: 95:5 (20 min) in 
20 min to 90:10 (20 min) in 20 min to 75:25 (20 min). UV-VIS detection was performed at 
254 nm. The solids were dissolved in MeOH and injected as such. The areas under the 
peaks in the chromatogram were measured against a known sample so the percentage of 
each compound, relative to the total area under all peaks, could be determined. (±)-5.8 Rf: 
38.72 min, (S)-5.5 Rf: 45.55 min, (S)-5.6 & (S)-5.7 Rf: 48.49 min, (R)-5.6 Rf: 51.20 min, 
(R)-5.5 Rf: 55.35 min, (R)-5.7 Rf: 60.80 min, (S)-5.4 Rf: 62.82 min, (R)-5.4 Rf: 77.65 min. 
1H-NMR and 
13C-NMR spectra were recorded on a Varian Mercury 300MHz machine. 
Chemical shifts are denoted in δ (ppm) and are referenced to the residual protic solvent. 
The coupling constant J is denoted in Hz. Splitting patterns are denoted as follows: s 
(singlet), d (doublet), dd (double doublet), t (triplet), dt (double triplet), m (multiplet) and 
bs (broad singlet). 
Mass spectra were recorded by API-ES (electron spray ionization) by dissolving the 
samples in MeOH and injecting the solution as such. Mobile phase: Acetonitrile : 0.1% 
formic acid in water 50 : 50 (1 min.), flow: 0.2 mL·min
-1, injection volume: 5 µl. 
Procedure for the deracemization of 5.4 at isothermal conditions as described in §5.3: 
A new 100 mL round-bottom flask equipped with a new PTFE coated egg-shaped magnetic 
stirrer (2.5 × 1.3 cm) was charged with 3.0 g (±)-5.4, 27 g MeCN and 7.5 g solid glass 
beads (Ø 2 mm) was stoppered and stirred at 1250 rpm for one hour. Fresh 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU, 150 µL) was added to the suspension and the 
stirring was continued. Samples were taken by filtration (P4) and washed with some 
TBME. The optical rotation of the material on the filter cake was analyzed according to 
Method 1 (see above). This method was also applied to deracemize 2.0 g (±)-5.5 (15 g 
MeCN, 0.67 g DBU and 7 g solid glass beads, stirring at 500 rpm, after 4 days: >99% ee). 
Procedure for the deracemization by sonication as described in §5.4: A new 
scintillation vial (20 mL) was charged with 10 g solid glass beads (Ø 2 mm), 0.36 g (±)-5.4, 
3.5 g MeCN. The bottom part (~1 cm) of the stoppered vial was placed in a ultrasonic 
cleaning bath (Bandelin Sonorex, RK 106, 35kHz) which was kept at 20°C by a thermostat 
(Huber, ministat cc) and was sonicated in the middle of the bath for 5 minutes. 
Subsequently, fresh 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 0.10 g) was added and the 
sonication was continued. Samples were taken by filtration (P4) and washed with some 
TBME. The optical rotation of the material on the filter cake was analyzed according to  
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Method 1 (see above). This method was also applied to deracemize 0.46 g (±)-5.5 under the 
same conditions as describes above. 
Procedure for the deracemization by crystallization as described in §5.5: Two new 
100 mL round-bottom flask were each charged with (±)-5.4 (6.02 g, 23.9 mmol, 1.0 eq), 
DBU (1.07 mL, 7.16 mmol, 0.3 eq), MeCN (35.0 g) and an PTFE coated egg-shaped 
stirring bar (1.0 × 2.0 cm). One flask was additionally charged with 15.0 g solid glass beads 
(Ø 2 mm) also. The loosely stoppered flasks were placed in a stirred water bath (1250 rpm) 
which was kept at 70°C by a thermostat (Huber, ministat cc) until complete dissolution was 
observed. The flasks were cooled to 20°C at 0.05, 0.5, 1.0 or 2.0°C·min
-1. When the 
mixture reached 20°C, stirring was continued for another 10 minutes. A sample was taken 
by filtration (P4), washed with TMBE and dried on air. The ee composition of the solids 
was determined by Method 1 (see above). The suspension was then reheated to dissolution 
and cooled to 20°C at a different rate. Samples of the mixture at 70°C confirmed the 
complete racemization of the material upon reheating. After a 5 heating/cooling runs 3.18 g 
(53%) 5.4 was isolated. 
Procedure for the crystallization of (±)-threonine as described in §5.6: A suspension of 
DL-threonine (22.0 g) in water (100 mL) was heated to dissolution and crash cooled to 
20°C. Since the solubility of DL-threonine is 212 mg/g H2O this solution has a 
(super)saturation of 103.8%. From this solution, 9 × 10 mL were transferred into separate 
Kimble reactor tube (Ø 25 × 150 mm) with a PTFE coated egg-shaped magnetic stirring bar 
(19 × 10 mm). The solutions were heated to 50°C and subsequently cooled to 20°C at 
0.3°C·min
-1 and at 600 rpm in a Reactiv8 computer controlled thermostated stirrer. 
Suspensions were observed in the tubes between 4h 10min and 5h 50 min. When a tube 
contained a suspension, the solids were collected immediately and sucked to dryness. A 
spatula tip of filter cake was mixed with dioxane (1.5 mL), 10% Na2CO3 (1.5 mL) and a 
spatula tip of fresh FMOC-Cl. The mixture was left to stir over night and was subsequently 
washed with Et2O (1.5 mL) and acidified with 1M citric acid (5 mL) (under formation of 
CO2). The resulting mixture was extracted with EtOAc and evaporated by a flow of N2. The 
residue was taken up in MeOH and analyzed by chiral HPLC: Column: Chirobiotic T (250 
× 4.6 mm), mobile phase: MeOH/20 mM NH4OAc in water (30 :70), flow: 0.5 mL·min
-1, 
UV detection at: 220 and 264 nm. 
Procedure for the deracemization by co-crystallization as described in §5.6: A mixture 
of (±)-5.5 (565 mg, 2.97 mmol 0.29 eq), (±)-5.6 (744 mg, 2.97 mmol 0.29 eq), (±)-5.7 (908 
mg, 2.97 mmol 0.29 eq), (±)-5.8 (649 mg, mg, 2.97 mmol 0.29 eq), DBU (356 µL, 2.38 
mmol, 0.23 eq) and MeCN (8.75 g) was sonicated to dissolution and filtered (P4) to remove 
dust particles. The solution was placed in a new 25 mL round-bottom flask, which was 
charged with a new PTFE coated egg-shaped magnetic stirrer (2.0 × 1.0 cm), 5.0 g solid  
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glass beads (Ø 2 mm) and (±)-5.4 (2.614 g, 10.4 mmol, 1.0 eq). The loosely stoppered flask 
was placed in a stirred water bath (1250 rpm), which was kept at 70°C by a thermostat 
(Huber, ministat cc) and complete dissolution was observed. The flask was cooled from 
70°C to 20°C at 0.05°C·min
-1 (16h, 40 min). When the mixture reached 20°C, stirring was 
continued for another 2.5 hours. The solids were collected by filtration (P4), washed with 
TMBE and dried on air to yield white solids. The solids were analyzed by both methods 1 
and 2 (see above) to determine the relative amount as denoted in Table 5.3 and the ee of 
each component as depicted in experiments 5–14 in Figure 5.8. Experiments 1–4 in Figure 
5.8 were performed in the same manner as described above but with exclusion of three 
imines. 
(±)-methyl 2-aminopropanoate hydrochloride (1a). Thionyl 
chloride (17.4 mL, 0.24 mol, 1.2 eq) was added dropwise to a 
suspension of (±)-alanine (17.8 g, 0.2 mol, 1.0 eq) in MeOH (100 
mL) upon which the reaction mixture started to boil. The reaction mixture was concentrated 
at 50°C when 
1H-NMR showed full conversion after 1.5 hours. The residue was stirred in 
TBME (200 mL) and 27.4 g (98%) of the title compound was isolated as a white solid. 
1H-NMR (300MHz, d6-DMSO): δ= 1.40 (d, J=7.2 Hz, 3H), 3.69 (s, 3H), 3.99 (q, J=6.9 
Hz, 1H), 8.76 (bs, 3H) ppm. 
13C-NMR (75MHz, d6-DMSO): δ= 15.7, 47.8, 52.8, 170.4 
ppm. MS (EI): m/z= 104 [M+H
+]. 
(±)-2-aminopropanamide hydrochloride (2a). To a concentrated 
solution of ammonia in water (150 mL) was added 1a (27.4 g, 0.2 
mol, 1.0 eq) and the resulting solution was stirred over the weekend. 
1H-NMR showed full conversion and the solution was concentrated 
to dryness and stripped with toluene to remove remaining water. This yielded the title 
compound (23.0 g, 92%) as a white solid. 
1H-NMR (300MHz, d6-DMSO): δ= 1.34 (d, 
J=6.9 Hz, 3H), 3.71 (q, J=7.2 Hz, 1H), 7.41 (bs, 1H), 7.98 (bs, 1H), 8.18 (bs, 3H) ppm. 
13C-NMR (75MHz, d6-DMSO): δ= 17.3, 48.3, 171.5 ppm. MS (EI): m/z= 89 [M+H
+]. 
(±)-2-(((2-methylphenyl)methylidene)amino)propanamide  (5.5). 
To a suspension of 2a (17.7 g, 142 mmol, 1.0 eq) in CH2Cl2 (250 
mL) was added Na2SO4 (25 g), o-tolualdehyde (16.4 mL, 142 
mmol, 1.0 eq) and DIPEA (23.5 mL, 142 mmol, 1.0 eq). The 
mixture was stirred overnight at room temperature. Subsequently, 
the mixture was filtered and the residue washed with CH2Cl2. The 
filtrate was concentrated to a white solid which was washed with 
TBME (250 mL), H2O (50 mL) and again TBME (100 mL). The filter cake was dried in 
vacuo. The solid was recrystallized from MeCN to yield 16 g (59%) 5.5 as a white solid. 
Me
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1H-NMR (300MHz, d6-DMSO): δ= 1.30 (d, J=6.6 Hz, 3H), 3.90 (q, J=6.9 Hz 1H), 7.07 
(bs, 1H), 7.13 (bs, 1H), 7.23 (t, J=7.7 Hz, 2H), 7.33 (t, J=8.1 Hz, 1H), 7.91(d, J=8.1 Hz, 
1H), 8.61 (s,  1H) ppm. 
13C-NMR (75MHz, d6-DMSO): δ= 19.0, 20.6, 68.3, 125.9, 127.5, 
130.5, 130.8, 133.7, 137.8, 160.3, 174.7 ppm. MS (EI): m/z= 191 [M+H
+]. Optically pure 
5.5 was prepared via the same method starting from optically pure 2a. 
(±)-methyl 2-amino-4-(methylthio)butanoate hydrochloride (1b). 
Thionyl chloride (17.4 mL, 0.24 mol, 1.2 eq) was added dropwise to 
a suspension of (±)-methionine (29.8 g, 0.2 mol, 1.0 eq) in MeOH 
(100 mL) upon which the reaction mixture started to boil. The 
reaction mixture was concentrated at 50°C when 
1H-NMR showed 
full conversion after 1.5 hours. The residue was stirred in TBME (3 
× 200 mL) and 39.0 g (98%) of the title compound was isolated as a yellowish solid. 
1H-
NMR (300MHz, d6-DMSO): δ= 2.03 (s, 3H), 2.07 (q, J=6.9 Hz, 2H), 2.50-2.70 (m, 2H), 
3.73 (s, 3H), 4.06 (t, J=6.3 Hz, 1H), 8.72 (bs, 3H) ppm. 
13C-NMR (75MHz, d6-DMSO): δ= 
14.3, 28.4, 29.3, 50.8, 52.8, 169.6 ppm. MS (EI): m/z= 164 [M+H
+]. 
(±)-2-amino-4-(methylthio)butanamide hydrochloride (2b). To a 
concentrated solution of ammonia in water (150 mL) was added 1b 
(39.0 g, 0.2 mol, 1.0 eq) and the resulting brown/orange solution 
was stirred over the weekend. 
1H-NMR showed full conversion and 
the solution was concentrated to dryness and stripped with toluene to remove remaining 
water. This yielded the title compound (35.6 g, 96%) as an off-white solid. 
1H-NMR 
(300MHz, d6-DMSO): δ= 1.94–2.00 (m, 2H), 2.04 (s, 3H), 2.50–2.60 (m, 2H), 3.76 (t, 
J=6.3 Hz, 1H), 7.51 (bs, 1H), 7.98 (bs, 1H), 8.04 (bs, 3H) ppm. 
13C-NMR (75MHz, d6-
DMSO): δ= 14.6, 28.5, 31.0, 51.7, 170.2 ppm. MS (EI): m/z= 149 [M+H
+]. 
(±)-2-(((2-methylphenyl)methylidene)amino)-4-
(methylsulfanyl)butanamide (5.6). To a suspension of 2b (25.2 g, 
136 mmol, 1.0 eq) in CH2Cl2 (250 mL) was added Na2SO4 (25 g), 
o-tolualdehyde (15.7 mL, 136 mmol, 1.0 eq) and DIPEA (22.5 mL, 
136 mmol, 1.0 eq). The mixture was stirred overnight at room 
temperature. Subsequently, the mixture was filtered and the residue 
washed with CH2Cl2. The filtrate was concentrated to a yellow oil 
which was stirred with TBME (250 mL). The solids were collected 
and washed with TBME (50 mL), H2O (50 mL) and again TBME 
(100 mL). The filter cake was dried in vacuo. The solid was recrystallized from MeCN to 
yield 26.7 g (79%) 5.5 as a white solid. 
1H-NMR (300MHz, d6-DMSO): δ= 1.80–2.10 (m, 
2H), 2.01 (s, 3H), 2.30–2.50 (m, 2H), 2.50 (s, 3H), 3.89 (dd, J1=4.5 Hz, J2=8.4 Hz, 1H), 
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7.08 (bs, 1H), 7.21 (bs, 1H), 7.23 (t, J=7.5 Hz, 2H), 7.34 (t, J=7.8 Hz, 1H), 7.90 (d, J=7.8 
Hz, 1H), 8.59 (s, 1H) ppm. 
13C-NMR (75MHz, d6-DMSO): δ= 14.5, 19.0, 29.6, 33.1, 72.4, 
126.0, 127.7, 130.5, 130.8, 133.6, 137.9, 161.5, 173.6 ppm. MS (EI): m/z= 251 [M+H
+]. 
Optically pure 5.6 was prepared via the same method starting from enantiopure 2b. 
(±)-methyl 2-amino-3-(1H-indol-3-yl)propanoate dihydro-
chloride (1c). Thionyl chloride (17.4 mL, 0.24 mol, 1.2 eq) was 
added dropwise to a suspension of (±)-tryptophan (40.8 g, 0.2 
mol, 1.0 eq) in MeOH (100 mL) upon which the reaction mixture 
started to boil. After 40 minutes, the reaction mixture crystallized 
as a very thick suspension and the mixture was stirred at 50ºC for 5.5 hours to complete the 
reaction as indicated by 
1H-NMR. The reaction mixture was diluted by addition of TBME 
(200 mL) and the solids were collected and washed with MeOH and TBME. After drying in 
vacuo this furnished the title compound (50.7 g, 88%) as a white solid. 
1H-NMR (300MHz, 
d6-DMSO): δ= 3.20–3.40 (m, 2H), 3.62 (s, 1H), 4.17 (t, J=6.0 Hz, 1H), 6.98 (t, J=7.5 Hz, 
1H), 7.07 (t, J=6.3 Hz, 1H), 7.23 (d, J=2.1 Hz, 1H), 7.35 (t, J=8.1 Hz, 1H), 7.49 (t, J=7.8 
Hz, 1H), 8.64 (bs, 3H), 11.11 (bs, 1H) ppm. 
13C-NMR (75MHz, d6-DMSO): δ= 26.1, 52.6, 
52.8, 106.4, 111.6, 118.1, 118.6, 121.1, 125.0, 127.0, 136.2, 169.7 ppm. MS (EI): m/z= 219 
[M+H
+], 203 [M-NH3+H
+]. 
(±)-2-amino-3-(1H-indol-3-yl)propanamide (2c). To a 
concentrated solution of ammonia in water (150 mL) was added 1c 
(39.0 g, 0.2 mol, 1.0 eq) and the resulting beige suspension was 
stirred over the weekend. 
1H-NMR showed full conversion and the 
suspension was cooled to 4°C and left to crystallize overnight. The 
solids were collected and washed with cold water (50 mL) and TBME (100 mL). The filter 
cake was dried in vacuo. This furnished the title compound (25.0 g, 61%) as white solids. 
1H-NMR (300MHz, d6-DMSO): δ= 1.63 (bs, 2H), 2.70 (dd, J1=8.1 Hz, J2=14.1 Hz, 1H), 
3.04 (dd, J1=4.8 Hz, J2=14.4 Hz, 1H), 3.39 (dd, J1=4.5 Hz, J2=8.1 Hz, 1H), 6.93 (bs, 1H), 
6.95 (dt, Jd=1.2 Hz, Jt=6.9 Hz, 1H), 7.04 (dt, Jd=0.9 Hz, Jt=7.8 Hz, 1H), 7.14 (d, J=2.4 Hz, 
1H), 7.31 (d, J=7.2 Hz, 1H), 7.31 (bs, 1H), 7.56 (d, J=7.8 Hz, 1H), 10.81 (bs, 1H). ppm. 
13C-NMR (75MHz, d6-DMSO): δ= 31.3, 55.5, 111.0, 111.5, 118.4, 118.7, 121.0, 123.9, 
127.6, 136.4, 177.5 ppm. MS (EI): m/z= 204 [M+H
+], 226 [M+Na
+], 202 [M-H
+]. 
(±)-3-(1H-indol-3-yl)-2-(((2-methylphenyl)methylidene) amino)propanamide (5.7). To 
a suspension of 2c (24.4 g, 120 mmol, 1.0 eq) in CH2Cl2 (250 mL) was added Na2SO4 (25 
g) and o-tolualdehyde (13.9 mL, 136 mmol, 1.0 eq). The mixture was stirred overnight at 
room temperature. Subsequently, the mixture was filtered and the residue washed with 
CH2Cl2. The filtrate was concentrated to white solid material. The solids were collected and 
CO2Me H2N
·2 HCl
NH
CONH2 H2N
NH 
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stirred in TBME. The solids were collected and washed with 
TBME (50 mL) and dried in vacuo. This yielded 32.7 g 
(89%) 5.7 as a white solid. 
1H-NMR (300MHz, d6-DMSO): 
δ= 2.50 (s, 3H), 2.99 (dd, J1=9.3 Hz, J2=14.1 Hz, 1H), 3.39 
(dd, J1=2.1 Hz, J2=14.1 Hz, 1H), 4.01 (dd, J1=4.2 Hz, J2=9.3 
Hz, 1H), 6.92 (t, J=6.3 Hz, 1H), 7.00–7.32 (m, 7H), 7.52 (d, 
J=8.1 Hz, 1H), 7.84 (d, J=7.8 Hz, 1H), 7.99 (s, 1H), 10.77 
(s, 1H) ppm. 
13C-NMR (75MHz, d6-DMSO): δ= 18.4, 30.2, 
74.2, 110.4, 111.4, 118.4, 118.6, 121.0, 124.1, 125.9, 127.3, 127.4, 130.3, 130.6, 133.6, 
136.3, 137.6, 160.3, 174.3 ppm. MS (EI): m/z= 306 [M+H
+], 328 [M+Na
+], 304 [M-H
+]. 
Optically pure 5.7 was prepared via the same method starting from enantiopure 2c. 
(±)-methyl 2-amino-3-methylbutanoate hydrochloride (1d). 
Thionyl chloride (27.4 mL, 0.38 mol, 1.9 eq) was added dropwise 
to a suspension of (±)-valine (23.4 g, 0.2 mol, 1.0 eq) in MeOH 
(100  mL) upon which the reaction mixture started to boil. The 
mixture was kept at reflux temperature by heating. The reaction mixture was concentrated 
at 50°C when 
1H-NMR showed full conversion after one day. The oily residue was 
tritruated in TBME (3 × 200 mL) and the solid was collected by filtration and washed with 
TMBE (50 mL). The title compound was dried in vacuo to yield 26.7 g (80%) as a white 
solid. 
1H-NMR (300MHz, d6-DMSO): δ= 0.905 (d, J=6.9 Hz, 3H), 0.956 (d, J=6.9 Hz, 
3H), 2.15–2.20 (m, 1H), 3.71 (s, 3H), 3.77 (bs, 1H), 8.72 (bs, 1H) ppm. 
13C-NMR (75MHz, 
d6-DMSO): δ= 17.6, 18.8, 29.3, 52.6, 57.5, 169.1 ppm. MS (EI): m/z= 132 [M+H
+]. 
(±)-2-amino-3-methylbutanamide hydrochloride (2d). To a 
concentrated solution of ammonia in water (150 mL) was added 1d 
(26.7 g, 0.16 mol, 1.0 eq) and the resulting solution was stirred 
over the weekend. 
1H-NMR subsequently showed full conversion 
and the solution was concentrated to dryness and stripped with toluene to remove 
remaining water. This yielded the title compound (23.9 g, 78%) as an off-white solid. 
1H-
NMR (300MHz, d6-DMSO): δ= 0.85–0.95 (m, 6H), 2.09 (q, J=5.7 Hz, 1H), 3.53 (d, J=5.4 
Hz, 1H), 7.48 (bs, 1H), 7.93 (bs, 3H), 7.97 (bs, 1H) ppm. 
13C-NMR (75MHz, d6-DMSO): 
δ= 18.1, 18.6, 29.6, 57.4, 169.9 ppm. MS (EI): m/z= 117 [M+H
+], 139 [M+Na
+]. 
(±)-3-methyl-2-(((2-methylphenyl)methylidene)amino) butanamide (5.8). To a 
suspension of 2d (21.2 g, 139 mmol, 1.0 eq) in CH2Cl2 (250 mL) was added Na2SO4 (25 g), 
o-tolualdehyde (16.1 mL, 139 mmol, 1.0 eq) and DIPEA (23.0 mL, 139 mmol, 1.0 eq). The 
mixture was stirred overnight at room temperature. Subsequently, the mixture was filtered 
and the residue washed with CH2Cl2. The filtrate was concentrated to a red paste which was 
CO2Me H2N
·HCl
Me Me
CONH2 H2N
·HCl
Me Me
CONH2 N
Me
NH 
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stirred in TBME (250 mL) to yield a pink suspension which was 
filtered. The filter cake was washed with TBME (50 mL) and the 
filtrate was concentrated and stripped with toluene. The resulting 
solid was recrystallized from MeCN to yield 21.0 g (69%) 5.8 as a 
white solid. 
1H-NMR (300MHz, d6-DMSO): δ= 0.83 (s, 3H), 0.85 
(s, 3H), 2.18 (m, 1H), 2.50 (s, 3H), 3.48 (d, J=5.7 Hz, 1H), 6.96 
(bs, 1H), 7.15–7.35 (m, 4H), 7.87 (d, J=6.9 Hz, 1H), 8.51 (s, 1H) 
ppm. 
13C-NMR (75MHz, d6-DMSO): δ= 18.0, 19.2, 19.4, 31.5, 80.0, 126.0, 128.0, 130.4, 
130.8, 133.7, 137.7, 161.0, 173.6 ppm. MS (EI): m/z= 219 [M+H
+], 239 [M+Na
+]. 
Optically pure 5.8 was prepared via the same method starting from enantiopure 2d.  
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The Resolution of Phencyphos. 
 
 
 
 
 
In this chapter
* the resolution of phencyphos by entrainment is described. An 
overview of the history of phencyphos, the screening for efficient resolving agents 
and methods to resolve phencyphos on a preparative scale are given. Also, a new 
method to resolve (±)-phencyphos is devised that relies on a pseudo polymorphic 
transition by hydrate formation. 
 
*  Parts of this chapter have been published in Org. Process Res. Dev.   
(DOI: 10.1021/op900171k).  
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6.1   Introduction 
The synthesis and resolution of cyclic phosphoric acids, shown in Scheme 6.1 (together 
with their trivial names), was described more than 20 years ago.
1 These phosphoric acids 
show excellent behavior as resolving agents because of their ability to form crystalline salts 
with high de’s with many (weak) bases. 
O
P
O
O OH
O
P
O
O OH
Cl O
P
O
O OH
OMe
Phencyphos Chlocyphos Anicyphos  
Scheme 6.1 Cyclic phosphoric acids and their trivial names. 
Racemic chlocyphos and anicyphos are resolved without much effort with standard 
resolving agents.
1 However, phencyphos, an excellent resolving agent itself, resists 
resolution with most standard basic resolving agents, a good example that reciprocal 
resolutions are not by definition successful.
2 
Chloramphenicol (Scheme 6.2) is produced as an antibiotic.
3 Since each 
enantiomer/diastereomer of most chiral drugs has a different activity and toxicity, the 
undesired enantiomer of an intermediate used in the synthesis: (+)-(1S,2S)-2-amino-1-
phenyl-1,3-propanediol (APPD), had to be discarded as waste. 
(S)
(S)
OH
HO
NH2
(+)-(1S,2S)-APPD
(R)
(R)
OH
HO
NH
Chloramphenicol
O2N
O Cl
Cl
 
Scheme 6.2 (+)-2-amino-1-phenyl-1,3-propanediol and 
Chloramphenicol. 
Since the costs of disposal of chemical waste are high, (+)-APPD was put on the market as 
an inexpensive optically pure basic resolving agent. This (+)-APPD proved to be an 
excellent resolving agent for phencyphos furnishing both (+) and (–)-phencyphos after  
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liberation of the isolated salts and mother liquors and subsequent crystallization of the free 
acids. 
However, today the production of Chloramphenicol has been largely ceased for use in 
western countries because of a rare but serious side effect: aplastic anemia.
4 Aplastic 
anemia is a condition in which bone marrow does not produce sufficient new cells to 
replenish blood cells.
5 Although the Chloramphenicol is still in use in third-world countries 
and in eye-drops against eye infections, the synthesis has been altered to an economically 
more attractive asymmetric route and hereby eliminating the formation of (+)-APPD.
6 
Hence, (+)-APPD is no longer available at a low cost, making the resolution of phencyphos 
both a time-consuming and an expensive business because of the non-quantitative recovery 
of the resolving agent. A more efficient method had to be found to resolve phencyphos.  
6.2   Screening of Resolving Agents 
Since large scale resolutions of phencyphos had to be performed, an inexpensive, readily 
available and easily recoverable resolving agent was required. Several standard basic 
resolving agents (depicted in Scheme 6.3) were screened to find an alternative for the 
resolution with (+)-APPD. 
NH2
(R)-PEA
N
MeO
HO N
H
H
Quinine
N
MeO
HO
N
H H
Quinidine
N
HO N
H
H
Cinchonidine
N
HO
N
H H
Cinchonine
NH2
O
HO
L-Leucine
OH
NH
(+)-ephedrine
NH
MeO
NH
Br
(S)-4MeOBnPEA (S)-4BrBnPEA  
Scheme 6.3 Basic resolving agents.  
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Resolutions were performed on 1 mmol scale, in several solvents. Some resolving agents 
that were tested either failed to produce crystalline salts, failed to form salts or gave hard to 
filter gel-like precipitates. The results of resolutions that provided crystalline salts are given 
in Table 6.1. 
Table 6.1 Results of small scale resolutions. 
Entry Resolving  agent  Solvent  Yield  (%)  de(%); (+/-)
a 
1  (+)-ephedrine EtOAc  41  0 
2  Quinine IPA 50  14;  (+) 
3  Quinidine EtOAc  57  12;  (+) 
4  Cinchonidine IPA  18  85;  (+) 
5  Cinchonine EtOAc  24  61;  (–) 
6  (R)-PEA IPA 50  36;  (–) 
7  (S)-4BrBnPEA Acetone  49  8;  (+) 
a enriched in either (+)-phencyphos or (–)-phencyphos 
 
Quinine and quinidine are considered to be pseudo enantiomers even though their 
relationship is diastereomeric. In this case one expects that one enantiomer of a racemic 
acid can be obtained when crystallized with quinine and the other enantiomer by resolution 
with quinidine. However, as can be seen from Table 6.1, the resolutions of (±)-phencyphos 
with these pseudo enantiomers do not deliver the opposite enantiomers of phencyphos. On 
the other hand, the resolutions with cinchonidine or with its pseudo enantiomer cinchonine 
did deliver the opposite enantiomers. 
The resolutions with cinchonidine, cinchonine and PEA (entries 4–6) showed potential and 
these were investigated further.  
6.2.1  Diastereomeric Salt Formation with One Half 
Equivalent of Resolving Agent 
Small scale resolution experiments were performed on 2 mmol scale with the aid of 
controlled cooling and stirring. Also, resolutions were performed by the Peachey and Pope 
method in which a half equivalent basic resolving agent is replaced by an inexpensive  
 
 
 
 
 
 
 
The Resolution of Phencyphos. 
147 
achiral base.
2,7 In resolutions by the Pope and Peachey method, the solubility of the less 
soluble salt is higher than in a normal diastereomeric salt resolution, which could allow for 
higher reactor loadings if the resolution were to be scaled up. Furthermore, only half of the 
relatively expensive resolving agent is used and most of it will precipitate as its 
diastereomeric salt during the resolution. In that event, only the precipitate has to be 
liberated to recover most resolving agent. The mother liquor will contain mostly the other 
enantiomer of phencyphos with the achiral base. Since the (±)-phencyphos salt of triethyl 
amine (TEA) is an oil at room temperature, or at least crystallizes very slowly, it was an 
ideal achiral base since the salt with phencyphos will remain in the mother liquor. In an 
attempt to perform a resolution by the method of half-quantities,
2,8,9 in which a half 
equivalent of resolving agent was left out without neutralization, the poorly soluble 
phencyphos crystallized as its free (racemic) acid. The results of the resolutions are given in 
Table 6.2. 
Table 6.2 Resolution of phencyphos with cinchonidine, cinchonine or 
(R)-PEA. 
Entry  Resolving agent  Achiral base  Solvent  Yield (%)  de (%); (+/-)
a 
1  cinchonidine (1.0 eq)  none  IPA  66  25; (+) 
2  cinchonidine (0.5 eq)  TEA (0.5 eq) 
toluene
/EtOH 
22 11;  (–) 
3  cinchonine (1.0 eq)  none  IPA  - 
b n.d.
c 
4  cinchonine (0.5 eq)  TEA (0.5 eq) 
MEK 
/IPA 
- 
d n.d.
c 
5  (R)-PEA (1.0 eq)  none 
IPA 
/H2O 
55  30 ; (+) 
6  (R)-PEA (0.5 eq)  TEA (0.5 eq)  IPA  - 
b n.d.
c 
a enriched in either (+)-phencyphos or (–)-phencyphos, 
b Gel-like material which was 
difficult to filter, 
c not determined, 
d slow crystallization 
 
The difference between the resolution with cinchonidine in entry 4 in Table 6.1 and entry 1 
in Table 6.2 may be explained by the higher concentration of the latter resolution 
experiment thus providing a higher yield and lower de.  
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The Pope and Peachey resolution in entry 2 shows enrichment in the opposite enantiomer 
compared to the resolution in entry 1. Most likely this is because of solvation of the 
phencyphos salt by 2-propanol, toluene and/or ethanol. Since both yield and de are low in 
entry 2, no further investigation was carried out on the possible occurrence of solvation.  
The resolutions with cinchonine (entries 3 and 4) delivered gel-like materials which were 
very difficult to filter and thus not suitable for large scale resolutions. The previous 
resolution with cinchonine in ethyl acetate (entry 5 in Table 6.1) did give salts with good 
filtration behaviour and these results seem due to a solvent (habit modification of solvate 
formation) or concentration effect. However, since the cinchonine salts of phencyphos 
dissolves poorly in ethyl acetate, this was no option for up scaling since the reactor loading 
would be too low. 
The resolution with (R)-PEA in entry 5 gave a enrichment in (+)-phencyphos which might 
be improved by a nucleation inhibitor on condition of the absence of an end-solid solution. 
An attempt to perform a Pope and Peachey resolution (entry 6) was foiled by the formation 
of difficult to filter gel-like salts. 
The resolutions with cinchonidine and (R)-PEA were further investigated as function of 
time in order to allow conclusions about the presence of an end-solid solution or metastable 
equilibria. 
6.2.2  Resolutions Followed in Time 
The resolution of (±)-phencyphos with cinchonidine was followed in time during the 
cooling of the experiment. Samples were taken immediately after material started to 
precipitate. The de’s of both the mother liquor and the (washed) solids were determined. 
The yield of crystallized solids can be determined from both de’s.
10 The results for the 
resolution with cinchonidine are depicted in Figure 6.1. 
As can be concluded from the figure, the slow decrease of de of the solids means that the 
crystallization of the more soluble salt is slow. Furthermore, the first salts which appear 
during cooling, have 78% de. This means the least soluble salt has an end solid solution and 
the isolated material will need several recrystallizations to arrive at >99% de. A better 
alternative would be to liberate the salt with 78% de and recrystallize the free phencyphos 
to high ee as was known to be possible from the original procedure with APPD.
1 After ~15 
hours, both mother liquor and precipitated solids have 74% de which means the yield is 
50%. The maximum yield which can be obtained for each enantiomer, provided 
phencyphos crystallizes as an conglomerate, is 50% × 74% de = 37% yield from a system 
that contains 50% of each enantiomer.  
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Figure 6.1 Resolution of (±)-phencyphos with cinchonidine in time. Lines 
are provided as a guide for the eye. 
The resolution of (±)-phencyphos with (R)-PEA was followed in time also. Again, samples 
were taken and analyzed when crystals started to form. These results are depicted in Figure 
6.2. 
 
Figure 6.2 Resolution of (±)-phencyphos with (R)-PEA in time. Lines are 
provided as a guide for the eye.  
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In this resolution, the more soluble diastereomer starts to crystallize within 2 hours of the 
start of the cooling program. Furthermore, a maximum of 71% de can be obtained in this 
resolution with only 36% yield. This means that if the salt is liberated and crystallized, the 
maximum yield which can be obtained for (+)-phencyphos, provided phencyphos 
crystallizes as a conglomerate, is 36% × 71% de = 26% yield.  
Clearly, the resolution of (±)-phencyphos with cinchonidine is superior to that with (R)-
PEA but still requires laborious recycling of the resolving agent and recrystallization to 
achieve high ee’s. Another method to obtain complete separation of the enantiomers was 
investigated: resolution by entrainment. 
6.3   Resolution by Entrainment
11 
The resolution of a racemate by entrainment is possible if the racemate crystallizes as a 
conglomerate (or a racemic compound with very low eutectic values). The ternary phase 
diagram was constructed in ethanol.   
The phase diagram showed that phencyphos crystallizes as a racemic compound with a 
eutectic at 70 % ee (A and A’) as shown in Figure 6.3 and is thus not suitable for resolution 
by entrainment.  
 
Figure 6.3 Top 10% of the solubility diagram of phencyphos in ethanol.  
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Solvates of phencyphos with either MeOH, EtOH or IPA should give different IR 
signatures. However, the signatures were similar which indicates that MeOH, EtOH and 
IPA do not give solvates with (±)-phencyphos as depicted in Figure 6.4. 
 
Figure 6.4 IR spectra from (±)-phencyphos crystallized from several 
solvents. The peaks at 2350 cm
-1 are from CO2. 
However, a recent report in the literature indicated that phencyphos, crystallized from 
water, can form a hydrate.
12 IR analysis of (±)-phencyphos which was crystallized from 
water is depicted in Figure 6.4. It is clearly seen that the fingerprint between 1250 cm
-1 and 
1050 cm
-1 is different in (±)-phencyphos crystallized from H2O than (±)-phencyphos 
crystallized from either MeOH, EtOH or IPA. Most likely, this hydrate was also isolated 
when the APPD-phencyphos salt was liberated with aqueous hydrochloric acid. In the 
original description of the synthesis of phencyphos the hydrate formation was apparently 
overlooked. However, it was noted that the isolated phencyphos crystallized as a 
conglomerate, information that can be found in the experimental section of that article.
1 
Because phencyphos hydrate has a low solubility in pure water (Table 6.3, entry 3), a co-
solvent should be added in order to increase the amount of phencyphos in the solution. The 
higher solubility will make the process economically more attractive. The solubility of  
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anhydrous phencyphos in dry co-solvents was investigated. A requirement for these 
solvents is that the co-solvent should be water miscible and should have a high solubility 
for phencyphos. The solubility data were determined by suspending phencyphos in the 
appropriate dry solvent and determining the phencyphos content in the filtrate by 
evaporation. The results are given in Table 6.3. 
Table 6.3 Solubilities of (±)-phencyphos in several water miscible 
solvents. 
Entry Solvent 
Solubility 
(mg (±)-phencyphos/mL 
solvent) 
1  MeCN <  1 
2  1,4-dioxane 1.1 
3  water 3.2 
4  ethylene glycol  4.0 
5  acetic acid  4.8 
6  1-butanol 5.7 
7  sec-butanol 5.8 
8  IPA 8.4 
9  MeOH 17 
10  DMF 81 
11  DMSO 142 
    
Most solvents dissolve (±)-phencyphos poorly. However, MeOH, DMF and DMSO show 
potential to increase the solubility of phencyphos hydrate but still allow the hydrate to 
crystallize. Solubility diagrams were constructed to determine the minimal water content of 
the solvent mixture to be able to isolate the hydrated conglomerate and not the anhydrous 
racemic compound.  
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6.3.1  Hydration of Phencyphos in DMSO/Water Mixtures 
Several mixtures of water and DMSO were prepared and the compositions of the mother 
liquors were determined and plotted in a phase diagram. Since the removal of DMSO from 
the filter cake without dehydration of the phencyphos is difficult, the composition of the 
solids was not determined.  
Small scale resolution by entrainment was attempted with enantiomerically enriched (~15% 
ee) in (–)-phencyphos. However, below 25% wt. water, no enrichment was found in the 
first solids even when the supersaturated solution was seeded with (–)-phencyphos hydrate. 
The mixtures with less than 25% wt. water were also difficult to filter, indicating a different 
crystal habit, polymorph, solvate and/or hydrate. The presence of a hydrate solvate which 
crystallizes as a racemic compound with unknown composition ((±)-phencyphos·x H2O·y 
DMSO) might explain this unexpected result. This hypothesis was further investigated by 
XRPD. 
 
Figure 6.5 XRPD of racemic phencyphos crystallized from 1) MeOH, 2) 
50% H2O  in MeOH, 3) DMSO and 4) 15% H2O in DMSO. 
Figure 6.5 depicts the XRPD spectra of crystals obtained from 15% H2O in DMSO (4). The 
solids were analyzed by XRPD and compared with that of anhydrous (±)-phencyphos from  
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MeOH (1), phencyphos hydrate from a H2O:MeOH mixture (2) and anhydrous 
(±)-phencyphos from DMSO (3). Although peak intensities of spectra 3 and 4 are different 
from anhydrous (±)-phencyphos (1), the location of peaks are the same. This means that 
with 15% H2O:DMSO anhydrous (±)-phencyphos (1) is isolated and these crystals have a 
different morphology and/or a different orientation of the crystals in the XRPD than the 
anhydrous (±)-phencyphos crystallized from pure MeOH. This was also confirmed by the 
more difficult filtration behavior of (±)-phencyphos crystallized from solvent mixtures with 
less than 25% H2O in DMSO mixtures.  
The phase diagram with (±)-phencyphos, water and DMSO is shown in Figure 6.6.  
During an entrainment experiment, the crystallization of the hydrate was slow compared 
with that of the MeOH/water mixtures (see Chapter 6.3.3). No further investigations were 
performed on this solvent mixture. 
 
Figure 6.6 Solubility diagram of (±)-phencyphos, water and DMSO in 
weight fractions. Open dots are measured points.  
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6.3.2  Hydration of Phencyphos in DMF/Water Mixtures 
In a similar fashion as the mixtures with DMSO/water, the phase diagram for DMF/water 
mixtures was determined. Again, we were unable to determine whether the solid phase 
consisted of phencyphos hydrate without dehydrating the solid phase during the removal of 
residual DMF. An assumption was made from the shape of the solubility line. The phase 
diagram is depicted in Figure 6.7 which shows that at least 13% wt. water in DMF is 
needed to form the hydrate. 
 
 
Figure 6.7 Solubility diagram of (±)-phencyphos, water and DMF in 
weight fractions. Open dots are measured points. 
Starting from 17% wt. H2O in DMF and phencyphos hydrate which was enriched in the (–)-
enantiomer (15% ee) gave high ee’s in the first crystals. However, before enrichment in the 
mother liquor could take place in the (+)-enantiomer, the latter crystallized leaving a 
racemic mother liquor and crystals with 55% ee. Apparently, phencyphos hydrate in this 
water/DMF mixture lacks fast crystal growth and/or a wide metastable zone width, which 
makes this system unsuitable for a resolution by entrainment.  
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6.3.3  Hydration of Phencyphos in MeOH/Water Mixtures 
The phase diagram of (±)-phencyphos, water and MeOH was constructed in the same 
manner as the previous phase diagrams. However, since MeOH is volatile, most MeOH 
evaporated on exposure to air overnight and after a further drying at 100°C in vacuo, the 
water (hydrate) content could be determined.
13 The phase diagram in Figure 6.8 shows that 
at least 22% wt. water in MeOH is needed for the formation of phencyphos hydrate. To 
make sure the process is reproducible even when the water content fluctuates, 30% wt. 
water was used in the entrainment process. 
 
Figure 6.8 Solubility diagram of (±)-phencyphos, water and MeOH in 
weight fractions. Open dots are measured points. 
6.3.4  Resolution by Entrainment in MeOH/Water 
Mixtures 
Entrainment experiments starting with 30% wt. water in methanol were tested with 
different concentrations of phencyphos. The racemic phencyphos from the commercial 
source contained 5.88% water, which is 0.84 equivalents water compared to phencyphos.
14  
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When a concentration of 23.3 mg (±)-phencyphos·0.84H2O per mL solvent mixture was 
used, the primary nucleation started 1.5 hours after the start of the cooling of the solution 
from 54.0°C to 28.9°C. When this mixture was enriched by addition of 3.7 mg (–)-
phencyphos hydrate for each mL solvent mixture prior to the cooling, primary nucleation 
started at 31°C so there was no need to seed the mixture with optically pure phencyphos 
hydrate. The suspension was left to age for another 30 minutes and then the suspension was 
filtered. Then, 7.3 mg (±)-phencyphos·0.84H2O per mL solvent was added to the mother 
liquor and the mixture was heated to 54.0°C (dissolution) and the cooling cycle was 
repeated to obtain (+)-phencyphos hydrate. The isolated filter cakes were only sucked dry 
but not washed to prevent the dilution of the mother liquor. These hydrates had an average 
optical purity of 93% ee due to a remainder mother liquor and premature primary 
nucleation of the unwanted enantiomer. Combined batches were heated and subsequently 
cooled in a mixture of 30% wt. H2O in MeOH to give crystals with >99% ee after filtration. 
In practice a yield of 41% was obtained. 
In this manner, phencyphos was resolved on 100 mL, 2L, and 35L scale. On 35L scale, in 
each run 270 gram of (–)-phencyphos hydrate or (+)-phencyphos hydrate were isolated in 
alternating turns. With a temperature programmed reactor, 5 batches were performed each 
day. Because of the metastable zone, the temperature program of the reactor should be 
controlled internally, precisely and not overshoot during cooling. The latter would result in 
premature crystallization of the unwanted enantiomer. Furthermore, care should be taken 
that the crystals are collected before (large amounts of) the unwanted enantiomer 
crystallizes. A correctly performed resolution by entrainment is schematically depicted in 
Figure 6.9. In step 1, say 0.5 mol optically pure (+)-phencyphos is added to a mixture of 
racemic phencyphos in the solvent and subsequently heated to dissolution. In step 2 the 
solution is cooled to supersaturation of both enantiomers and 1.0 mol (+)-phencyphos 
hydrate crystallizes and is collected by filtration. In step 3, 1.0 mol racemate is added to 
the, now enriched in (–)-phencyphos and supersaturated mother liquor and this mixture is 
heated to dissolution. The mixture is cooled in step 4 and now 1.0 mol (–)-phencyphos 
hydrate is collected. In step 5, 1.0 mol racemate is added and the mixture is heated to 
dissolution and hereby producing the same situation as existed after step 1. 
The case in which the desired enantiomer, say (+), is isolated before the crystallization is 
complete is depicted in Figure 6.10. The mixture is first biased in (+)-phencyphos and 
heated in step 1. After cooling less (+)-phencyphos hydrate is isolated than normal in step 
2. The separated mother liquor has a lower ee than in a correctly performed entrainment. In 
step 3 racemate is added and the mixture is dissolved by heating. During the cooling in step 
4, the more concentrated (–)-phencyphos starts to crystallize, shortly followed by the now 
more concentrated than normal (+)-phencyphos. This produces solids with a relatively low  
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ee and a racemic mother liquor. In step 5, addition of racemate to the mother liquor will not 
produce the situation after step 1 but the same situation as before step 1.Re-biasing the 
mother liquor with enough (–) or (+)-phencyphos will allow the entrainment procedure to 
resume. 
 
Figure 6.9 Representation of resolution by entrainment. 
 
Figure 6.10 Schematic representation of an entrainment failure.  
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Cycles could be repeated up to 50 times without refreshing the mother liquor. Impurities 
from the starting material were accumulated in the mother liquor during entrainment and 
started to affect the entrainment after 50 runs by slow crystallization in the now yellow 
mother liquor. The reactor did not need cleaning between runs because complete 
dissolution was obtained during the next heating cycle. 
6.3.5  Nucleation Inhibition of Phencyphos Hydrate 
If nucleation inhibition of phencyphos hydrate by addition of a proper racemic additive 
could be performed, the process could be performed at higher concentration and thus, a 
higher yield could be obtained. Nucleation and crystallization of the enantiomer of 
phencyphos in excess might then start by itself because of the high concentration or be 
forced to start by addition of enantiopure seeds. Anicyphos and chlocyphos (See Scheme 
6.1) were tested as potential nucleation inhibitors against a blank crystallization. 
Six suspensions of (±)-phencyphos hydrate in 30% wt. H2O in MeOH were heated to 
dissolution and then cooled to 20°C under continuous stirring. On average, primary 
nucleation was observed after 11 minutes (standard deviation (sd): 1.3 min). When 
anicyphos (~3% wt.) was added to three of these tubes and the dissolution and cooling 
procedure was repeated, on average, primary nucleation was observed after 11 minutes (sd: 
1.2 min). When chlocyphos (~3% wt.) was added to the other three tubes and the 
dissolution and cooling procedure was repeated, on average, primary nucleation was 
observed after 13 minutes (sd: 1.5 min). 
Neither anicyphos nor chlocyphos changes the metastable zone width significantly. One 
may conclude that these compounds are not useful in the resolution of (±)-phencyphos by 
entrainment. Also, if incorporation of these additives would be found, the recycling of the 
mother liquor will become more difficult as will be the purification of the resolved 
phencyphos hydrate which will be contaminated with small amounts of anicyphos or 
chlocyphos. 
6.4   Resolution of Phencyphos by Hydrate Formation 
When anhydrous (±)-phencyphos, which was crystallized from dry MeOH, was placed in a 
moist chamber, no hydration took place.
13 Apparently, the anhydrous (±)-phencyphos 
cannot interconvert into the hydrate through the solid phase.   
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Figure 6.11 Solubility diagram of (±)-phencyphos in methanol and water. 
However, when anhydrous (±)-phencyphos (A) was placed into a mixture of enough 30% 
wt. water in methanol (dotted line) as depicted in the phase diagram in Figure 6.11, the 
anhydrous (±)-phencyphos becomes metastable as the system arrives at point B. 
Conversion to (–)- and (+)-phencyphos hydrate can take place through the liquid phase via 
primary nucleation. Since the supersaturation will be low, the primary nucleation will take 
some time. However, if seeds are added, these will grow and will consume the anhydrous 
(±)-phencyphos. When all anhydrous (±)-phencyphos is consumed, the solids will have 
composition C and the mother liquor will have composition D  If the seeds are placed 
separated in isolated areas (e.g. a filter) the seeds can grow and be isolated in a simple 
manner.  
Point B’ represents the case in which a lack of water is present. Then, when the equilibrium 
has been reached, the mother liquor will have composition D’ and the solids composition 
C’. This means that a mixture of (±)-phencyphos, (–)-phencyphos hydrate and (+)-
phencyphos hydrate will be isolated. 
An experimental setup as depicted in Figure 6.12 was constructed in which the “U” shaped 
lines represent soxhlet filters which are placed inside a plastic casing. The filter on the left 
is charged with a suspension of 10 gram of anhydrous (±)-phencyphos in 30% wt. H2O in 
MeOH (226 mL). The middle filter is charged with ~200 mg enantiopure (–)-phencyphos 
hydrate seeds and the filter on the right with ~200 mg enantiopure (+)-phencyphos hydrate. 
A pump transports the saturated filtrate to the filter on the left where it dissolves some of 
the metastable anhydrous (±)-phencyphos which gives a solution that is supersaturated in  
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phencyphos hydrate. This solution passes on to the middle filter in which the supersaturated 
(–)-enantiomer crystallizes on the seeds of the (–)-phencyphos hydrate. The supersaturated 
(+)-enantiomer passes though the filter and crystallizes on the seeds of the (+)-phencyphos 
hydrate in the filter on the right. The filtrate from this filter is then pumped to filter on the 
left for another run. 
 
Figure 6.12 Schematic representation of the resolution of (±)-phencyphos 
by pseudo polymorphic transition. 
After 3 days the filters were inspected and the filter on the left contained 270 mg of racemic 
material, the middle filter contained a dense cake of 3.30 gram of (–)-phencyphos hydrate 
with 98% ee (without further washing) and the filter on the right contained a dense cake of  
3.70 gram of (+)-phencyphos hydrate with 99% ee (without further washing). Because the 
solution also contained some phencyphos, the sum of all filter contents is not equal to the 
amount of material put into the top filter. 
6.5   Discussion 
It has been shown that the resolution of phencyphos can be performed by diastereomeric 
salt formation with cinchonidine. However, this relatively expensive resolving agent has to 
be recycled and the isolated diastereomeric salts have a maximum of 74% de. These solids 
have to be recrystallized after liberation to enrich the phencyphos to >99% ee with a 
maximum yield of 37% for each enantiomer. In practice this yield will be lower because of  
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loss of material on filters and washings, incomplete or unwanted crystallization during 
filtration of the diastereomeric salt and not optimal conditions during recrystallization of 
the hydrate. 
Since phencyphos hydrate crystallizes as a conglomerate, resolution by entrainment can be 
performed. This process, although quite laborious, has a yield of 41% for each enantiomer. 
Almost no waste is produced since the mother liquor is recycled after each run up to 50 
runs depending on the purity of the racemate. Furthermore, no expensive resolving agent 
has to be used (and recycled). Sometimes, premature nucleation of the unwanted 
enantiomer was observed. This may be prevented to a large extend by filtration at a higher 
temperature or by a more dilute entrainment procedure. In total, 30 kg of each enantiomer 
have been prepared. 
The resolution by hydrate formation as described in §6.4 seems to be an ideal method to 
resolve anhydrous (±)-phencyphos by a pseudo-polymorphic transition into the hydrate. 
However, a large scale application still is troublesome since filters become clogged easily 
and the process is relatively slow and a lagging supersaturated liquid phase could start 
primary nucleation and ruin the process. Perhaps with some optimization, this type of 
resolution might be useful for the resolution of conglomerates which form hydrates/solvate 
or have a metastable polymorph. 
6.6   Experimental Section 
General Information: Reagents were obtained form commercial sources and used without 
further purification.  
Chiral HPLC analysis of phencyphos (phencyphos) salts was carried out on a Chiralpak 
QN-AX column with MeOH:AcOH 97:3 + 0.25g NH4OAc/100 mL as mobile phase at 
room temperature and 1.5 mL·min
-1. UV-VIS detection was performed at 254 nm. The free 
acid or the corresponding salts were dissolved in MeOH and injected as such. (+)-(S)-
phencyphos Rf: 7.34 min, (–)-(R)-phencyphos Rf: 8.44 min. 
IR spectra were recorded on a Thermo Nicolet 380 FT-IR with Smart Orbit. 
Procedure for the construction of phase diagrams as depicted in Figure 6.6, Figure 6.7 
and Figure 6.8: Just enough (±)-phencyphos·0.84H2O to achieve a suspension, was 
slurried in known mixtures of water and DMSO, DMF or MeOH for a couple of days at 
20°C. After removal of the solid phase the composition of the mother liquor was 
determined by weighing the weight loss after evaporation of the solvents in vacuo. The 
solubility of (±)-phencyphos in several pure solvents (Table 6.3) was performed in a similar 
fashion.  
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Procedure for the entrainment of phencyphos as described in §6.3.4: A temperature 
controlled (Huber Unistat 510) 40L double jacketed glass reactor was charged with (±)-
phencyphos·0.84H2O (861 g, 3.35 mol, 1.0 eq), water (9.25 L) and MeOH (27.75 L) and 
stirred at 300 rpm throughout the entrainment.  
 
Figure 6.13 Temperature program for the resolution by entrainment of 
phencyphos hydrate. 
The mixture was biased with (–)-phencyphos hydrate (137 g, 0.52 mol, 0.16 eq) and a 
temperature program was run where the internal temperature was heated from 28.9°C to 
54.0°C as fast as possible for 46 minutes and then cooled to 28.9°C as fast as possible for 
81 minutes and then the temperature program was repeated. The temperature profile is 
depicted in Figure 6.13.  
Solids were collected (P2) 10 minutes prior to the reheating to 54.0°C. Filter cakes were 
sucked dry but not washed. Chiral HPLC analyses (as described above) on the solids 
showed were measured. If the solids had an ee greater than 85%, (±)-phencyphos·H2O (270 
g, 1.04 mol, 0.31 eq) was added to the filtrate. If the collected solids had 0% ee, more water 
was added and the entrainment repeated with the filter cake. If the collected solids had ee 
between 30% and 85% the entrainment was repeated with the filter cake replacing some  
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filtrate by MeOH. In a typical run, solids were collected with an average ee of 93%. 
Combined enriched batches were heated and subsequently cooled in a mixture of 30% wt. 
H2O in MeOH to give crystals with >99% ee after filtration. In practice the whole 
resolution process yielded 41% of each enantiomer of optically pure phencyphos hydrate. 
Procedure for testing of nucleation inhibition of phencyphos hydrate as described in 
§6.3.5: Six tubes were charged each with 50 mg (±)-phencyphos·0.84H2O and 1.70 mL 
30% wt. H2O in MeOH. These mixtures were heated to reflux (dissolution) and 
subsequently cooled to 20°C with stirring (600 rpm). The time before the first crystals 
appeared was denoted. Three of these tubes were charged with respectively 1.4, 1.6 and 1.5 
mg (±)-anicyphos. The other three tubes were charged with respectively 1.1, 1.4 and 1.2 mg 
(±)-chlocyphos. The contents of the tubes were recrystallized as described above and the 
crystallization time was denoted. 
Procedure for the resolution by hydrate formation as described in section 6.4  A batch 
commercial (±)-phencyphos was recrystallized from MeOH to obtain the anhydrous (±)-
phencyphos. The top soxhlet filter (35 × 150 mm) was charged with 10.0 gram of this 
material and the filter was put in a HDPE single-use casing (without filter) for automated 
column chromatography (44 × 224 mm) from Semco. (–)-(R)-phencyphos hydrate was 
prepared by recrystallization of (–)-phencyphos from 30% wt. H2O in MeOH. A few drops 
of this suspension (~200 mg phencyphos) were added to the middle soxhlet filter and 
plastic casing as described above. The charging of the soxhlet with (+)-(S)-phencyphos 
hydrate was performed in a similar fashion as for (–)-(R)-phencyphos hydrate. A mixture of 
water and MeOH (30% wt. H2O, 150 mL) was added to the top filter and when the solution 
arrived at the bottom of the setup, it was pumped to the top filter by a Liquiport NF300 
pump with the slowest pump speed. After 3 days the top filter contained 270 mg of racemic 
material, the middle filter contained a dense cake of 3.30 gram (+)-phencyphos hydrate 
with 98% ee (without further washing) and the bottom filter contained a dense cake of  3.70 
gram (with 99% ee) (–)-phencyphos hydrate (without further washing). 
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Future Prospects 
 
 
 
 
 
In this chapter some future prospects are given for a continuation of the research 
on direct crystallization of racemic compounds and additives which aid the 
diastereomeric salt resolution. Furthermore, some processes are described which 
allow racemic compounds to be resolved by crystallization or attrition enhanced 
Ostwald ripening. Finally, a method is introduced to determine whether a 
racemate is a conglomerate or not.  
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7.1   Nucleation Inhibitors for Diastereomeric Salt 
Formation 
As described in Chapter 3, in a resolution by diastereomeric salt formation, additives with 
two or three repeating structures that resemble either the resolving agent or the racemate are 
very effective nucleation inhibitors. A new class of additives can be envisioned that 
combine even more functional groups. Functionalized soluble polymers have been shown 
to be effective as nucleation inhibitors in the resolution of conglomerates.
1  
7.1.1  Polyfunctional Nucleation Inhibitors 
Once the polymer is in close proximity of a crystal nucleus several ‘dockings’ can take 
place since the functional groups in such a polymer are packed closely together. This 
process should very effective and block the growth of the nucleus. 
The synthesis of a soluble polymer that might be an effective nucleation inhibitor for 
1-phenylethylamine derivatives is shown in Scheme 7.1. 
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Scheme 7.1 Suggested synthesis of a polymer nucleation inhibitor based 
on 1-phenylethylamine 
A commercially available polyglycerol 7.1 of an appropriate length and branching reacts 
with tosyl chloride to furnish compound 7.2. This compound is allowed to react with 
phenol 7.7, which is synthesized from acetophenone 7.5 via a Leuckart-Wallach reaction,
2 
hydrolysis and Boc-protection. The reaction of 7.2 with 7.7 gives compound 7.3.  
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Deprotection of the Boc-group will furnish 7.4. The intermediate 7.6 can be resolved with 
an appropriate resolving agent. 
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Scheme 7.2 Suggested synthesis of a polymer additive based on 
(S)-mandelic acid. 
Furthermore, additives based on mandelic acid may be designed in a similar fashion as 
depicted in Scheme 7.2. Starting from (optically pure) methyl mandelate 7.10 and tosylate 
7.2 compound 7.8 can be isolated. Deprotection of the ester will give the functionalized 
polymer 7.9. Although this synthesis is short and simple, the solubility of the polymer 
might be low. 
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Scheme 7.3 Suggested synthesis of a polymer based on both mandelic 
acid and 1-phenylethylamine.  
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A polymer which is functionalized with both the resolving agent and the racemate might be 
a very effective nucleation inhibitor. If one-half equivalent of methyl mandelate 7.10 is 
allowed to react with the tosyl protected polyglycerol 7.2 and after complete conversion, 
one-half equivalent of Boc-protected amine 7.7 is then allowed to react with the remaining 
tosylates of the polymer backbone, compound 7.11 is expected as product. Deprotection of 
the Boc- and methyl ester-groups will furnish compound 7.12. 
Another variation of this ‘mixed’ polymer is the synthesis of polymers with a family of, 
say, substituted mandelic acids. More variety in the polymer might promote ‘docking’ at 
several places on the nucleus. Such a polymer might be a more generic nucleation inhibitor 
for several different resolutions with the same resolving agent (or family). 
In Chapter 3.2.3, the bifunctional achiral additive 7.13, depicted in Scheme 7.4, was found 
to, our surprise, to be a potent inhibitor. This compound was found to be a nucleation 
inhibitor and a growth inhibitor in the resolution of racemic 1-(3-methoxy-
phenyl)ethylamine with optically pure mandelic acid. Furthermore, with the same 
diastereomeric salt pair, this additive proved to be able to redissolve the crystallized more 
soluble diastereomer as described in Chapter 4.4.1. Perhaps reaction of polyglycerol with 2-
(4-fluorophenyl)propan-2-amine could give polymer 7.14, parallel to the reactions 
described above. 
NH2 H2N O
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H HO
n
H
H
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Scheme 7.4 Achiral inhibitors and based on 1-phenylethylamine. 
7.1.2  1-PES 
In good resolving agents, the acidic or basic moiety is closely located to the chiral center. In 
this manner, there is a large structural difference between both diastereomeric salts which 
can result in different solubilities. Furthermore, it should form crystalline salts, which in 
practice means the ability to form a hydrogen bonding network.
3  
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Although 1-phenylethyl sulfonic acid (1-PES) shows great potential as a resolving agent 
and has been known for some time, it has not been used much in resolutions by 
diastereomeric salt formation.
4 Actually, the synthesis of 1-PES is quite easy,
5 as shown in 
Scheme 7.4. 
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Scheme 7.5 The synthesis of optically pure 1-PES. 
The first step in the synthetic route is the reaction of commercially available racemic 
1-chloro-1-phenylethane (7.15) with sodium sulfite to give sodium salt 7.16. Furthermore, 
synthetic routes that use 1-bromo-1-phenylethane with or without a phase transfer catalyst 
are also known.
6,7 The racemate can then be resolved with L-4-hydroxyphenylglycine (7.17) 
to produce both enantiomers of 1-PES optically pure.
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Scheme 7.6 Additives based on 1-PES.  
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A suitable resolution (high yield, low de and preferably no end-solid solution) with 
optically pure 1-PES and a racemate may be improved by use of proper additives. Some 
possible additives are shown in Scheme 7.6. 
The synthesis of compounds 7.18 to 7.22 should not be difficult and may be accessible via  
similar routes as given in Scheme 7.5 and §7.1.1. As described in Chapter 3, racemic 
additives may be used to screen for a nucleation inhibition effect. 
7.26
SO3R RO3S
7.24
SO3H HO3S
Esterification
7.25
SO3R RO3S 1) BuLi
2) iodomethane
7.23
SO3H HO3S
Saponification
 
Scheme 7.7 Proposed synthetic scheme for a achiral bissulfonic acid. 
The achiral bissulfonic acid 7.23 could be synthesized by starting with alkylation of ester 
7.24 as is known from the literature.
8 Subsequently, saponification of ester 7.25 would 
furnish the target compound 7.23 as depicted in Scheme 7.7. 
7.2   Racemizable Conglomerates 
In a classical resolution, the unwanted enantiomer is regarded as waste. The process will be 
more economical if the unwanted enantiomer can be racemized and recycled. Such a 
process, Dynamic Kinetic Resolution (DKR), can produce in principle 100% yield and 
100% ee.  
In Chapter 5.5, it was shown that racemizable conglomerates can be made into optically 
pure compounds by heating, cooling, racemization in solution and grinding in a short time 
frame. 
It should be possible to adapt this methodology to existing or new drugs by making them 
racemizable somewhere in the synthetic route. By functionalizing a non crucial part of the 
molecule (e.g. protective group or by salt formation) conglomerates could be found by, for 
example, Second Harmonic Generation (SHG) as discussed in Chapter 5.6.1 or a new 
technique as described in section 7.4.  
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7.3   Like Resolves Like 
On crystallizing optically pure phencyphos and when several racemic family members were 
added, these were selectively incorporated with the same absolute configuration as shown 
in Chapter 4.4. One could imagine a process in which one poorly soluble pure enantiomer 
is crystallized in a solution of a very soluble racemic family member. These compounds 
should form a solid solution for this principle to work as is explained below.  
Figure 7.1a represents a theoretical phase diagram for four compounds: pure enantiomer: 
AR, both enantiomers of compound B: BS, BR and solvent (S). The solvent is directed 
upwards to infinity, hence, the top of the prism is open. The front side of the prism 
represents solid solution formation of mixtures of AR
 and BR. The left-back side of the 
prism represents mixtures of AR and BS. These do not show interaction and thus have 
conglomerate like solubility lines. The right-back side of the prism represents the 
conglomerate forming enantiomers of compound B (BR and BS). The inside of the prism 
thus represents mixtures of all these compounds. It is clear from the phase diagram that AR 
(point a) has a lower solubility than compound B (points b and c). 
In Figure 7.1b the same phase diagrams is represented in a Jänecke projection.
9 The lines in 
the Jänecke projection represent the monovariant lines (eutectics) of the bivariant surfaces 
(solubility planes) from Figure 7.1a, viewed from above. The arrows in the Jänecke 
projection, point to the highest solubility (lowest point in Figure 7.1a). Although some 
information is lost, such a projection might be easier to read since it is not three 
dimensional. 
Starting from an undersaturated racemic mixture of compound B, represented by point d, a 
small amount of AR is added so point e represents the total composition of the system 
which is located along line (d,AR). After a recrystallization, the resulting suspension may 
be filtered. The mother liquor will then have composition f and the solids composition g. 
As can be seen from both figures, addition of a small amount of a ‘chiral chaperone’ AR 
results in solids which consist of only ~15% AR and the rest of  ~85% consists of  BR (point 
g). Furthermore, the composition of point g is 100% ee for both compound A and B. 
Of course, resolution of a racemic conglomerate (compound B) as in Figure 7.1 can be 
performed by direct crystallization as described in Chapter 1.4.3.3 also. However, 
resolution by direct crystallization of a racemic compound is not possible.
10 
Figure 7.2 represents the case where the to be resolved compound is a racemic compound 
(compound B). In the same manner as the previous example, a mixture of AR and a solution 
of slightly undersaturated racemic B (point d) will give point e. Recrystallization will give 
a mother liquor (point f) and the solids will have composition g which has a higher AR  
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content compared to the previous example in Figure 7.1. However, the solids will still only 
contain optically pure BR. Even higher yields may be obtained when compound B is 
racemized during the crystallization. Since only optically pure AR is used, it does not matter 
whether compound A crystallizes as a conglomerate or a racemic compound. 
 
Figure 7.1 Theoretical phase diagram a) exploded view with solvent to 
infinity b) Jänecke projection.  
Note that this concept resembles the ‘replacing and preferential crystallization’ proposed by 
Shraiwa et al
11 where an optically pure additive is used to induce crystallization of a single 
enantiomer of an supersaturated conglomerate with the same absolute configuration. 
However, Shraiwa states that a conglomerate is needed for this concept to work and 
requires an oversaturated solution of the conglomerate. The process described above in this 
paragraph shows that both are actually not required. Such a resolution has already been 
described by Collet et al although the incorporation was only 8% in mass.
12 
To conclude, a resolution by addition of a chiral chaperone as described above can only 
work with two structurally related compounds that can form solid solutions forming 
compounds and thus structurally closely related: family members as is known from the rule 
of Kitaigorodskii.
13 The rule of Kitaigorodskii states that the ratio between the overlap and  
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the non-overlap between molecules represents the likelihood of solid solution formation 
and thus the percentage of co-crystallization. Furthermore, the amount of the chiral 
chaperone in the isolated solids depends on the solubility difference between AR (point a) 
and the solubility of racemic B (and thus the position of point d). 
 
Figure 7.2 Theoretical phase diagram a) exploded view with solvent to 
infinity  b) Jänecke projection. 
Finally, when a slight excess of BS is present, this system can still deliver BR when (more) 
AR is added. 
A practical application of the above procedure could be two consecutive compounds in a 
synthesis as depicted in Scheme 7.8. Using a racemic chloride 7.26 and as chiral chaperone 
the same compound, for example reduced and optically pure (7.27), this could deliver an 
optically pure mixture of the chlorinated and reduced material. By reduction of the chloride 
7.26a, optically pure 7.27  could be isolated and a part could then be used as chiral 
chaperone for the next resolution batch. Note that, as described above, it does not matter 
whether either 7.26 or 7.27 is a conglomerate or a racemic compound. The only 
requirement is that the compounds form a solid solution together. From the rule of 
Kitaigorodskii
13 it follows that the formation of solid solutions between two compounds  
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that differ in only one atom will be more likely if the molecules are large and thus the 
differences between the compounds are minimal. 
+
Pd/C, H2
7.26
7.27
7.26a 7.27 7.27
Cl
R1 R2
Cl
R1 R2 R1 R2 R1 R2
R1 R2
 
Scheme 7.8 Route for the synthesis of an optically pure amine. 
7.4   Finding Conglomerates 
Resolution by direct crystallization (described in §1.4.3.3) only is feasible if a racemate 
crystallizes as a conglomerate. Such a process is attractive since no resolving agent is 
required. However, since only 5-10% of all racemates are conglomerates,
10a one finds 
him/herself screening derivatives of the to be resolved compound in order to find a 
conglomerate which can be resolved by direct crystallization and subsequently converted 
into the desired product. 
The screening process often requires the racemate and one of the pure enantiomers.
14 
Second Harmonic Generation (SHG) requires only the racemate, however, the accuracy is 
90% and additional screening has to be performed. If one has the access to an expensive 
single crystal X-ray diffractor and large crystals of the racemate, the analysis of a single 
crystal of a conglomerate will show that this crystal contains only one enantiomer. 
In §5.6 a slightly supersaturated solution of DL-threonine (a conglomerate) was crystallized 
under abrasive grinding conditions. The first formed crystal should be either a pure D- or 
pure L-crystal. This crystal is readily ground up by the grinding action of the stirrer (or even 
better by addition of glass beads) and produces more crystals and thus more crystal surface 
which consumes the supersaturation of this enantiomer. Shortly after the primary nucleation 
event of, say the D-enantiomer, the L-enantiomer will start to crystallize. By filtering the 
suspension shortly after crystals are observed, often, a significant enantiomeric enrichment 
is found in one of the enantiomers. By waiting too long before the isolation of the solids, 
the other enantiomer will have crystallized also and racemic solids will be found.   
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The process described above might be a general method to find conglomerates. The 
racemate should then be suspended in a solvent at, say 25.0°C. After a while, the racemate 
is filtered to produce a solution that is saturated in both enantiomers. This solution is then 
stirred vigorously and cooled to, say 24.0°C, to produce a slight supersaturation. This 
solution then is monitored manually for produced solids which are subsequently isolated. 
Racemic compounds will, of course always produce completely racemic solids as will 
solids solutions. Some racemic conglomerates form crystals that display alternating regions 
(plates or rods) of both pure enantiomers. During the crystallization, an enantiopure crystal 
forms a template for the other enantiomer to grow on. This phenomenon is known as 
epitaxy.
15 It may be possible that racemates that display this epitaxial growth may not give 
a significant ee in the crystallized solids. On the other hand, these compounds will not be 
suitable for a resolution by direct crystallization anyway. 
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De Nederlandse samenvatting is een hoofdstuk voor diegene die wel bekend zijn 
met chemie maar niet zozeer met chiraliteit en het scheiden van zogenoemde 
enantiomeren door kristallisatietechnieken die beschreven staan in dit proefschrift. 
Ook worden hier enkele resultaten besproken die tijdens het promotieonderzoek 
gevonden zijn. NEDERLANDSE SAMENVATTING 
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Chiraliteit 
Als een molecuul gespiegeld wordt en dit spiegelbeeld niet ruimtelijk identiek is aan het 
origineel, spreekt men over chiraliteit. Zoals te zien is in Figuur 1 levert verbinding 1 geen 
andere verbinding op als hij gespiegeld is. Bij het roteren van het spiegelbeeld wordt 
immers het origineel terug gevonden. Maar als verbinding 2, waarbij het stikstof atoom 
naar voren staat en het waterstof atoom naar achteren, gespiegeld wordt, levert dit 
verbinding  3 op. Door het draaien van verbinding 3 wordt nooit verbinding 2 terug 
gevonden. Deze spiegelbeeldmoleculen worden enantiomeren genoemd en een 1:1 mengsel 
van enantiomeren wordt racemaat genoemd. 
O
Spiegelvlak Spiegelvlak
O
11
NH2
Me
H
2
NH2
Me
H
3
 
Figuur 1 Achirale moleculen en chirale moleculen. 
Enantiomeren hebben exact dezelfde fysische eigenschappen (smeltpunt, kookpunt, kleur 
etc.) en zijn alleen te onderscheiden doordat ze gepolariseerd licht respectievelijk naar links 
of naar rechts draaien of door verschillende interacties met een andere zuiver enantiomeer.  
Het proces van het scheiden van enantiomeren wordt een splitsing genoemd (ook wel 
resolutie). De meest gebruikte methode voor de splitsing van enantiomeren is door 
diastereomere zoutformatie zoals hier onder beschreven.  
Door een racemaat te laten reageren met een zuiver enantiomeer van een andere verbinding 
(een zogenaamd splitsingsmiddel) ontstaan diastereomeren. In het voorbeeld in Figuur 2 
wordt een diastereomeer zout gemaakt met amandelzuur (4). Diastereomeren zijn geen 
spiegelbeeld moleculen en hebben dus andere fysische eigenschappen die gebruikt kunnen 
worden om ze te scheiden. De eenvoudigste manier om deze diastereomeren te scheiden is 
door ze te laten kristalliseren vanuit een verzadigde oplossing waarbij het ene 
diastereomeer beter oplost dan het andere. Dit wordt ook wel klassieke resolutie genoemd. 
Er zijn echter ook andere methoden om enantiomeren te scheiden. 
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Figuur 2 Diastereomeren, geen spiegelbeelden. 
In ongeveer 10% van alle racematen, kristalliseren beide enantiomeren elk uit in hun eigen 
kristal. Elk van deze kristallen zijn dus enaniozuiver hoewel alle kristallen bij elkaar 
racemisch zijn. Deze kristalvorm wordt conglomeraat genoemd en is voor het eerst 
gebruikt in 1848 door Louis Pasteur. Hij nam de kristallen van een racemisch mengsel van 
het natrium ammonium zout van wijnsteenzuur en kon beide kristalvormen met de hand 
scheiden omdat de kristallen elkaars spiegelbeeld zijn zoals te zien is in. 
 
(R) NaO2C
OH
CO2NH4
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Figuur 3 Beide kristal vormen en enantiomeren van het natrium 
ammonium zout van wijnsteenzuur. 
Kristallisatie 
Wanneer een oplossing van een verbinding (chiraal of niet) oververzadigd is betekend dit 
dat het de opgeloste verbinding liever bijvoorbeeld een kristal vormt (uitkristalliseert) dan 
opgelost blijft. Kristallisatie begint met nucleatie, het proces waarbij moleculen van de 
verbinding in de oplossing beginnen met samenklonteren in een geordende manier. Deze 
(nog onzichtbare) kernen lossen weer op of groeien dan verder tot zichtbare kristallen. Als NEDERLANDSE SAMENVATTING 
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het evenwicht zich ingesteld heeft zal er een verzadigde oplossing met kristallen 
overblijven. 
Het Effect van Onzuiverheden 
Onzuiverheden, al dan niet opzettelijk aangebracht kunnen het kristallisatieproces van elk 
van de verbindingen in oplossing ernstig beïnvloeden. Als een verbinding interactie 
vertoont met bepaalde vlakken van een kristal dan zal de snelheid waarmee dit vlak groeit 
langzamer worden. Omdat de rest van de vlakken door blijven groeien, zal het uiterlijk van 
het kristal anders worden. In het voorbeeld in Figuur 4 wordt de groei de kleine facetten 
van het grijze kristal afgeremd door een groei-inhibitor. Het lange facet van het kristal kan 
dus doorgroeien en zal kleiner worden totdat het uiteindelijk verdwijnt en er een vierkant 
kristal overblijft. Dus, hoe groter het facet, hoe langzamer het groeit. 
 
Figuur 4 Groei-inhibitie van de kleinste vlakken van het grijze kristal. 
Het is bekend dat het toevoegen van kleine hoeveelheden van optisch zuivere verbindingen 
die lijken op bijvoorbeeld een conglomeraat dat gaat kristalliseren, het tegenovergestelde 
enantiomeer oplevert. Met andere woorden, het enantiomeer dat lijkt op de onzuiverheid 
wordt in de oplossing gehouden doordat deze de nucleatie bemoeilijkt terwijl het andere 
enantiomeer niet wordt beïnvloed en dus gewoon kan kristalliseren. Een dergelijke 
onzuiverheid wordt dan een nucleatie inhibitor genoemd. Ook de kristallisatie van 
diastereomere zouten kunnen beïnvloed worden door het toevoegen van nucleatie 
inhibitoren. Deze moeten dan lijken op het racemaat of het splitsingsmiddel. Het 
splitsingsmiddel is in beide diastereomere zouten met dezelfde absolute configuratie 
aanwezig. Maar omdat diastereomeren geen spiegelbeeld moleculen zijn, zullen nucleatie  
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inhibitoren, die op het splitsingsmiddel lijken, op elk van de diastereomeren anders werken 
en bijvoorbeeld de kristallisatie van het beter oplosbare diastereomeer wel verstoren maar 
die van het minder oplosbare diastereomeer niet. 
Dutch Resolution 
In 1998 hebben Nederlandse wetenschappers een nieuwe methode ontwikkeld om een 
splitsing uit te voeren door diastereomere zoutformatie, door niet gebruik te maken van één 
splitsingsmiddel maar van drie tegelijkertijd, een mix. Zo waren ze in staat om splitsingen 
uit te voeren die met elk van de splitsingsmiddelen apart niet waren gelukt. Deze techniek 
werd Dutch resolution gedoopt en bleek meer kans op succes te geven dan een klassieke 
resolutie. De kans om in een klassieke resolutie bij de eerste zouten een redelijke verrijking 
te krijgen is geschat op 20–30% en voor Dutch resolution ligt dit op 90–95%. 
De drie splitsingsmiddelen moeten familieleden van elkaar zijn, dus structureel veel op 
elkaar lijken zoals te zien in Figuur 5. De afgebeelde mix van splitsingsmiddelen is 
gebaseerd op amandelzuur (4) en wordt de M-mix genoemd. 
CO2H
OH
4
CO2H
OH
5
CO2H
OH
6
Me Br
 
Figuur 5 Familie van amandelzuren: de M-mix 
Het bleek dat van de drie splitsingsmiddelen in een dergelijke mix soms maar twee werden 
ingebouwd. Als het niet ingebouwde splitsingsmiddel er uit werd gelaten dan bleek soms de 
splitsing veel minder effectief te zijn dan daarvoor. Dit niet ingebouwde splitsingsmiddel 
fungeerde dan als nucleatie inhibitor.  
Dit Proefschrift 
De inhoud van dit proefschrift gaat vooral over het maken van enantiozuivere verbindingen 
door het toepassen van diverse technieken die het kristallisatieproces beïnvloeden. Eerst 
wordt in hoofdstuk 1 de geschiedenis weergegeven van chiraliteit en de toepassing van 
chiraliteit in het dagelijks leven. In hoofdstuk 2 wordt kristalgroei en het effect van 
additieven hierop beschreven. Tevens worden fase diagrammen beschreven en de noodzaak 
hiervan voor het voorspellen van splitsingen. NEDERLANDSE SAMENVATTING 
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In hoofdstuk 3 wordt klassieke resolutie verbeterd door nucleatie inhibitoren toe te voegen 
aan splitsingen. De nucleatie inhibitoren zijn zo ontworpen zodat ze familieleden zijn van 
het splitsingsmiddel of het racemaat. Het bleek dat verbindingen die lijken op twee of meer 
aan elkaar gekoppelde racemaat moleculen of splitsingsmiddel moleculen zeer potent 
waren. Ook kon op redelijke schaal een splitsing worden uitgevoerd die verbeterd werd 
door het toevoegen van een nucleatie inhibitor. Zelfs na het toevoegen van enten van de 
beter oplosbare diastereomeer, kristalliseerde deze niet verder uit. Naast nucleatie inhibitie 
werd ook groei inhibitie gevonden zoals in Figuur 4 al is aangegeven. 
Additieven die worden toegevoegd aan een splitsing kunnen zorgen voor nucleatie inhibitie 
en groei inhibitie maar ook andere effecten kunnen gevonden worden. Deze effecten staan 
beschreven in hoofdstuk 4 waarin ook een methode wordt beschreven om met een één 
enantiomeer, andere racemische familieleden met dezelfde absolute configuratie te laten 
kristalliseren in hetzelfde kristal. Ook wordt er een methode beschreven om het 
diastereomere zout uit hoofdstuk 3 te splitsen door het toevoegen van een additief aan de 
suspensie van beide diastereomeren en deze te malen. 
Het malen van kristallen kan ook andere effecten geven, zoals beschreven staat in 
hoofdstuk 5. Door een suspensie te nemen van een racemisch conglomeraat dat racemiseert 
in de oplossing en deze een maand lang fijn te malen bestonden de kristallen slechts uit één 
enantiomeer. Deze methode is aangepast om met malen binnen één uur één enantiomeer te 
geven vanuit volledig racemisch materiaal. Als een mengsel van vijf verschillende 
racemiseerbare aminozuurderivaten werd genomen en deze werden gekristalliseerd onder 
malen, gaf dit kristallen met een willekeurige absolute configuratie. Wel waren alle 
aminozuurderivaten ingebouwd in de gevormde kristallen met dezelfde absolute 
configuratie.  
De splitsing van phencyphos staat beschreven in hoofdstuk 6. Phencyphos is een zeer goed 
splitsingsmiddel maar is als racemaat lastig te splitsen tot enantiozuiver phencyphos. In 
hoofdstuk 6 staat de route beschreven die is bewandeld om tot een succesvol proces te 
komen. Dit proces is opgeschaald wordt op mol-schaal uitgevoerd bij Syncom BV. Ook 
wordt een nieuw proces beschreven waarin een spontane splitsing plaats vindt door hydraat 
formatie van racemisch phencyphos. 
Met de bevindingen van hoofdstuk 3 in het achterhoofd, worden in het laatste hoofdstuk 
een aantal ideeën gegeven voor nieuwe nucleatie inhibitoren. Tevens staan er een aantal 
nieuwe splitsingsmethoden in die zijn afgeleid van experimenten uit hoofdstukken 4 en 5.  
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Dankwoord 
Na 4 jaar promotieonderzoek ben ik aangekomen bij het laatste gedeelte: het schrijven van 
het dankwoord. Zoals zo velen al voor mij schreven: een promotieonderzoek doe je niet 
alleen. Daarom wil ik een aantal mensen bedanken voor hun bijdrage tijdens mijn 
promotieonderzoek. Ten eerste wil ik mijn tweede promotor, Prof. Kellogg, erg bedanken 
voor de goede begeleiding en de leuke en inspirerende discussies die we hebben gehad 
tijdens het promotieonderzoek. Prof. Minnaard wil ik bedanken om tijdens de laatste fase 
van mijn promotieonderzoek mijn eerste promotor te worden en voor de snelle correcties 
van het proefschrift. Verder wil ik via deze weg de algemeen directeur van Syncom B.V., 
Ton Vries bedanken voor het geven van deze kans en het vertrouwen in een goede afloop 
van mijn promotieonderzoek. 
Starten met een project dat Ultimate Chiral Technology (UCT) heet schept hoge 
verwachtingen. Gelukkig verliep het samenwerkingsproject met Rijksuniversiteit 
Groningen, Radboud universiteit Nijmegen en DSM zeer voorspoedig en mag ik wel 
zeggen dat dit interdisciplinaire project zijn vruchten heeft afgeworpen. Daarom wil ik 
Thomas Jerphagnon, Hans de Vries, Jorge Verkade, Floris Rutjes, Elias Vlieg, Willem van 
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